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Fibronectin positive cells, probably derived from the meninges, 
were found to be the major contaminant of astrocyte-enriched cultures. 
4) Astrocytes and meningeal cells in vitro contained glycogen and 
+ both cell cultures responded to changes in the extracellular K 
concentration ([K+J o ) by alterations in glycogen metabolism. The 
+ 
effects of changes in [K J o on astrocyte and meningeal cell culture 
glycogen content were different. Astrocytes responded to smaller 
. + 
changes Ln [K J o than did meningeal cell cultures. 
5) Membranes prepared from astrocyte-enriched cultures possessed 
binding sites for three neurotransmitter receptor ligands [3 HJ _ 
d;hydroalprenolol, [3HJ-serotonin and [3HJ-QUinUClidinYl benzilate. 
Membranes prepared from meningeal cell cultures also possessed 
binding sites for [3HJ-dihydroalprenolol and [3Hl-serotonin but not 
for [3 HJ -quinuclidinyl benzilate. 
6) Noradrenaline, but not serotonin or carbachol reduced the 
glycogen content of astrocyte-enriched cultures. Compounds which 
raised the level of intracellular cAMP without interaction with 
neurotransmitter receptors, e.g. forskolin, also induced 
glycogenolysis in astrocyte cultures. Noradrenaline and forskolin 
also promoted net glycogen breakdown in meningeal cell cultures. 
7) Selective a- and B-adrenoreceptor agonists phenylephrine and iso-
proterenol respectively did not evoke changes in the net glycogen content 
of astrocyte-enriched cultures. In contrast, bot~ of these compounds 
caused net glycogenolysis in meningeal cell cultures. 
8) The action of noradrenaline on cell culture glycogen stores was 
not blocked by the a- and B-adrenoreceptor antagonists pheAtolamine 
and propranolol respectively, though these compounds themselves 
caused glycogenolysis. More selective a-adrenoreceptor subtype 
antagonists did not block the slight effect of phenylephrine on 
astrocyte glycogen content. In the case of yohimbine, an u
2
-
adrenoreceptor antagonist, the glycogenolytic action of phenylephrine 
was potentiated. Prazosin, an u 1adrenoreceptor antagonist, markedly 
reversed the action of phenylephrine on meningeal cell glycogen 
content. 
9) Reserpine treatment of astrocyte-enriched cultures caused a 
marked increase in glycogen content and in the efficacy of serotonin 
to evoke glycogenolysis. In contrast, reserpine treatment of 
meningeal cell cultures LA~&~ a net loss of glycogen. 
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CHAPTER 1 
General Introduction 
The 19th century anatomist Virchow was the first to divide the 
ceLls of the mammalian central nervous system (CNS) into two classes, 
the neurons and neuroglia (see Penfield, 1932; Privat, 1975; ~turrock, 
1975;· Privat and Fulcrand, 1977 for historical revi.ews). The early 
microscopists, some using the techniques of metallic impregnation 
of nervous tissue pioneered by Golgi (e.g. Golgi, 1885), further 
divided the neuroglia into subclasses, the macroglia comprised of 
astrocytes and oligodendrocyes, and the microglia (Weigert, 1895; 
Ramon y Cajal, 1909; Rio-Hortega, 1919). This thesis is primarily 
concerned with the biochemistry of one class of neuroglial cell, 
namely the cerebral cortical astrocyte. These cells are numerous, 
constituting approximately 15 - 20% of the total number of cells 
present in the cerebral cortex (Parnavelas et al, 1983). Until 
recently, they have been generally considered to constitute a packing 
tissue in the brain or to contribute to the blood-brain barrier (e.g. 
Peters et al, 1976). Recent evidence, such as the presence of neuro-
transmitter receptors linked to second messengers on astrocytes (see 
review by Van Calker and Hamprecht, 1980), has suggested a more 
dynamic role for astrocytes in CNS function. 
Since the early observations, extensive investigations using 
the light and electronmicroscope have resulted in a detailed analysis 
of the morphology and distribution of neuroglia in the adult and 
developing brain, a synopsis of which is given here (see Peters et 
al, 1976; Palay and Chan-Palay, 1977; Privat and Fulcrand, 1977; 
Parnavelas et al, 1983). 
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Astrocytes in the adult mammalian brain have a rounded 
perikaryon of about 9 - 10 ~m in diameter~ The cytoplasm 
characteristically contains glycogen granules and 9 - 10 nm 
diameter filaments which penetrate into the large number 
of branching processes which radiate from the cell body. Some of 
the processes form terminal expansions (end feet) which are applied 
to the surfaces of blood vessels, or are associated with a basement 
membrane and constitute a layer covering the surface of the brain, 
the glia limitans. Astrocytes are abundant in all parts of the eNS 
although their fine structure and morphology varies between regions. 
In the grey matter, astrocytes, whilst retaining the basic morphology 
previously described, generally contain fewer glial filaments than 
those in the white matter. Thus, following the original work by 
Weigert in 1895, grey matter astrocytes are termed protoplasmic 
and those in the white matter, fibrous. However, it must be noted 
that the difference in filament content between the two cell types 
is not always evident. For example, the "protoplasmic" astrocytes 
of the cerebellar grey matter (Golgi epithelial cells or Bergmann 
glial contain few filaments whilst the "protoplasmic" astrocytes 
of the inferior olive are very similar to fibrous astrocytes in 
this respect (cf. Peters et al, 1976). 
Oligodendrocytes are often described as more phase dark or 
electron dense cells than astrocytes when viewed by the light 
microscope or electronmicroscope. They do not contain glial 
filaments or glycogen granules and have finer, more delicate 
processes than astrocytes. The processes may contain myelin and 
wrap round some neuronal processes to form a myelin sheath. 
Microglial cells are smaller than astrocytes or oligodendrocytes, 
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often appearing more dark under the microscope than oligodendrocytes 
as the nucleus, containing heavy clumps of chromatin, constitutes 
most of the cell volume. Again, like "oligodendrocytes, they contain 
no glycogen or glial filaments in the cell body or in their rather 
broad processes. 
Macroglia and microglia, whilst both being Eermed neuroglial cells, 
have separate embryological origins. Microglial cells are mesodermal 
cells and are thought to be derived from,circulating monocytes which 
penetrate the nervous system from the vascular system early in development 
(see Ling, 1981, for review). In contrast, macroglial cells are 
neuroepithelial cells derived from the subventricular zone (SV) of 
the developing neural tube,although the exact course of their 
development is unclear. 
Initially, His (1889) suggested that neurons and neuroglia 
were formed from separate precursor cells dividing in the SV. 
However, Schaper (1897) proposed an alternative view, that the 
precursor cells in the SV were indeterminate and gave rise to 
cells which migrated out to the intermediate zone of the developing 
brain where they divided to yield neurons and neuroglia. 
Subsequently, Sidman et al (1951) and Fujita (1963; 1966) proposed 
that the mitotically active precursor cells in the SV first gave 
rise to neurons and then to neuroglial cells. However, glial cells, 
in particular the radial glial cells and Golgi epithelial cells 
whose processes span the width of the developing brain, were seen to 
be present at early stages during neurogenesis (Ramon y Cajal, 1911; 
Rakic, 1971; Antanitus et ai, 1976; Levitt et ai, 1983). It also 
became clear that a distinct population of dividing glial cell 
precursors co-existed with neuronal precursors (Skoff, 1980; 
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Rakic, 1981; Levitt et al, 1981; 1983). Therefore, it was 
proposed that at this stage neurons and glia were derived from 
separate stem cells as originally stated by His. Radial glia 
are thought to divide later in development (Schmechel and Rakic, 
1979) arid differentiate into mature astrocytes constituting some, 
but not all, of those found in the brain (see Rakic, 1981, for review 
also Pixley and de Vellis, 1984). Some oligodendrocytes are also 
believed to be formed from radial glia,as suggested by the electron-
microscopic and immunohistochemical studies of Choi et al (1983). 
Oligodendrocytes and one type of astrocyte, derived from the optic 
nerve, do indeed share a common precursor cell (Raff et al, 1983, 
1984; Temple and Raff, 1985), although it is not known whether this 
common precursor cell represents a radial glial cell. The 
differentiation of the macroglia is, as previously stated, not 
fully understood and is presently the subject of intensive examination 
in several laboratories. 
Since the early division of CNS cells into neurons and 
neuroglia it has become axiomatic that neurons are involved in the 
signal processing function of the CNS, whilst to the neuroglia 
have been ascribed a variety of supportive roles. Thus oligoden-
drocytes are considered to be responsible for the laying down of 
insulating myelin sheaths around some CNS neurons, analogous to the 
function of Schwann cells in the peripheral nervous system (see 
Johnston and Roots, 1976; Palay and Chan-Palay, 1977). Microglial 
cells have been assigned a role as CNS macrophages, removing damaged 
or effete material from the brain (Vaughn and Peters, 1974; Ling, 1981). 
Due to the highly complex nature of the mammalian cerebral cortex, 
many of those examining the function(s) of differentiated CNS glial 
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cells have sought to obtain. pure or enriched populations of 
astrocytes for study. Three methods have been used; the bulk 
separation of cells from the adult cortex, the primary culture of 
cells (usually derived from the ~Qocortex), or the use of 
clonal cell lines. The two former methods are reviewed more fully 
later (Chapter 2 and 3). Bulk isolation of astrocytes might be 
considered to be an ideal model for astrocytes in situ. Theoretically 
such a procedure should yield metabolically active, identifiable and 
intact cells with little contaminating material from other cell types. 
, 
It would have an advantage over in vitro preparations in that the 
astrocyte population would be obtained from a mature brain and thus 
be fully differentiated. This is unlike the growth of astrocytes 
in culture where the cells are derived from undifferentiated 
(perinatal) brain, maintained as a monolayer and, in the most part, 
in the absence of other cell types. The development of astrocyte 
function in vitro might therefore not follow the same course as that 
in vivo because possible inductive effects from other cell types may 
be removed. Similarly, clonal cell lines, i.e. cells derived from 
a naturally occuring or artifiCially produced tumour (transformed 
cells), may not express the same characteristics as non-transformed 
astrocytes in vivo (see Pf~~ffer, 1978, for review). In addition, 
cell lines are distinct from astrocytes in vivo and those in primary 
culture in that they possess the ability to divide continually 
over many cell cycles and,as such,constitute an immortal cell 
line. Furthermore, the most commonly used glial cell line, C6, 
induced in a rat by N-nitrosomethylurea in 1968 (Benda et aI, 1968), 
possesses mixed glial properties. For example, it not only expresses the 
astrocyte specific protein S-100 (Benda et aI, 1968) but also the 
oligodendrocyte specific enzyme glycerol phosphate dehydrogenase 
(see Van Calker and Hamprecht, 1980). 
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In spite of the interpretative problems associated with the 
use of primary cultures of astrocytes and glial cell lines, they 
have been used extensively a5 models for differentiated astrocytes 
in vivo, in the large part due to the numerous technical difficulties 
inherent in bulk isolation methods. It must however be borne in 
mind that they may not entirely reflect the astrocyte in vivo and, 
where possible, comparisons must be made to the behaviour of 
astrocytes in situ. 
A wide variety of functions have, however, been suggested for 
the astrocyte based on experiments using the techniques described 
above. Some of these roles are seen as either bio-
chemically or structurally supportive to the functions of neurons. 
. + For example, the clearance of potass~um (K ) released from active 
neurons into the extracellular space; (Walz and Hertz, 1984; see also 
Chapter 4 or this thesis), or. the guidance of migrating neurons (Rakic, 
" 
1971 et seq.). However, the wide range of proposed functions 
suggested for astrocytes do not fall readily into categories. For 
example the well documented ability of astrocytes to inactivate a 
wide range of neurotransmitters (Henn and Hamberger, 1971; 
Schousboe et al, 1976; Hertz, 1979; Kimelberg and Pelton, 1983; 
Hansson, 1983; Inoue et aI, 1984) overlaps, in the case of glutamate, 
with the removal of toxic ammonia. Thus the astrocyte_specific 
enzyme glutamin~ synthetase combines glutamate- and-ammonia to 
form .. glutamine .' (Sadasivudu et al, 
1977; Norenberg and Martinez-Hernandez, 1979). Similarly, the 
postulated release of trophic factors from astrocytes which influence 
the growth and division of neurons (Rudge et al, 1985) may overlap 
with a more direct metabolic support of neurons through the transfer 
of metabolic intermediates. For example, Selak et al (1984) suggest 
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that a transfer of pyruvate from astrocytes to neurons may 
constitute part of the trophic action of astrocytes on neurons. 
Shank and Campbell (1981; 1982; 1984a,b) and Yu et al (1983) have 
proposed that astrocytes may release pyruvate, a-ketoglutarate and 
malate,to be taken up and ut;i,lised by neurons as an energy source 
or to replenish amino-acid neurotransmitter pools. 
Thus astrocytes are generally viewed as nurse cells for 
neurons (Johnston and Roots, 1976). Indeed, astrocytes are 
localised between the-neuron and its ultimate source of energy 
which is glucose derived from the blood stream (Sokoloff, 1977; 
Siesjo, 1978). One characteristic feature of astrocytes is the 
abundance of the glucose polymer glycogen. Moreover, 
the astrocyte is intimately associated with the surface membrane 
of the neuron in situations where the cell or its axon are free 
from myelin (Wolff, 1970; Johnston and Roots, 1976; Peters et al, 
1976; Palay and Chan-Palay, 1977). Indeed Sotelo and Palay (1968) 
showed that in Deiter's nucleus, astrocyte processes were closely 
applied between the neuron and the myelin sheath. Thus astrocytes 
situated between, and in close. conjunction with, both blood supply 
and neuron are ideally situated to fulfil a nutritive or nurse cell 
role for neurons (Wolff, 1970). 
In invertebrates a role for neuroglial cells in the maintenance 
of energy supplies to neurons has also been proposed recently by 
Pentreath and co-workers (Pentreath, 1982; see also Chapter 4 of this 
thesis). Glycogen stored in glial cells in the leech Haemopsis 
sanguisuga and the snail Planorbis corneus is proposed to be a major 
store of energy which is utilised by the neuron during periods of 
increased activity. Furthermore, it is suggested that the turnover 
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of glial glycogen is under the control of neurons via changes in 
+ + 
extracellular K ([K] 0) whin are taken to constitute signal·s between 
neurons and glia. 
Previously it had only been suggested or presumed that the various 
supportive functions of glia were controlled by signals from neurons 
to glia (Galambos, 1961; Varon andSomjen, 1979). The term signal is 
used. here to describe any factor which is influenced by the behaviour 
of one cell type (e.g. neurons) and which in turn offects the behaviour 
of other cell types (e.g. astrocytes). Indeed many reports have shown 
+ 2+ 
that astrocytes are responsive to factors (signals) such as K ,Ca or 
neurotransmitters.which might be derived from, or influenced by, neurons 
(Orkand,. 1978; Van Calker and Hamprecht 1980; Latzkavits et al, 1982; 
Suginoet a~, 1984). 
Astrocyte processes ramify extensively throughout the CNS .and .are 
2 3 
believed to possess surface areas_constituting 10 - 40 cm /mm of 
neuropil, the fine, densely matted cellular processes which fill 
the "intercellular spaces" of the CNS. This represents a very 
large receptive field available for any signals which mi.ght be 
released by neurons. In addition the synapse is enclosed and 
invested by a~trocyte processes (Johnston and Roots, 1976; 
Peters et al, 1977; Palay and Chan-Palay, 1977). There are also 
reports of "synaptoid" contacts between neurons and glia in the 
mammalian CNS similar to classical synapses (Guldner and Wolff, 1973; 
Henrikson and Vaughn, 1974; Peters et al, 1976; wolff et al, 1979; ( 
Edmunds and Parnavelas, 1983) although the reported frequency of 
such contacts is low. Thus astrocytes in vivo may be exposed to 
neuronally released neurotransmitters. Moreover, the vertebrate CNS 
contains several groups of monoamine releasing neurons whose processes 
extend throughout the cerebral cortex and cerebellum but do not 
make typical synaptic contacts on other neurons. Such cells may 
release neurotransmitters over the surface of neurons and glia alike 
(Lapierre et al, 1973; Moore and Bloom, 1979; Lauder, 1983; Florey, 1984). 
I j 
In summary, previous biochemical and morphological work has 
suggested that astrocytes form a link between the neuron and blood 
supply. This may constitute a system transporting and storing 
metabolic substrates which may be controlled by signals derived 
from neurons. In particular, glycogen has been proposed to be a 
store of metabolic intermediates sensitive to neuronal activity. 
Indeed the possession of-large stores of glycogen is one of the 
few known biochemical characteristics of astrocytes in vivo. 
This thesis will examine the effects of various conditions which 
might be considered to mimic naturally occuring signals released 
from neurons, on the glycogen stores of rat cortical astrocytes 
The remainder of this thesis is divided into discrete 
chapters, each with introduction, methods, results and discussion 
sections, except for the last, where general conclusions and the 
possible future directions of research are discussed. Chapters 2 
and 3 describe attempts to produce a model system for astrocytes, . 
first using a previously published technique to separate adult 
astrocytes from the rat cerebral cortex in bulk. Various 
modifications of the basic technique are described which were 
designed to increase the y~~ld and purity of the astrocyte-
enriched fraction thus produced. The results from experiments to 
develop an alternative method for the separation of adult cortical 
astrocytes by immunaffinity separation are also shown. Due to 
the unsuitability of the resulting fractions, astrocytes were 
derived from cultures of neonatal rat brain. The method used 
for this is described in Chapter 3, together with the extensive 
characterisation of the cultures by various morphological, 
immunocytochemical and biochemical means. A method for the culture 
of meningeal cells is also described as these cells were considered 
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to be the princip .. , if not sole, contaminants of the astrocyte 
cultures. 
Chapter 4 reveals that astrocytes in primary culture do 
indeed metabolise stores of glycogen. When it had been established 
that meningeal cells in vi.tro also contained glycogen, the effects 
of increased [K+l o on astrocyte glycogen stores w~examined using 
+ the corresponding effects of increasing [K 10 on the glycogen 
content of meningeal cell cultures as control. This work was 
carried out with the broad aim of determining whether mammalian 
+ astrocyte glycogen stores might be affected by increases in [K 1
0
, 
as had been shown in invertebrate glia. This is seen to be so for 
both cell types,although the net effects of [K+l
o 
on meningeal cell 
glycogen stores are different from those on astrocyte glycogen stores. 
Other possible signals between neurons and astrocytes are 
considered in Chapters 5 and 6. Chapter 5 describes 
binding studies of three neurotransmitter receptor ligands [3Hl _ 
serotonin (serontonin receptors), [3Hl-di~YdrOalprenolol (S-adrenergic 
receptors) and [3Hl-QuinuclidinYl benzilate (muscarinic cholinergic 
receptors) to membranes prepared from cultured astrocytes and meningeal 
cells. Binding sites for [3Hl-serotonin and [3Hl-dihydroalprenolol 
are found on both astrocyte and meningeal cell membranes. However, 
[3 H1 -quinuclidinYl benzilate - bOUAd-. i-a astrocyte bur "OY 
~ Q..,...; ""'i 1lcJ. 
lmembranes. The effects of serotdnergic, adrenergic and muscarinic 
cholinergic receptor agonists and antagonists on stores of glycogen 
in both cell types are then described in Chapter 6. Transmitter 
agonists and antagonists both produce effects on astrocyte and meningeal 
glycogen stores, although the two cell types show different net responses. 
- 10 -
Finally, these results and others from the same laboratory 
are discussed under the broader hypothesis that neuron-glia 
signalling employs a variety of means, and speculations are made 
with respect to the extent of the metabolic interactions 
between neurons and astrocytes. 
- 11 -
CHAPTER 2 
Bulk separation of astrocytes from adult rats 
Introduction 
In vivo, the astrocyte is intimately associated with neurons 
and other cell types. Thus experiments to examine the direct 
effects of putative signals released from neurons on astrocyte 
biochemistry require the preparation of an isolated, viable and 
pure preparation of cells. As previously discussed in Chapter 1, 
three types of preparation have been commonly used: bulk isolated 
cells from adult tissue, primary cultures of perinatal cells and 
clonal cell lines. This chapter describes attempts to separate 
astrocytes from the adult rat cerebral cortex. 
A variety of techniques for the isolation of astrocytes from 
the adult mammalian brain have previously been used in biochemical 
studies of these cells. The first attempts at the isolation of 
CNS cells employed free-hand microdissection of Deiter's 
nucleus to separate neurons and glial cells, although the yield 
of cells limited any extensive biochemical examination (e.g. Hyden, 
1959). Korey (1957) reported that glial cells could be purified 
in bulk from bovine white matter using differential density 
centrifugation and sucrose gradients. This preparation contained 
cellular debris and other cell types (Fewster et al, 1976) and 
more recent work began with the reports of Rose (1965, 1967) which 
described the separation of neurons and glia (neuropil) from 
the rat cortex. This system, primarily designed to yield 
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neuronal cells, used a dissociation technique passinq the tissue 
through sieves and then separating the resultant cell suspension 
with Ficoll - sucrose density gradients. Since this initial 
work, many other authors have reported methods for the separation 
of neurons and glia, (or more specifically astrocytes), using broadly 
similar techniques, e.g.Flangas and Bowman (1968); Blomstrand and 
Hamberger (1969); Sellinger et al (1971); Chao and Rumsby (1977); 
Farooq and Norton (1978). These methods have been reviewed by 
Henn (1980) and all follow the same basic pattern. First, the 
tissue ~s minced and then mayor may not be treated with enzyme(s) 
(such as trypsin), to weaken cell - cell bonds. The chopped tissue 
is then mechanically disaggregated by passing it through steel and/ 
or nylon meshes to produce a cell suspension. The buffer used for 
the cell separation varies between authors, e.g. Rose (1965) used a 
buffer with a high [K+] to maintain intracellular K+ levels and 
to reduce cell damage (Sinha and Rose 1971), whereas that of 
Blomstrand and Hamberger (1969) contained lower concentrations 
of K+. Separation of the cell suspension into various fractions 
is then achieved by differential and/or density gradient 
centrifugation using sucrose (Korey, 1957), sucrose-Ficoll (Rose 
1965), Ficoll (Flangas and Bowman, 1968) or Percoll (Trachtenberg 
and Packey, 1984; Chatterjee and Sarkar, 1984). The purity of 
the cell enriched fractions produced by these methods was usually 
established on morphological grounds, although estimates of glial-
specific proteins such as glutamine synthetase (Albrecht et ai, 
1982), carbonic anhydrase (Snyder et ai, 1983) or glial fibrillary 
acidic protein, (Grisar et ai, 1983) have also been used to 
establish the enrichment of a fraction with a particular cell type. 
Farooq and Norton (1978) reported a method for the separation of 
rat forebrain astrocytes which yields cells in the highest purity 
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~70%) and level of structural integrity, with a good yield (2 mg 
astrocyte protein per 60 day old rat forebrains). Their method 
uses a dissaggregation technique of aspirating trypsin-treated 
rat forebrains through glass nozzles and filtration under 
gravity of the resultant suspension through a comparatively wide 
(420 ~m) nylon mesh. There is only one step in the disaggregation 
process of Farooq and Norton (1978) where the tissue is forced 
through the mesh and. this produces a fraction enriched in cells 
having a small nucleus, little perinuclear cytoplasm and extensive 
long delicate processes. These cells ~ere identified as 
protoplasmic and fibrous astrocytes under the light microscope, 
however the more rigorous techniques of cell identification by 
cell specific antibodies have not commonly been used to check the 
homogeneity of cell types in fractions obtained by bulk separation. 
With hindsight, the precise purity of bulk separated cell fractions 
must be considered to some extent to be unproven. 
New methods of cell separation have been suggested which are 
more rapid (to reduce the inevitable cell damage involved in tissue 
disaggregation), of a higher yield and also more specific (see 
Varon and Manthorpe, 1980). The most promising methods use cell 
type-specific surface antibodies, for example to label with a 
fluorochrome linked antibody, cells which are then separated by 
fluorescence activated cell sorting (FACS). This is a process 
whereby each individual cell in a suspension pre-treated with a 
fluorochrome linked antibody is then automatically examined and 
then selected for the presence or absence of fluorescent label 
by the measurement of their laser stimulated fluorescence emissions 
(Bonner et ai, 1972). Alternatively, antibodies may be used to 
remove particular cells directly from a mixed cell suspension by 
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imrnunoaffinity methods (Varon and Manthorpe, 1980), which involve 
the binding of a cell type specific surface antibody to a substrate 
to act as a bond between the selected cell and the substrate. 
These techniques have been limited primarily to use in neonatal 
brain tissue culture. For example the oligodendrocyte surface 
specific antibody 04 linked to magnetic microspheres has been used 
to select for a population of oligodendrocytes from a neonatal rat 
cerebellar suspension (Meier et al, 1982; Meier and Schachner, 1982). 
Unfortunately the lac~ of an antibody specific to the astrocyte 
cell surface has restricted the use of these methods. 
It would appear that the separation of astrocytes from the 
adult rat cortex, theoretically the best model for differentiated 
astrocytes, is best achieved by the use of the bulk separation 
technique of Farooq and Norton, {1978). This chapter will therefore 
describe experiments to examine the possible use of this method, or 
modifications thereof to produce a preparation enriched in viable 
and identifiable astrocytes which might then be used in further 
experiments to determine the effect of various and putative 
neuronal signals on the biochemistry of astrocytes. The .enrichment 
of the astrocyte fractions was determined not only by light 
microscopy but also by immunofluorescence studies using an antiserum 
to GFAP. The viability of the cells was judged by trypan blue 
exclusion and two nucleic acid dyes, ethidium bromide and acridine 
orange. As the y~eld and viabi~ity 0(- t~~ ~~lk-prepared cells were 
unsatisfcatory, efforts 
/were made to raise an antiserum to membranes prepared from the 
astrocyte enriched fraction derived from a modified Farooq and 
Norton (1978) technique and the results from this work are also shown. 
The aim of these latter experiments was to produce an astrocyte 
surface specific antibody which could be used in the separation of 
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Bstrocytes from the adult rat cortex 
Hethods 
The method chosen to form the basis of a technique for the bulk 
separation of astrocytes from the adult rat cortex was that of 
Farooq and Norton (1978). After initial studies using the original 
procedure, various modifications of this method were made with the 
aim of determining the optimal separation conditions for the preparation 
of intac't and apparently viable cells (see Cell Viability). The 
modifications were made as a result of numerous control experiments 
including:-
a) a comparison of the use of siliconised and non-siliconised glassware 
during tissue dissaggregation. 
b) the reduction of the differential density. gradient centrifugation 
speed. 
c) a comparison of vortexing and manual dispersion of the precipitate 
from Si (see Farooq and Norton, 1978). 
d) replacement of the final aspiration of non-disrupted tissue 
by a process 6f gently forcing the tissue through nylon mesh covering 
the end of a disposable syringe. 
e) studies on the opitmal method of removing contaminating Ficoll 
from astrocyte-enriched fraction~. Preliminary studies such as 
these resulted in the use of two methods for the separation of 
astrocytes. 
- I~A. -
------------------------------------" 
Method 1 
This was very similar to the original Farooq and Norton 
(1978) method but differed primarily in the elimination of part 
il\ 
of the differential density gradients andLthat it was performed 
both with and without trypsin. The original procedure employed 
a 32% Ficoll layer below the interface at which astrocytes were 
found (22% and 28% Ficoll) and this was eliminated. 
Six 50 day old rats were killed by decapitation, the brains 
removed and cleaned of cerebellum·, midbrain and brain stem. The 
remaining tissue was chopped into 16-20 slices per brain using a 
scalpel and transferred to a tube containing 9mls of disaggregation 
buffer (8% w/v glucose, 5% w/v fructose and 2% w/v Ficoll, 
in 10 mM KH 2P04-NaoH buffer, pH 6.0) with or without 
0.1% acetylated trypsin (Sigma, Type V-S). The tissue was 
incubated at 37°C for 90 minutes after which time the buffer was 
removed and 9 mls of 0.1% soybean trypsin inhibitor (Sigma, Type l-S) 
in disaggregation buffer was added if trypsin had been used. 
After five minutes the inhi~itor solution was discarded and 
the slices washed in ice-cold disaggregation buffer four or five 
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times. 
All subsequent steps were carried out at 4°C. Disaggregation 
was achieved by sucking the slices through a cut off glass 
pipette of nozzle diameter 2.2- 2.4 mm and length 3.4 - 3.5 mm, 
attached by a 2 cm length of tubing to a 250 ml side-arm conical 
flask containing 20 mls of disaggregation buffer. The flask had 
been siliconised with Repelcote (Hopkins and Williams Ltd.), as 
had the glass pipette and tubing. A slight negative pressure to 
draw the tissue through the glass nozzle was provided by a water 
pump connected through the neck of the flask. 
After the material had been drawn through the nozzle, the 
residue in the pipette and side-arm were flushed through with 
10 mls of disaggregation buffer and the partly dispersed tissue 
was filtered over a 425 Ilm nylon mesh (Stanier Ltd., Manchester) 
into a beaker to give a filtrate F 1 • Any material remaining on 
the screen was then re-drawn through the nozzle into fresh buffer 
and filtered to give a filtrate F2 . This procedure was repeated 
to give two more filtrates F3 and F4 . The material remaining on 
the mesh after the final filtering was washed into 10 ml of 
disaggregation buffer and transferred into a 10 ml disposable 
syringe whose end had been replaced with a covering of 425 Ilm 
mesh. The suspension was then gently pushed through the nylon 
mesh into 10 ml of disaggregation buffer to give a filtrate F
5
. 
All five filtrates were then combined and allowed to settle for 15-
20 minutes. The supernatant (Sl) was retained and the precipitate 
resuspended in 20 mls of disaggregation buffer and shaken by hand. 
This was left to settle for 15 minutes, whereupon the supernatant 
was added tOS 1 and the precipitate discarded. The combined 
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suspensions were concentrated by centrifugation at 2,000 r.p.m. 
(720 g) for 15 minutes. The cell rich pellet thus obtained was 
suspended in 64 ml..of 7% Ficoll in disaggregation buffer and 
divided into two tubes which were spun at 1,200 r.p.m. (280 g) 
for 10 minutes to give a pellet PI. A second pellet P
2 
was 
obtained by re-centrifugation of the supernatant for 2,000 
r.p.m. (720 g) for 10 minutes. This also gave a new supernatant 
which was diluted 1 : 1.125 with disaggregation buffer and 
recentrifuged at 2,500 r.p.m. (1120 g) for 15 minutes to give the 
astrocyte enriched pellet P3 • P2 and P3 
were then resuspended in 
34 ml of 7% Ficoll in disaggregation buffer and 15 mls of each were 
layered into four three step gradients of 10%, 22% and 28% Ficoll 
in disaggregation buffer. These gradients were centrifuged for 
5 minutes at 7,000 r.p.m. (6,400 g) in a Prepspin 75 ultra-
centrifuge (MSE Scientific Instruments). Various fractions from 
these gradients were taken for further analysis. In some 
experiments the astrocyte enriched fraction P 3/22, i.e. those 
layers on the P3 gradients at the 22% and 28% Ficoll interfaces, 
were transferred to 2 x 50 ml centrifuge tubes to be washed free 
of contaminating Ficoll. This was performed by the slow, dropwise 
addition of a modified Kreb's solution to the P 3/22 fractions 
(NaCl, 110 mM; KCil, 40 ml1; CaCl2 , L2mH;MgC12.6H20, 1.3 mM; 
Na H2 P04 .H20, 1.2 mM; glucose, 10 mM; HE PES buffer, 20.0 mM). 
When the fraction had been diluted 8 - 10 times the dilution rate 
was increased until 35 mls of buffer had been added. The diluted 
fraction was then centrifuged at 1,100 r.p.m. (210 g) for 55 
minutes. The supernatant was discarded and the pellet re suspended 
in 1 ml of the modified Kreb's solution. 
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Method 2 
In this variant, the gradient centrifugation step was 
removed in an attempt to increase cell yield and instead the P
3 
pellets were resuspended in 10 - 15 mls of disaggregation buffer 
and passed through a t.5 x 1.2 cm diameter column of glass beads 
(Sigma Type V, 450 - 500 UM; pre-cleaned in nitric acid) made in 
a plastic funnel whose end was covered with 425 urn mesh. This 
gave a final suspension PP
3
• 
Aliquots were taken at various stages during the separation 
processes and examined under the light microscope or analysed for 
protein content (Lowry et al., 1951) using bovine serum albumen ~ 
as standard (BSA; Sigma fraction V). Fracti9ns were also taken 
for viability estimation using trypan blue and ethidium bromide/ 
acridine orange, immunofluorescence studies and to raise an anti-
body to membranes prepared from an astrocyte fraction. 
Cell viability 
Cells were judged as viable if they excluded trypan blue 
(0.1%) or fluoresced green after exposure to an equimolar mixture 
of 1 ppm ethidium bromide and acridine orange, red/orange 
fluorescent cells being regarded as dead (Pantazis and Kniker, 1979; 
Jarnagin and Luchsinger, 1980). For fluorescence-examination, cells 
were viewed under flu~escein and rhodamine optics mounted on a Zeiss 
photomicroscope II. 
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GFAP immunofluorescence 
In two experiments unwashed P3/22 aliquots were labelled 
with an antiserum to GFAP (a gift of Prof. M. Raff) using the 
indirect immungfluorescence technique. Aliquots of cell 
suspension (approx. 50 - 100 ~l) were placed onto 22 x 22 mm 
glass coverslips coated with gelatin (0.5% gelatin; 0.05% chrome 
alum) and allowed to settle for 15 minutes. The coverslips were 
then rinsed in phosphate buffered saline (25 mM NaH
2
PO /Na HPO , 
. 2 2 4 
0.9% NaCl -'pH 7.4; PBS). The cell s were fixed- in ac id/ alcohol (1 % 
HCl in 70% ethanol) for 5 minutes at -20°C and rinsed again in PBS. 
100 ~l of anti-GFAP antiserum diluted 1 : 125 in PBS was then 
added to the coverslips for 30 minutes. In order to wash out any 
non-bound anti-GFA~and to block non~specific binding of the second 
antibody, the coverslips were then rinsed 4 - 5 times in 5% normal 
lamb's serum (Gibco) in PBS over 10 minutes. The second antibody 
was then added at a dilution of 1 : 50 in PBS for 30 minutes (goat 
anti-rabbit-rhodmine conjugate, Miles Biochemicals Ltd.). After 
this time the cells were rinsed in 5% normal lamb's serum as 
before. The coverslips were then mounted onto glass slides in 
glycerol and examined under rhodamine optics using a Zeiss photo-
microscope II. Photographs of the labelled cells were taken using 
Kodak Ektachrome 400 ASA film. 
Bl antiserum 
Adult cortical astrocyte membranes were prepared by lysing 
in ice cold distilled water a suspension of material obtained by 
passing a P3/22 fraction through glass beads as in Method 2 and 
centrifuging the lysate at 50,000 g in a Sorvall RC-SB ultra-
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centrifuge (Du Pont Instruments) for 30 minutes. The membranes 
were resuspended in PBS and mixed with an equal quantity of 
Freund's Complete Adjuvant to a final concentration of 200 ug 
protein/ml. 500 Ul of this solution was injected intradermally 
at 5 sites on the back of a female New Zealand white rabbit 
(2.5 - 3 kg). Two and five weeks later the animal was boosted 
with the injection of 400 Ug protein of the membrane preparation 
-in Freund's Complete Adjuvant at 10 sites along the animal's back .. 
Blood was taken from the ear vein at 6, 11, 13 and 20 weeks after 
the initial injection. After. allowing the blood to clot overnight 
at 4°C, the serum was separated by centrifugation at 2,500 r.p.m. 
(1100 g) for 15 minutes. Immunoglobulins were extracted from the 
serum by double ammonium sulphate precipitation (0.31 g/ml serum) 
and centrifugation at 50,000 9 for 30 minutes. The final pellet 
was resuspended in 50 mM sodium phosphate pH 7.4 to a concentration 
of 5 mg protein/ml and aliquots frozen at -70°C. This antiserum 
was partly screened by immunodotting, immunoblotting and 
immunofluorescence. 
Immunodotting 
Immunodotting, based on Hawkes et al (1982) was carried out 
as follows. Approximately 2.0 and 0.2 Ug protein aliquots of 
various tissue homogenates in distilled water were dotted onto 
nitrocellulose paper grids (1 x 1.5. cm,·Bio-rad) in duplicate or 
triplicate and allowed to dry overnight. The grids were washed 
twice in 1 ml of Tris buffered saline (TBS; 50 mM Trizma base; 
200 mM NaCl, pH 7.4) with shaking at room temperature. A 
solution of 3% BSA (Sigma, fraction V) in TBS was applied for 
60 minutes to block non-specific binding sites for protein on the 
grids and incubated at 4°C overnight after which they were washed 
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4 times with 1 ml of TBS for 20 minutes each. Blocking of non-
specific sites was performed as before and then 1 ml of the second 
antibody (goat anti-rabbit-horseradish peroxidase conjugate) 
diluted 1 : 500 in 3% BSA/TBS was added to the grids for 2 hours. 
Any non-bound antiserum was removed by washing four times with 1 ml 
TBS each for 20 minutes. Finally, the bound second antibody was 
visualised by incubating the samples with a solution of 0.06% 
chloro-l-nap~thol, 20% methanol, 0.07% hydrogen peroxide in TBS. 
Incubation was continued until reaction product appeared at the site 
of the dot, and was then stopped by washing with distilled water. 
Immunoblotting 
Immunoblotting was performed by transfering proteins from 
homogenates of rat cerebral cortex, astrocyte and meningeal cell 
cultures (see Chapter 3 for culture methods). separated by sodium 
dodecyl sulphate polyacrylamide gel electrophoresis (SOS-PAGE) 
onto nitrocellulose paper as described by Towbin et at (1979). 
SOS-PAGE separation of proteins was essentially by the methods of 
Laemmli (1973) and Mahadik et al (976). Briefly, homogenates in 
5 mM Tris HCl pH 8.4 were diluted 1 : 1 with dissociation buffer 
(SOS, 1.25%; 2-mercaptoethanol, 1%; EOTA, 2 mM; sucrose, 10%; 
Tris-HCl, 125 mM; pH 6.8) to 1 mg protein/ml and boiled for 5 
minutes. 100 ~l aliquots and molecular weight markers (Sigma, 
SOS - 6H) were then run On a 10% polyacrylamide gel at 40 mA 
for 4 - 5 hours using bromophenol blue to show the gel front. The 
gel-separated proteins were then transferred to nitrocellulose paper 
using a Biorad immunoblotting apparatus Ivith a current of 1.8 A, 
60 mV for two hours. The immunoblot was then divided into vertical 
strips containing either molecular weight standard proteins or 
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homogenate proteins. Strips were strained for proteins 
with amido black (0.1% w/v amido black, 10% acetic acid, 25% iso-
propyl-alcohol) i strips with separated homogenate proteins were 
treated as described for immunodots using either B1 antiserum 
(1 : 50) or rabbit pre-immune serum (1 : 50) in 3% BSA/TBS. 
Immunofluorescence studies 
The intracellular and extracellular distributions of the 
antigen(s) bound by B1 were examined immunofluorescence 
on astrocyte enriched cultures (Chapter 3), cerebellar 
granule cell cultures (prepared by Dr. B. Pearce by the method of 
Dutton et ai, 1981) and growth cones from 5 day old rat forebrain 
(prepared by Dr. P. Gordon-Weeks as in Gordon-Weeks and Lockerbie, 
1984). The method used.for immunofluorescence was essentially 
as described here and is shown in Chapter 3. 
+ 
"Panning" for B1 cells 
Two attempts were made to use the panning technique of Wysocki 
+ 
and Sato (1978) to separate B1 cells from suspensions using the 
second modified method of Farooq and Norton (1978). 
B1 antiserum was diluted 1 : 100 or 1 : 1000 (50 and 5 ~g 
protein/ml) in 50 mM Tris-HCl pH 9.5 and 5 mls of each dilution 
were added to 6 x 50 mm diameter non-tissue culture grade plastic 
petri dishes (Sterilin) for 40 minutes at room temperature. The 
dishes were then washed four times with 5 mls of PBS and once in 
3 mls of 1% foetal calf serum (Flow; FCS) in PBS. Cell suspensions 
(3 mls) from the pooled filtrates (F 1 - F S)' cell rich pellet (non 
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cell enriched) resuspended in 5% FCS/PBS and astrocyte enriched 
suspension (PP~) were then added to the antibody coated dishes 
J 
in duplicate. After 40 minutes at 4°C or room temperature, the 
dishes were gently swirled, then left for a further 30 minutes 
before being examined under the light microscope, washed four 
times with 1% FCS/PBS and further examined. 
Results 
Bulk cell separation 
When fractions prepared by the original Farooq and Norton 
(1978) method, and the two variations previously described ~~r~ 
examined under the light microscope, cells of a morphology 
previously described as astrocytic (Farooq and Norton, 1978; 
Albrecht et al, 1982) could be observed in the P3/22 and PP
3 
fractions. These cells were characterised by the possession of 
a small bean-like nucleus with little cytoplasm and extensive 
fine processes. They could be observed in the P3/22 fraction with 
or without pre-treatment with trypsin although not in P3/22 
fractions prepared using the higher speed gradient centrifugation 
(8,500 g) of Farooq and Norton (1978). The elimination of the 
lowest step in the density gradient centrifugation process (32% 
Ficoll in disaggregation buffer) did not have any apparent effect 
on the yield and composition of the P3/22 fraction and presumed 
astrocytes in the P3/22 and PP3 fractions could be washed free of 
Ficoll without further noticeable cell damage. Photomicrographs 
of cells variously prepared are shown in Figs 2.1. 
Additionally, cells of the above morphology are seen to label 
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Table 2.1 Protein yield of cell separation fractions 
Fraction R. e..c..ove.i~ (°(0 ') 
P 1 2.6 ± 0.3 ( 16) 
P2 1.2 ± 0.3 (15) 
P3 0.7 ± 0.1 (14) 
P2/22 0.4 ± 0.1 (6) 
P3/22 0.2 ± 0.1 (8) 
PP3 0.2 ± 0.1 (6) 
Legend 
The results shown here are the mean ± SEM of the recovery (expressed 
as % starting material, assuming 100mg protein per pair of rat-
cortices) , ~ , in various 
fractions pooled from all three methods with or without trypsin. 
All PP 3 determinations were made on cells prepared without trypsin. 
All aliquots were washed by centrifugation with 10-15 vols of PBS 
(750g, 15 mins) prior to protein estimation. Numbers in brackets 
refer to the number of experiments 
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Fig. 2.1 
Micrographs of cells separated from the 
adult rat cortex 
a) A typical cell of the type seen in "astrocyte" 
fractions, in this case the p3/22 fraction, x ~50. 
b) A cell from the PP3 fraction, xISOO., 
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with antiserum to GFAP (Fig 2.2) . However, the yield 
and composition of the "astrocyte enriched" fractions varied 
greatly. Table 2.1 shows the protein yield at various stages 
during the cell separation processes. The yield in the two 
"astrocyte enriched" fractions is partiE:1.Jlarly low, P3/22 = 
1.2 ± 0.3 mg, PP3 = 1'.2 ± 0.4 mg from 6 x 40 day rat cortices. 
If it is assumed that one rat brain constitues 100 mg of cortical 
protein-this repre~ents a recovery of ·approximately 0.2%. 
-
Furthermore, frequently nothing of a well defined cellular shape 
could be determined in the P3/22 or YP
3 
fractions and debris 
always predominated. None of the cells observed excluded trypan 
blue and most fluoresced predominantly red when exposed to 
acridine orange/ethidium bromide, indica~ing cell damage. Moreover, 
presumed capillaries were often observed in the P3/22 fraction 
(Fig 2.3). The PP3 suspension however did not contain obvious 
capillary contamination, and neuronal cell bodies, (identified as 
phase bright cells with a pear shaped perikaryon and few processes) 
were rarely seen in the P3/22 and PP
3 
fractions. 
B1 antiserum 
Attempts to raise an astrocyte cell-surface specific anti-
serum resulted in an antiserum B1 which bound readily to homo-
genates of rat brain, Fig 2.4a. However, the antigen(s) recognised 
by B1 in rat brain is/are also present in peripheral tissues such 
as liver, kidney, heart and lung, Fig 2.4b. Immunoblotting SDS-PAGE 
of 50 day rat cortex and astrocyte and meningeal cell cultures with 
B1 produced a labelled band of protein of approximate molecular 
weight 42,000 Daltons Fig 2.4c. B1 also binds to purified actin (from 
chick brain, a gift from P. Tilson) Fig 2.4b. Additionally in immuno-
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Fig. 2.2 
Immunofluorescence micrographs of cells 
separated from. the adult rat cortex 
a) and b) GFAP immunofluorescence micrographs of 
cells present in the p3/22 fraction, x 3000. Control 
coverslips incubated with PBS instead of anti-GFAP anti-
serum showed no fluorescence. Cells in micrograph (a) 
and (b) are viewed through gelatin/chrome alum which 
produces a hazy image. 
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Fig. 2.3 
Micrograph of a capillary 
A presumed capillary observed in the p3/22 
fraction, x ~oo. 
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Fig. 2.4 
Characterisation of Bl by immunohistochemistry 
a) Immunodots of duplicate 2 0 0 and 0.2fg aliquots 
using Bl (left) and pre-immune rabbit serum (right) 
b) Immunodots of duplicate 2.0 and 0.2 r g aliquots 
of actin and from left to right, top to bottom, heart, 
lung, actin, liver and kidney, using Bl 
c) Immunoblot of homogenates uf astrocyte-enriched 
(A) and meningeal cell (F) cultures using Bl (+) and 
pre-immune serum (-) 
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Fig. 2.5 
Immunofluorescence micrograph of growth 
cones from neonatal rat cortex 
Immunofluorescence micrograph of Bl internally 
labelling growth cone aggregates in vitro, xl&oo. 
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36 . 
fluorescence studies of astrocyte enriched cultures, Bl labels 
intracellular fibres of all cells present but only at low 
dilutions < 1 : 5. In addition the antiserum labels growth 
cones markedly (Fig. 2.5). The antiserum labels the surfaces 
of all cells present in astrocyte-enriched cultures and in 
~ 
cerebellar granule cell cenriched cultures with a speckle!, dot-
like appearance. 
The use of Bl in panning experiments resulted in almost no 
cells or debris from any of the suspension becoming attached 
to the substrate before washing in 1% FeS/PBS abd· nothing remained 
attached after washing. 
Discussion 
The results have been presented from experiments designed to 
modify a previously existing technique (Farooq and Norton, 1978) 
to produce reproducibly a fraction enriched in viable adult rat 
cortical astrocytes free from contaminating cell types. Previous 
studies using this method or its earlier version (Norton and Poduslo, 
1970) or modifications of these techniques (Albrecht et ai, 1982) 
suggested that a good yield of well preserved astrocytes could be 
obtained. The cells observed in such fractions have generally been 
identified as astrocytes on light microscope morphological analyses 
alone however. Electron microscope examination of cells produced 
by these methods is reportedly hindered by the marked tendency of 
astrocytes to swell and burst during processing for examination 
(see Hannuniemi et ai, 1980) and immunocytochemical analyses of 
the fractions have not been performed. 
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The yield stated by Farooq and Norton (1978) for the P3/22, 
fraction was 12 mg per six 60 day old rats, although this was from 
the entire forebrain. Indeed their method has formed the basis 
of a number of biochemical studies (Hannuniemi et aI, 1980; 
Hannuneimi and Oja, 1981; Snyder et al, 1983; Snyder and Wilson, 
1983). Hannuniemi et al (1981) used three week old rat cortices 
and a modified version of the technique of Norton and Poduslo (1970) 
to prepare astrocytes with a yield of 10 mg protein per g wet 
weight cortex. However, the yield reported here of astrocytes, 
+ (identified as GFAP cells by immunofluorescence), from the rat 
cerebral cotex is very low (x = 1.2 mg from six rats, or approximately 
0.2 mg per,g'wet weight cortex assuming two cortices/q wet 
weight). This is so when using the original unmodified technique 
or a slightly modified version which reduces the number of gradient 
layers in the density gradient step. 
In an attempt to increase the yield of astrocytes and to 
remove the capillary contamination noted here in the P
3 
fraction 
and also reported by Farooq and Nortori (1978), a second 
modification was used whereby the astrocyte enriched pellet P
3 
was 
resuspended and filtered through .a column of glass beads. This 
principle has been used previously tp remove capillaries from a cell 
suspension (Rose and Sinha, 1970). Whilst the removal of 
• 
capillaries was successful, the yield was again low, being 
approximately 1.2 mg protein for 6 rat brains. 
The reason for such low yields obtained here is unclear. 
Notably, Chatterjee and Sarkar (1984) have stated that protoplasmic 
astrocytes, the predominant cell type in the cerebral cortex, are 
very susceptible to damage by a proteolytic enzyme (trypsin). 
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This may account for the relatively low yield and high amounts of 
debris in astrocyte fractions apparent here when using trypsin 
treated cerebral cortex. Farooq and Norton (1978), whilst also 
using trypsin, utilised the entire forebrain as starting material 
which contains both protoplasmic and fibrous astrocytes. Also, 
although Hannuniemi et al (1980) prepared astrocytes from the 
cerebral corte~ they used a reduced (45 minutes) incubation with 
trypsin. A marked sensitivity to proteolytic enzymes may also 
account for the comparatively meagre yield of astrocytes observed 
even when the cortices were not exposed to added trypsin. The non-
trypsinised, chopped tissue, which was also incubated at 37°C for 
90 minutes as it proved-easier to disaggregate than if no 
incubation was used, may release a variety of proteases from 
damaged cells which could have had deleterious effects on the 
intact astrocytes. 
Certainly the cells which are produced by the original method 
and its modifications are badly damaged and non-viable as judged 
by trypan blue exclusion and acridine orange/ethidium bromide 
staining irrespective of whether the cortices had been pre-treated 
with trypsin. Moreover, intact cells were by no means always 
present in the "astrocyte" fractions. It has been reported 
previously that cells prepared by the Farooq and Norton (1978) 
method or similar are badly-damaged and may lose cytoplasmic 
constituents such as the astrocyte-specific enzyme glutamine 
synthetase (Hannuniemi et ai, 1980; Albrecht et ai, 1982). This 
damage is apparent before any attempts are made to remove the non-
physiological disaggregation buffer containing Ficoll and/or 
sucrose. Hannuniemi et al (1980) have suggested that this must be 
performed by very slowly diluting the disaggregation buffer by 
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dialysis with a physiological buffer. The astrocytes prepared 
here could be washed apparently free of Ficoll and still remain 
intact but only by a very slow dilution with buffer added 
manually and pelleting by centrifugation. 
Due to the low yield and poor structural integrity of the 
Lsolated astrocytes, alternative methods for producing enriched 
cell populations were examined. One of these was the possibility 
of raising an astrocyte specific cell surface antibody which 
could be used to separate astrocytes by an irnmunoaffinity method. 
Thus a P3/22 astrocyte fraction (prepared without trypsin) was 
passed through glass beads to remove capillaries and then membranes 
prepared from this fraction were injected into a rabbit. The 
serum resulting from this innoculation contained antibodies to 
determinant(s) in the adult cortex as shown by irnmunodotting 
(Fig 2.6). However, the determinant(s) were also found in 
homogenates prepared from other tissues such as kidney, lung, 
heart and liver. The immunoblotting study showed that the anti-
serum bound most avidly to a protein of molecular weight 42,000 
Daltons and immunofluorescence showed that it bound to intra-
• cellular filaments in astrocyte or meningeal cell cultures 
although only at low dilutions (1 : 5 or less). 
- 'to 
The resulting serum (Bl) did indeed label the surfaces of astrocytes 
in culture at a comparatively high dilution (1 : 50). However, all 
the cells in astrocyte cultures were labelled, including cells believed 
to be derived from meninges (see Chapter 3). Furthermore, cerebellar 
granule cells in vitro were also labelled with B1. When immunoblotting 
studies were performed (figs. 2.4a,b) it was clear that whilst Bl 
bound to determinant(s) in the adult cortex, it also bound to determinant(s) 
in the kidney, lung, heart and liver. Immunoblotting studies were 
therefore performed to examine further the nature of the antigen(s) 
labelled by B1. These studies (fig. 2.4c) showed that B1 bound most 
avidly to a 42,000 Dalton protein from 10% polyacrylamide gels of 
cell culture homogenates. This result suggested that B1 bound to 
actin. Indeed B1 bound to actin immunodots and also to actin rich 
growth cones in immunofluorescence studies (fig. 2.5).Bl also labelled 
intracellular fibres in cell cultures as shown by immunofluorescence 
although at lower dilutions than that seen for surface labelling 
(1 : 5 compared to 1 : 50). It is unlikely therefore that actin-
immunoreactivity accounts for the labelling by B1 of cell surfaces. 
In one B1 immunoblot of a 10% polyacrylamide gel of astrocyte culture 
homogenates, a dar~kly labelling band was observed at the top of the 
blot suggesting that the antiserum recognised a high molecular weight 
determinant (> 200,000 Daltons). This determinant may be that which 
is present on the surfaces of cells in vitro. However, as the surface 
antigen was not cell-type specific and therefore unlikely to be suitable 
for use in cell separation, further investigation was not attempted. 
• 
In spite of the lack of specificity of the antiserum to 
cells in vitro it was possible that the antigen might become 
restricted to astrocytes at a later developmental stage. 
Therefore attempts to use the BI antiserum to separate adult 
cortical astrocytes by the "panning" method of Wysocki and Sato 
(1978) were continued. This method was originally developed 
for the separation of B and T lymphocytes and involves the 
binding of a cell specific antibody to non-tissue culture grade 
dishes and allowing cells expressing the corresponding antigen 
to bind to the antibod~ thus providing a means for separation. 
However, this technique did not result in the binding of any cell 
or cell fragment from a variety of cell suspensions prepared from 
the adult rat cortex to the BI coated substrate. The reason for 
this is not clear but might reflect a lack of binding of Bl to 
the substrate or alternatively that the B1 antiserum cross-reacts 
with a determinant present on the surface of cells in vitro which 
is not expressed in the adult cortex. 
In summary therefore, an enriched fraction containing a high 
yield of predominantly viable, identifiable astrocytes could not 
be produced by applications of the bulk separation technique of 
Farooq and Norton (1978) to the adult rat cerebral cortex, 
although cells identified as astrocytes by anti-GFAP immuno-
fluorescence could be observed. Attempts to raise an antiserum 
specific to the surface of astrocytes which could provide the 
basis for an alternative immunoaffinity separation method 
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were also unsuccessful. In the light of these results 
an alternative model preparation for astrocytes in vivo was 
considered, namely the in vitro cultivation of neonatal rat 
cortical tissue to yield astrocyte-enriched primary cultures. 
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CHAPTER 3 
Astrocytes in primary culture 
Introduction 
The previous chapter described attempts to produce an 
enriched preparation of viable astrocytes from the cerebral 
cortex of-adylt rats by modifications of a previously published 
method. These attempts resulted in a preparation which did not 
always contain identifiable astrocytes and was n~ver free of 
substantial amounts of contaminating material as judged by light 
microscopy. Cells, tentatively identified as astrocytes, were 
also seemingly damaged. It was therefore decided to examine the 
possibility of using one of two alternative techniques by which 
a preparation, measurably enriched in rat cortical astrocytes, 
might be obtained. These alternatives were the use of clonal 
cell lines such as C6 glioma or of primary cultures of the neonatal 
rat cortex. The former technique was not chosen for reasons 
outlined in Chapter 1. Thus primary cultures of neonatal rat 
cortex were evaluated for their degree of enrichment with astrocytes 
and the presence of identifiable contaminating cell types. 
The first tissue culture of CNS was performed in 1907 by 
Harrison who cultured embryonic frog spinal cord in lymph clots to 
examine the outgrowth of nerve fibres. Between the two World Wars 
most CNS culture work was performed using glioma cells e.g. Buckley 
(1929), see Ponten and MacIntyre (1968) for references. In the 
1950s, explant culture of neural tissue was used to examine a 
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variety of properties of CNS cells e.g. pulsatile activity 
(Pomerat, 1951) or electrophysiological studies (Hild et al, 
1958). Nakai in 1956 reported the first dissociated-cell cultures 
of nervous tissue, using spinal cord dorsal root ganglia, and 
dissociated culture techniques_were used by Shein (1965) to 
prepare cultures of human foetal brain astrocytes . 
More recently, most studies of astrocytes in vitro have used 
monolayer cultures of glioma cells, usually C6 glioma, or primary 
-cultures from perinatal rodent or chick brain (Varon and Raiborn, 
1969; Booher and Sensenbrenner, 1972). Explant cultures of rat 
brain stem and spinal cord are still in use, particularly in 
electrophysiological studies (e.g. Hosli et al, 1984), and the 
growth of astrocytes from adult brain has been reported (Gilden 
et al, 1976; Singh and van Alstyne, 1978; Lindsay et al, 1982; 
Vernadakis et al, 1984). In order to produce dividing astrocytes 
I 
from adult brain, the induction of reactive gliosis in vivo before 
tissue dissociation is usually considered essential. Singh and 
van Alstyne (1978) and Lindsay et al (1982) used, respectively, 
pretreatment with intracerebral injections of the neurotoxin kainic 
acid, and surgical lesioning, both at least five days prior to 
culture of the resultant reactive tissue. The need for induction 
of a glial reaction before adult astrocytes will divide in vitro 
is also reflected in the early work of Ponten and MacIntyre (1968) 
They, whilst describing the growth of normal as well as neoplastic 
astrocytes from (presumably) adult human brains, used biopsy 
tissue for their 'normal' glial cultures from wound debridement or 
from areas around haematoma or aneurysms. In contrast, the report 
of Vernadakis et al (1984) suggests that astrocytes can be grown 
from adult mouse brain without prior insult if the dissociated 
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cells are left for 9-10 days to allow adherence to the culture 
substrate. Also Gilden et al (1976) report that dividing 
astrocytes in vitro may be obtained from explants of adult human 
white matter. The use of in vitro adult astrocytes however is 
very limited and as previously stated most primary cultures of 
rodent astrocytes use neonatal brain as starting material. 
In general, most methods for the preparation of astrocyte 
enriched primary cultures from neonatal rodent brain follow the 
A. 
same basic principl~J. First, the brains from neo~al pups are 
removed and cleaned of surrounding meninges. Neonatal pups are 
used as the bulk of astrocyte division occurs at this stage in 
vivo (see e.g. Parnavelas, 1983). Cultures of forebrain 
astrocytes are usually derived from pups at 1 or 2 days post-
.< 
natal and of cerebellar astrocytes from 8 days postnatal (Cohen et aI, 
1979; Currie and Dutton, 1980). After removal of meningeal 
tissue, further dissection may then take place to separate 
particular areas (e.g. Hansson, 1984) or to mince the brain prior 
to enzyme treatment. Enzymes, usually trypsin, mayor may not 
be used prior to disaggregation of the tissue by gently forcing 
through nylon mesh (Booher and Sensenbrenner, 1972; McCarthy and 
de Vellis, 1978) or trituration in glass pipettes (Cohen et aI, 1979) 
or syringes with needles of one diameter (Pettmann et aI, 1981) 
or two needles of decreasing diameter (Chapman and Rumsby, 1982). 
The resulting cell suspension is then pelleted by centrifugation, 
diluted in culture medium and seeded onto culture dishes or 
flasks which may be coated with poly-lysine, poly-ornithine, collagen 
or left untreated. The cells are grown to confluence at 2-3 weeks, 
with medium changes every 2 - 4 days. 
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Often the cAMP analogue dibutyryl cyclic AMP (dBcAMP) or 
brain extracts are added to the culture medium during the last week 
of growth. This is reported to produce a change from the flattened 
polygonal astrocytes seen after two weeks in vitro to multi-
'. processed cells, described as a 'differentiation' of the cultured 
astrocytes from immature astroblasts to fibrous astrocytes 
(Sensenbrenner et ai, 1972; Lim et ai, 1973). dEcAMP treated 
cells express a number of astrocyte specific markers e.g. GFAP 
(Bock et ai, 1975), S-100 protein (Lim et ai, 1977), and glial 
filaments as seen by electron microscopy (Moonen et ai, 1976). 
There is however a current debate as to whether flattened polygonal 
• astrocytes differentiated by dEcAMP are fibrous astrocytes or 
reactive astrocytes (Fedoroff et ai, 1984). 
There have been a number of variations from the basic methods 
of astrocyte culture preparation described previously, designed to 
enrich further the cultures with astrocytes. McCarthy and de Vellis 
(1980) used mechanical shaking to remove oligodendrocytes from the 
surface of astrocyte cultures. This technique was also used by 
Rougon et al (1983) in conjunction with the method of Cohen et al 
(1979) and a period (48 hours) of exposure to the mitotic inhibitor 
cytosine arabinoside to kill rapidly dividing cells which were 
presumed to be fibroblasts. After treatment with cytosine arabinoside 
the cells were removed from the tissue culture flasks and replated 
'. 
onto poly lysine coated glass coverslips for immunofluorescence studies. 
In general most studies requiring bulk preparation of 
astrocyte cultures have used either glioma cell lines or the 
comparatively simple methods of primary culture i.e. those of 
Booher and Sensenbrenner (1972); McCarthy and de Vellis (1980), 
- 46 -
Kimelberg et al (1978) or slight variations therefrom, rather 
than more complex methods (e.g. Rougon et aI, 1983). This latter 
technique, and those of Cohen et al (1979) and Fedoroff et al (1977), 
have been used for studies of glial cell development in vitro 
(e.g. Levi et aI, 1983; Wilkin et aI, 1983; Fedoroff, 1984) or fo; 
experiments where large numbers of cultures or a lot of 'astrocyte' 
'. 
material are not necessary (e.g. Pearce et ai, 1981; Rougon et aI, " 
1983) 
Early morphological and immunohistochemical studies using 
antibodies to the astrocyte specific protein GFAP, or electron-
• microscopy (Bock et aI, 1975; 1977; McCarthy and de Vellis, 1980) 
suggested that astrocyte cultures produced by the methods of 
Booher and Sensenbrenner (1972) and McCarthy and de Vellis (1980) 
were highly enriched in astrocytes. However the immunocytochemical, 
histochemical and morphological studies of Raff et al (1979), Steig 
et al (1980) and Hansson et al (1980; 1982) have shown that newborn 
rat forebrain primary cultures prepared using the methods of Cohen 
et al (1979), Kimelberg et al (1978), and Booher and Sensenbrenner 
(1972) respectively may contain a variety of cells other than 
astrocytes. These include oligodendrocytes, mesenchymal cells, 
endothelial cells, macrophages and ependymal cells. These 
contaminants may constitute as much as 20 - 30 % of cells present 
in astrocyte cultures. In particular cells which express 
fibronectin (FN) at their surfaces are found in astrocyte 
cultures (Raff et aI, 1979; Steig et aI, 1980). FN is a large 
glycoprotein (220 kilo daltons) involved in a variety of cellular 
functions such as migration and adhesion (Hynes & Yamada, 1982) 
but is not found on astrocytes in vivo (Schachner et aI, 1978) or 
in vitro (Raff et aI, 1979; Steig et aI, 1980). However, 
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Kimelberg and Pelton (1983) and Kimelberg (1983) claim that 
careful removal of the meninges, commonly regarded as a source 
+ 
of FN cells in astrocyte cultures, can result in 95% pure 
astrocyte cultures. This figure is in agreement with the figure 
quoted by Hertz et al (1982) using a culture method similar to 
that of Booher and Sensenbrenner (1972). These results show the 
importance of carefully characterising a neural cell culture 
system. 
There is a growing range of antibodies to cell specific 
molecules (markers) that are useful in determining the type of 
cells present in neural cell culture systems. The term 'antibody' 
is used here to cover both monoclonal antibodies and polyclonal ~ 
antisera. Most of those antibodies relevant to this current 
study are reviewed by Mirsky ( 1982). In addition a range of 
monoclonal antibodies to the cerebellum have been raised and used 
to examine cerebellar development (Schachner, 1982). Other 
cell markers to which antibodies have been raised and used to 
characterise cell cultures and/or to investigate cell lineages 
include the intermediate filament proteins vimentin (Bignami et 
al, 1982) and neurofilament protein (Wood and Anderton, 1981); 
glutamine synthetase (Norenberg and Martinez-Hernandez 1979; 
Hallermayer et"al, 1981); non-neuronal enolase, a glycolytic 
enzyme specific to astrocytes in the cerellum (Ghandour et al, 
2+ 1981a); S-100 protein, an acidic Ca binding protein found 
predominantly in astrocytes (Ludwin et al, 1976; Ghandour et al, 
1981b; Michetti et al, 1983); 2' , 3' - cyclic nucleotide - 3' 
phosphohydrolase and myelin basic protein, two myelin associated 
proteins found in conjunction with oligodendrocytes (Sternberger 
et al, 1978; McMorris et al, 1984); and ganglioside GQ1c' A2 Bs 
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antibody (Eisenbarth et al, 1979; Kasai and Yu, 1983). 
This chapter will describe a method for the production of 
an astrocyte enriched (approximately 85%) culture preparation 
characterised by the use of an assay for glutamine synthetase 
and of several antibodies to cell specific markers. Also attempts 
to enrich further the cultures with astrocytes by three methods 
are described and discussed with respect to their possible use in 
routine preparation of large numbers of astrocyte cultures. In 
addition,a method is -described for the preparation of cultures of 
~ 
m~ingeal cells, which were considered to be the major source of 
contaminating cells in astrocyte cultures. 
Methods 
Preparation of cell cultures 
Astrocyte enriched cultures were prepared by a modification 
of previously published methods (Booher and Sensenbrenner, 1972; 
Pettmann et al, 1981) .. Neonatal (newborn - 2 days old) rat 
cortices were cleaned of meninges and subcortical structures under 
aseptic conditions in PBS and transferred to conical tubes 
~Sterilin) containing 3 ml of medium, 3 brains per tube. The 
tissue was then dissociated into a single cell suspension by 
passage through a 1.5 mm diameter stainless steel cannula. 
Undisrupted material was allowed to settle under gravity and the 
cell suspensions (supernatants) were transferred to fresh conical 
tubes using sterile siliconised pasteur pipettes. Cell debris was 
removed from the cell suspensions by centrifugation (5 minutes at 
180 g) through a 4% (w/v) underlay of bovine serum albumen {Sigma 
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fraction V). The resultant supernatants were discarded and the 
cell pellets resuspended in 1 ml of culture medium per tube and 
pooled. A 20 ~l aliquot was then taken from the pooled cell 
suspension, diluted to 20 mls with Isoton buffer (Coulter) and 
counted using a Model. ZB Coulter counter (Coulter Electronics Ltd. ) __ 
fitted with a 140 ~m orifice tube. The cells were plated onto 
poly-D-lysine (50 ~g/ml) coated 60 mm diameter plastic-petri dishes 
(Falcon), 5 mls medium per dish, or similarly coated 13 mm 
diameter glass coverslips in a 24 place tissue culture multiwell 
(Falcon), 0.25 ml medium per coverslip. The seeding density was 
-2 6 
780 cells mm which represents approximately 2.2 x 10 cells per 
5 
culture dish and 1 x 10 cells per 13 mm diameter coverslip. When 
cells were plated onto coverslips, the cell suspension was allowed .J 
to settle onto the coverslip for 30 minutes before the addition of 
0.5 ml of medium per coverslip. 
Culture medium consisted of Minimal Essential Medium with 
Earle's salts (Gibco) supplemented with 10% foetal calf serum 
(Northumbria Biochemicals); 2.5% chick embryo extract (Flow); 2 mM 
glutamine; 33 mM glucose and 65 ~g/ml gentamycin sulphate. 
Meningeal cell cultures were prepared by incubating the pooled 
meninges removed from cortices used for preparation of astrocyte 
cultures with 2.5 mls of collagenase (2 mg/ml, Sigma Type 11) in 
2+ 2+ Earle's Basic Salt Solution, Ca and Mg free (Gibco) at 37°C for 
60 minutes. The tissue was-then disrupted by passage through a 
stainless steel cannula as previously described. The resultant 
cell suspension was plated onto poly-D-lysine coated 60 mm dishes 
in normal medium without chick embryo extract. Typically the 
meninges from 12 animals were used per 20-30 dishes, 5 mls of 
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medium per dish. 
All cell cultures were grown to confluence before use in 
experiments: 18 -22 days in vitro (d.i.v) for astrocytes, 14 - 18 
d.i.v. for meninges. The medium was changed at 6 and 13 d.i.v. for 
astrocyte cultures and at 6 d.i.v. for meningeal cultures. 
Immunofluorescence studies 
Experiments to examine the cellular composition of astrocyte 
enriched cultures using cell specific antibodies and the indirect 
immunofluorescence technique were carried out on confluent cultures 
grown on 13 mm coverslips. 
The coverslips were placed in a humidified chamber and the 
cells washed with 2 - 3 mls of PBS. If the antigen being 
examined was intracellular, then the cells were fixed in acid/ 
alcohol (5% glacial acetic acid/95% ethanol) at -20°C for 10 
minutes. Fixed cultures were then washed with PBS as before. 
Prior to the addition of the first antibody, the cells were 
incubated with 100 ~l of 50% PBS/normal goat serum (NGSi Gibco) 
or rabbit non-immune serum to block non-specific retention of the 
first antibody. After removal of the blocking agent, the cells 
were further incubated with the first antibody (100 ~l or 50 ~l) 
diluted in 50% PBS/NGS + 0.02% sodium azide. 
The first antibody dilutions were as follows: 
a) anti-fibronectin Dr. R. Morris 1:100 
b) anti-GFAP Prof. M. Raff & Dr. A. 
Bignami 1:100 - 1:200 
c) anti-galactocerebroside Dr. B. Ranscht 1:50 
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·e 
d) 
e) 
f) 
g) 
h) 
anti-Thy-1 (OX-7) 
anti-neurofilament protein 
(RT97 clone supernatant) 
anti-glutamine synthetase 
anti- Y -glutamyl transpeptidase 
Chagasic serum 
Dr. A. Williams 1:100 
Dr. B. Anderton 
Undiluted - 1:150 
Dr. G. Pilkington 1:10 - 1:50 
Dr. S. Murphy 1:50 
Dr. G. Wilkin 1:20 
At the end of the incubation, the antibodies were removed 
and cold washed with PBS as before. In order to block 
non-specific retention of the fluorochrome-linked second antibody, 
the cells were again incubated with 100 ~l of 50% PBS/NGS for 10 
minutes before the addition of the second antibody (50 ~l for 20 
minutes). For polyclonal antisera raised in rabbits the second 
antibody was goat anti-rabbit rhodamine conjugate (Miles Immuno-
chemicals Ltd.); for moneclonal antibodies, goat anti-mouse rhodamine 
(Nordic) and for Chagasic serum, goat anti~human fluorescein (a 
gift from Dr. G. Wilkin) was used. All second antibodies were used 
at 1:40 or 1:50 diluted in 50% PBS/NGS + 0.02% sodium azid~ except 
goat anti-human fluorescein which was used at 1:20. 
After incubation with the second antibody, the cells were 
again washed with 2 - 3 ml PBS. Where extracellular antigens were 
being labelled the cultures were now fixed as previously noted. 
The coverslips were then mounted onto glass slides in glycerol 
sealed onto the slide using clear nail varnish. 
For double-labelling experiments, the above procedure was 
followed first for labelling of extracellular antigens then, 
following fixation, repeated for intracellular antigens. 
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The controls used for immunofluorescence studies were the 
omission of the first antibody, its replacement with non-immune 
rabbit serum or the complete absence of any antibodies or sera 
except for 50% PBS/NGS. 
The labelled cells were then viewed using a Zeiss Standard 
microscope fitted with a VI FL fluorescence unit containing 
selective filter sets for rhodamine and fluorescein fluorescence. 
All photographs of these cells were taken using a Nikon camera 
attachment and 400 ASA Kodacolour or 125 ASA Ilford FP4 film. 
Immunodotting 
Immunodotting experiments were performed on homogenates 
prepared from primary culture of astrocytes as in Chapter 2. 
Briefly, in two separate experiments, a culture grown in a 60 mm 
diameter dish was washed twice with PBS and the cells harvested 
into 1 ml of distilled water at 4°C and sonicated on ice (10 sec. 
at an amplitude of 12, Soniprep, MSE Scientific Instruments). An 
aliquot was taken for determination of protein content (Lowry et 
ai, 1951) and then approximately 2 ~g and 0.2 ~g protein were 
dotted onto nitrocellulose paper grids in duplicate. The procedure 
for visualisation of antigens using the antibodies stated below 
was as described in chapter 2. 
anti-GFAP (Prof. M. Raff) 1 :300 
anti-fibronectin (Dr. R. Morris) 1:200 
anti-galactocerebroside (Dr. B. Ranscht) 1:400 
anti-Thy 1 (Dr. R. Morris) 1:125 
a) 
b) 
c) 
d) 
e) 
f) 
anti-neurofilament protein (Dr. B. Anderton) 1:10 
anti- y-glutamyl transpeptidase (Dr. S. Murphy) 1:50 
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Glutamine synthetase assay 
Confluent astrocyte cultures grown in 60 mm diameter petri 
dishes were assayed for glutamine synthetase essentially as in 
Ward and Bradford (1979). The cells were washed twice with 3 mls 
of iice cold 0.9% NaCl and hfested into Lml of buffer containing 
imidazole buffer (150 mM, pH 7.2), MgCl
2 
(19 mM) and 
mercaptoethanol (30 mM) and sonicated on ice (10 sec. at an 
amplitude of 12, Soniprep, MSE Scientific Instruments). Then 
100 ~l aliquots of disodium ATP (30 mM), monosodium glutamate 
(1.5 M), hydroxylamine (3 M freshly neutralised to pH 7.2 with 
-1 KOH) and pyruvate kinase (500 units ml ) were added, together 
with 300 ~l aliquots of ouabain (10 mM) and phosphoenol pyruvate 
(130 mM). The mixture was incubated at 37°C for 30 minutes at the 
end of which, duplicate 400 ~l aliquots were taken and added to 
800 ~l of a mixture of FeCl 3 (50 mM), perchloric acid (400 mM) and 
HCI (400 mM). After standing on ice for 30 minutes the protein 
precipitate was pelleted by centrifugation at 12,400 g for 10 
minutes (Microfuge 12, Beckman Instruments) and the optical 
density of the supernatant was read at 500 ~m. Standard curves 
were constructed by the addition of 10 - 1000 nmoles of y_ 
glutamylhyroxamate to the FeCl
3 
mixture. 
Further enrichment of astrocyte cultures 
Three possible methods for the further enrichment of the 
cell cultures with astrocytes were evaluated:-
a) Cytosine Arabinoside 
The first of these was essentially that of Rougon et al (1983). 
Astrocyte cultures were grown on poly-D-Iysine coated coverslips as 
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previously described. At the first medium change (6 d.i.v.), 6 
cultures were treated with 20 ~M cytosine arabinoside and 6 
cultures left untreated as controls. After 48 hours the cultures 
were washed twice with 0.5 ml of fresh medium and left to grow to 
confluence. No further megium changes were made . 
.. 
b) Thy 1 immunocytolysis in suspension 
The destruction of Thy 1+ cells in suspension by immunocytolysis 
prior to cell culture was attempted. Three aliquots of cells (3.5 _ 
6 _ 
5xl0) were taken from_the cell suspension produced during a normal 
culture preparation. These aliquots were incubated in medium ± 25 ~g 
of anti-Thy 1 (OX-7) for 30 minutes at room temperature and then 
washed twice in fresh medium by centrifugation at 600 r.p.m. for 10 _ 
minutes. After washing, the cells were re suspended in 200 ~l of 
medium ± 100 ~l guinea pig complement or medium alone and incubated 
for 45 minutes at 37°C in a shaking water bath. Again, the cells 
were washed twice in fresh medium after which the cells were counted 
and plated onto 13 mm coverslips as before. 
c) Immunocytolysis in situ 
Finally, the feasibility of using immunocytolysis to kill 
cells in confluent cultures in situ was examined by the use of Bl 
and anti-GGT antiserum. In short, astrocyte cultures grown on 
coverslips were treated with 25~g of Bl or anti GGT in 0.5 ml of 
medium for 20 minutes at room temperature. The medium was then 
removed and the cultures washed with 0.5 ml of fresh medium which 
was replaced with 300 ~l of medium with or without 2:1 guinea pig 
complement. The cultures were then incubated for 45 minutes at 
37°C. After removal of the guinea pig complement, the cultures 
were washed once with 0.5 ml of fresh medium and left for one 
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week in 0.75 ml of medium when they were examined under the 
microscope. 
Results 
Astrocyte-enriched cultures 
The method for._producing astrocyte-enriched cultures from the 
neontal rat cortex produces an initial yield of approximately 15 
million cells per animal at all ages used (0 - 2 days) Table 3
0
1. 
Cellular debris mounted to some 30% of the total particle count. 
The cells begin to put out processes after 2 - 3 days in vitro 
and divide and enlarge to produce confluent cultures by 18 - 22 d.i.v., 
with a protein content of between 300 - 800 ~g per 60 mm dish (mean 
480 ± 13 ~g, n = 205). A representative field of a confluent 
astrocyte culture at 19 d.i.v. is shown in Fig 3.1. The most COmmon 
cell type is of a flattened polygonal morphology. Observations of the 
cultures under the light microscope suggests that there are no 
neurons, defined as ovoid cells with one or two fine processes. 
Similarly, there are no cells with beating cilia which are commonly 
regarded as ependymal cells. However, two cells types other than 
flattened polygonal cells are seen in these cell culture, e.g. 
densely packed columnar cells which form loops or whorls. These 
cells are very similar to those seen in Fig. 3.2, a micrograph of 
a confluent meningeal cell culture. Also, rounded phase bright 
cells with a granular cytoplasm are seen. These cells readily take 
up Indian ink and are probably macrophages. 
Immunodotting shows that the most prominent antigens in 
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Table 3.1 0-Yield of cells from neoital cortices 
Age (days) Cells (x106 ) ± s.e.m. % Debris ± s.e.m. 
0 15.2 ± 0.6 (23) 31 ± 1 (23) 
1 14.9 ± 1.2 (15) - 28 ± 2 (15) 
2 14.7 ± 1.3 (10) 34 ± 1 (10) 
Legend 
The yield of cells in suspensions of neonatal rat cortices 
was estimated as described in Methods using a Coulter Counter. 
The number of cells was determined by subtracting the amount 
of debris (particles under 6 ~m) from the total number of 
particles present (particles above 6 ~m). The numbers in 
brackets refer to the number of individual culture preparations; 
all counts were made in triplicate. 
- 57 -
Fig 0 ·3.1 
Astrocyte-enriched culture 
A phase contrast micrograph of a representative 
astrocyte-enriched culture at 19 d.i.v., x 640. A large 
processed astrocyte (Lp) is indicated together with a 
macrophage (M) against a background of predominantly 
flattened, polygonal astrocytes. 
Fig. 3.2 
Meningeal cell culture 
A phase contrast micrograph of a representative 
meningeal cell culture at 14 d.i.v., x 500. Densely 
packed columnar cells (col) are observed together with 
flattened polygonal cells (Fp). 
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homogenates prepared from confluent astrocyte cultures are GFAP 
and FN (Figs 3.3 and 3.4). Neurofilament protein, galactocerebroside 
(GC) and Thy 1 immunoreactivity are almost completely absent; the 
only other antigen which is positively identified in the cultures 
is y-glutamyl transpeptidase (GGT). 
-. 
The use of the immunofluorescent technique to identify antigens 
expressed by individual cells in astrocyte cultures shows that the 
cultures stain extensively for GFAP (Fig. 3.5) and that the cells 
labelled with GFAP are of at least three different morphological 
types. Most common are large flattened polygonal cells 
(Fig 3.5). However, large processed cells (Fig. 3.6) and 
smaller processed cells (Fig. 3.7) are also seen. Examination of 
GFAP immunofluorescence staining of astrocyte cultures might suggest 
+ that the cells .. re almost exclusively 100% GFAP. However, FN is 
also present in these cultures, and.is found in both cell-
associated and non cell-associated forms. Fig. 3.8 illustrates 
the most common staining pattern for FN and shows a densely 
packed, multilayered grouping of cells. These cells conform to 
the columnar cell type seen in Fig. 3.2. Due to the dense packing 
+ 
of the FN cells, no count of the number of cells was possible. 
Cells of this morphology are also seen to label with anti-Thy 1, 
although the intesity of labelling was variable. FN is also 
present in a non cell associated form (Fig. 3.9) where it forms 
'trails' or very rarely 'mats' (Fig. 3.10). Additionally a weak 
but specific intracellular perinuclear staining of FN is observed 
in most cells which do not express the very marked cell 
associated staining pattern. 
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Fig. 3.3 
-
. 
Characterisation of astrocyte-enriched 
cultures by immunodotting I 
Immunodots of duplicate 2.0 and 0.2 ~g aliquots 
of astrocyte-enriched culture homogenates using anti-
GFAP, anti-FN, anti-GGT and pre-immune rabbit serum. 
Fig. 3.4 
Characterisation of astrocyte-enriched 
cultures by immunodotting 11 
1mmunodots of duplicate 2.0 and 0.2 ~g aliquots 
of astrocyte-enriched culture homogenates using anti-
Thy-1, anti-GC, anti-neurofilament protein (NF) and 
no 1st antihody. 
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Fig. 3.5 
GFAP immunofluorescence micrograph I 
Flattened polygonal cells in astrocyte-enriched 
cultures labelled with antiserum to GFAP, xllQO. 
Fig. 3.6 
GFAP immunofluorescence micrograph II 
'. + 
.'Highly fluorescent, large, mul·tiprocessed,.· 'CFAP cells 
+ (Lp) and flattened polygonal.·GFAP " cells. (Fp) ih an 
astrocyte-enriched culturej 'x1200 
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Fig. 3.7 
GFAP immunofluorescence micrograph III 
+ Finely processed GFAP cells in astrocyte-
enriched cultures, x lOOO. 
Fig. 3.8 
Fibronectin immunofluorescence micrograph I 
+ Dense, multilayered aggregation of FN cells 
underlying FN cells in an astrocyte-enriched culture, 
x 1400 •. 
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Fig. 3.9 
Fibronectin immunofluorescence micrograph 11 
Non cell-associated FN "trails" in astrocyte-
enriched cultures underlying cells with faint cytoplasmic, 
perinuclear labelling FN antiserum, x l~oO. 
Fig. 3.10 
Fibronectin immunofluorescence micrograph III 
Non cell-associated FN "mat" observed in an astrocyte-
enriched culture, l( l'toO, 
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I 
It is important to note that whilst whorls of columnar cells, 
which ~e observed to be the major cell type associated with FN 
in astrocyte cultures, can be found in such cultures, routine 
examinations of the cultures under the light microscope showed 
that whorls of cells are by no means always present in a 
particular culture dish. Further, the degree of contamination 
varies between different culture preparations. Although the 
+ densely packed and multilayered nature of the FN columnar cells 
prohibits an accurate cell count, examination of more than 10 
separate cultures using FN immunofluorescence and routine light 
microscopic observation of astrocyte cultures suggests that 
whorls of columnar cells commonly account for no more than 10 - 15% 
of the total number of cells present. Moreover, when cultures 
contained more than this approximate amount they were discarded. 
+ 
Thy 1 cells (other than columnar cells) were present in these 
+ cultures and represented 10% of the total number of GFAP cells 
in one experiment. In a separate experiment however, this figure 
+ + 
appeared to approach 50% or more Thy 1 cells. Thy 1 cells other 
than those of the morphology labelled with FN were of a flattened 
polygonal appearance. 
+ 
GC cells were very rarely seen in astrocyte cultures. 
+ Similarly no cells which were neurofilament protein were observed. 
An antiserum to GGT, a supposed capillary cell marker, labelled 
the surface of all cells in astrocyte enriched cultures as did 
the antiserum B1 as previously mentioned (Chapter 2.) 
Serum from humans with Chagas' disease when added to unfixed 
cultures produced a subsequent pattern of widely scattered dots of 
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fluorescence but control cultures labelled with anti-human 
fluoresce in alone also produced a similar pattern though not as 
dense. The labelling of cells with Chagasic serum and other 
surface labelling antibodies proved difficult to reproduce 
o 
Pho~raPhiCallY, partly due to the high level of background 
autofluorescence seen in these dense cell cultures. Control 
slides either incubated with no first antibody or with pre~ 
immune rabbit serum also showed a high-level of qutofluorescence 
- which could not be reduced using alternative fixatives e.g. 
methanol or 4% paraformaldehyde, or a different mounting agent 
e.g. DPX (BDH Biochemicals). Non-specific fluorescence i.e. that 
fluorescence seen in control slides which was not autofluorescence, 
was very low in most cases. 
Cultures incubated in the absence of any cell specific anti-
bodies sometimes contained cells which were labelled with all the 
fluorescence conjugated second antibodies used. These cells had 
the appearance of the phase bright, rounded, granular cells 
previously seen to take up Indian ink. They were considered to 
be macrophages and were present in cultures to a varying 
degree, from almost total absence to approximately 11% of total 
cells. However, the macrophages were loosely attached to the 
surface of the cultures and washing the dishes with 2 x 3 mls of 
PBS with swirling was sufficient to lower this value to 
approximately 2%. Generally macrophage contamination was low and 
the numbers remaining after washing prior to use in the experiments 
described later were negligible. 
An antiserum to glutamine synthetase (Dr. G. Pilkington) 
showed no specific staining. In contrast, when homogenates of 
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astrocyte enriched cultures were assayed for glutamine 
synthetase an activity of 0.95 ± 0.11 ~mol/mg/hr (n = 14) was 
measured. 
Enrichment of astrocytes in cell cultures 
Three methods were assessed for their possible routine use 
in purifying astrocyte cultures further. None were found to be 
useful. Treatment of the cells with cytosine arabinoside 
resulted in 'the almost total destruction of all cells present. 
Similarly, no cells which were treated during separation of the 
neonatal cell suspension, prior to plating, with anti-Thy 1 and 
complement, complement alone or those cells just subjected to 
the immunocytolysis procedure, survived in culture. Further, 
microscopic examination of confluent astrocyte cultures treated 
with B1 or anti-GGT in combination with complement showed no 
lysis of cells and no difference between antibody and complement 
treated, complement treated or untreated cultures. 
As a result of these three preliminary experiments and the 
results from the characterisation of the cell cultures, a method 
was devised for the growth of meningeal cells in vitro to use as 
a control for all future experiments using astrocyte-enriched 
cultures. 
Meningeal cell cultures 
Fig. 3.2 shows a phase contrast micrograph of a confluent 
culture of meningeal cells at 14 d.i.v. After initial plating, 
the meningeal cells grow and divide rapidly producing confluent 
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at 11-15 d.i.v. containing 300-1200~g protein, mean 512±23~g (n=216). 
Confluent meningeal cell cultures if left until 18-22 d.i.v., the 
age at which astrocyte enriched cultures are used, have a tendency 
to detach from the culture dish. 
The cell types seen in meningeal cultures show some similarities to 
those in astrocyte-enriched cultures Le. cells of flattened, polygonal 
shape and cells of columnar morphology organised into closely packed 
"whorls". The columnar cells are generally more numerous in meningeal 
cell cultures than in astrocyte cultures although the abundance of 
these cells varies widely. No ciliated cells and very few macrophages 
are present in these cultures. 
Immunodotting experiments performed in our laboratory using antibodies 
to FN, GFAP, GGT and THY - 1 (Murphy, unpublished observations) have 
shown that the most prominent antigens present in homogenates of 
meningeal cells in vitro are FN and GGT. There is some Thy 1 
immunoreactivity and notably some GFAP is also present which indicates 
that there are some astrocytes present/although the labelling is 
markedly less than in astrocyte cultures 
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-1 Discussion 
A comparatively simple method for the production of astrocyte 
enriched cultures from the cortex of the neontal rat has been 
described together with the results of extensive characterisation 
of these cultures. The method has many advantages over the adult 
cell separation technique described in Chapter 2. The brain of 
one newborn rat yields five confluent cultures after 18-22 d.i.v. 
which represents on average 2400 ~g of protein in total. This is 
compared to 200 ~g of protein which was the yield of the astrocyte 
fraction from one adult rat cortex using the cell separation method. 
Sufficient material for several biochemical experiments on viable, 
intact cells can be obtained from one culture preparation compared cS 
to the very limited scope for experimentation on adult cells 
prepared by a very long separation process. Furthermore the 
cultures are astrocyte enriched (approximately 85% astrocytes) 
which could not be stated positively for the material in the 
fraction derived by the adult cell separation method. Finally, 
the contaminating cells present in the astrocyte enriched cultures 
I 
could be identified and attempts made to control for them. 
Immunodotting studies showed that GFAp, an astrocyte specific 
protein in vivo thought to be associated with glial filaments 
(Bignami and Dahl, 1974; Schachner et aI, 1977) was the most 
prominent antigen in astrocyte culture homogenates. Similarly, 
immunofluorescence experiments show an intense labelling of the 
cells with anti-GFAP antiserum which, if taken in isolation, 
+ 
would suggest that GFAP cells comprised almost all of the cells 
present. Indeed the culture conditions were chosen to favour the 
growth of glia in general and astrocytes in particular. In the rat 
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cerebral cortex at birth, neurons have, in the main, ceased 
dividing and glial cells are the most mitotically active cell 
type (see e.g. Parnavelas et al, 1983). Moreover the concentration 
+ 
of K in the culture medium «5mM) is known to be unfavourable for 
neuronal growth in vitro (Lasher and Zagon, 1972). The seeding 
density of the initial cell suspension was low to reduce the 
proliferation of oligodendrocytes (see Ki~elberg, 1983). Furthermore, 
the presence of serum in the culture medium is known to favour the 
differentiation of astrocytes rather than oligodendrocytes from a 
common precursor cell in optic nerve cultures (Raff et al, 1983). 
In addition, chick embryo extract was used in an attempt to inhibit 
the growth of fibroblasts as described by Coogan et al (1968). 
.f 
The expression of GFAP by the cells in culture not only shows 
that they are astrocytic but also, as astrocytes in vivo mostly 
express GFAP at myelination (at the second or third post-natal 
week; Dahl, 1981), that at least in one respect the astrocytes are 
differentiated. 
The specific activity of glutamine synthetase (0.95 ± 0.11 ~mol/ 
mg/hr) an astrocyte specific enzyme in vivo (Norenberg and 
Martinez-Hernandez, 1979) is similar to other values previously 
reported for astrocyte cultures after three weeks in vitro 
(Hallermayer et al, 1981; Tardy et al, 1982; Juurlink, 1982). 
However, it must be noted that this level of activity is not as 
high as is seen in homogenates prepared from adult rat cortex e.g. 
2.5 ~mol/mg/hr (Patel et al, 1983). These results indicate that, 
while the cell cultures obtained using this method contain 
predominantly astrocytes and may be differentiated in some aspects of 
their biochemistry,they do not appear to be identical to astrocytes 
in vivo. 
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+ The morphology of the GFAP cells was predominantly of a flatte~d 
polygonal appearance (Fig. 3.5), resembling the Type 1 astrocytes 
described by Raff and co-workers (see Temple and Raff, 1985). 
Large multiprocessed GFAP+ cells (Fig. 3.6) were also usually present 
in the cultures althougb their number varied quite widely and no cell 
counts were attempted. + . Smaller, processed GFAP cells wh~ch resembled, 
morphologically,Type II astrocytes as described by Raff and co-
workers (see Temple and Raff, 1985) were comparatively rare in the 
astrocyte cultures used here.. These cells were usually found at the 
edges of the coversl.ips on which the cells were grown (Fig. 3.7) and 
were not in contact with other cells. However, on rare occasions 
+ it was possible to observe small,. processed GFAP cells in close 
+ 
conjunction with larger flattened GFAP cells in the confluent areas 
of the cell cultures even after three weeks in vitro. Such small 
+ GFAP cells had clearly not changed into large, polygonal astrocytes 
+ 
on contact with other GFAP cells as is believed to occur in 
cerebellar astrocyte cultures (Wilkin, pers. comm.) 
- 7'tA-
When astrocyte cultures were labelled with anti-FN, a 
proposed cell specific marker for meningeal cells, endothelial 
cells and fibroblasts in vitro (Schachner et al, 1978; Raff et al, 
+ 1979), it became clear that GFAP cells, whilst in the majority, 
were not the only cell-type present. Immunodotting studies showed 
that FN was a prominent antigen in homogenates of astrocyte 
cultures. Also, cells which expressed FN on their surface were 
observed in astrocyte cultures using immunofluorescence. These 
+ 
FN cells were arranged in densely packed bundles or whorls, were 
of a columnar shape and were readily identified under the light 
microscope. Cells of this morphology also label with anti-Thy 1, 
although with varying intensity. This is not in agreement with the 
results from anti-Thy 1 immunodotting (Fig. 3.4) but probably 
+ + 
reflects the use of different antibodies. FN, Thy 1 cells in CNS 
cultures are thought to be meningeal fibroblasts (Raff et al, 1979) 
+ 
whereas FN Thy 1 cells were taken to be pial and arachnoid cells 
from the meninges, although this distinction is unclear (Bartlett 
et al, 1981). 
The number of FN+Thy 1+ meningeal fibroblasts in astrocyte 
cultures was very difficult to assess due to their aense local packing 
-Considering (a) the variatiory in the number of columnar cells in 
astrocyte cultures as seen during routine examination, (b) the 
degree of cell associated FN staining and (c) the fact that cultures 
with high proportions of columnar cells were discarded, an estimate 
+ 
of 10-15% FN cells in astrocyte cultures is given. Moreover, the 
biochemical experiments described in Chapte~s 4, 5 and 6, in 
+ particular the differential effects of [K 10 and neurotransmitter 
agonists on glycogen stores of astrocytes and meningeal cells, 
strongly suggest a minimal meningeal cell contamination in astrocyte 
cultures. 
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FN staining not associated with a particular cell type is 
also observed in astrocyte cultures. This may be derived from 
the serum present in the culture medium as the antiserum used 
was raised against blood serum fibronectin which cross reacts 
with extracellular matrix fibronectin (Dr. R. Morris, pers. comm.; 
Yamada and Olden, 1978). Alternatively, the trails of FN may be 
+ left by migrating FN cells. 
Anti-FN was also observed to label intracellularly the majority 
of cells present in astrocyte-enriched cultures
o 
This result was 
unexpected as astrocytes are not reported to express FN (Raff et aI, 
1979). As astrocytes are known to take up serum proteins in vivo 
(Trachtenberg, 1983), and as the anti-FN antiserum used here was 
raised against serum fibronectin, th~ intracellular staining in 
astrocyte cultures may represent labelling of endocytosed serum 
fibronectin. 
Anti-Thy 1 also labelled cells of a flattened, polygonal 
morphology, (a morphology not seen to be labelled with anti-FN), 
+ in addition to the FN columnar cells. These cells were taken 
+ + 
to be Thy 1 , GFAP astrocytes which are know to occur in 
astrocyte cultures after 1 week in vitro (Raff et aI, 1979) and 
may consitute 58% of the total cells present (Pruss, 1979): 
Double-labelling experiments using anti-GFAP and anti-Thy 1 proved 
unsuccessful due to the detachment of the majority of cells 
during the procedure. 
Visual examination of the cultures indicated the absence of 
neurons. In agreement with this is the complete absence of any 
positive reaction with anti-neurofilament protein antiserum in 
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immunofluorescence or immunodotting studies. This result was 
expected as rat astrocyte cultures prepared using a variety of 
similar methods are never reported to contain neurons and the 
culture conditions had been chosen to inhibit the survival of 
neurons. Notably, Hansson et al (1980) state that neurons are 
absent from rat hemisphere cultures on the basis of cell 
morphology and, moreover, the absence of cells positive for 
14-3-2 protein, i.e. neuron specific enolase (Marangos et ai, 
1976; Langley et ai, 1980), in immunofluorescence studies. 
+ As expected from the choice of culture conditions GC cells 
(oligodendrocytes; Raff et ai, 1978) were very rarely observed in 
astrocyte cultures, in spite of a slight immunoreactivity seen in 
immunodotting experiments. This is probably due to the removal 
of these cells by the washing process involved in the immuno-
fluorescence procedure as they are attached to the surface of 
mixed glial cultures and may be removed by shaking the cultures 
(McCarthy and de Vellis, 1980). 
Macrophages, identified as round, phase bright granular cells 
which accumulated Indian ink and fluoresced after exposure to any 
fluorochrome linked antibody, were also readily removed from the 
cultures by washing. 
Capillary endothelial cells which have been reported to 
contaminate astrocyte cultures (Hansson et ai, 1980; Woodhams et ai, 
--1981) could not be positively identified by Chagasic serum in the 
culture preparation used here. Chagasic serum is derived from 
patients with Chagas' disease, a South American trypanosomiasis 
caused by T. cruzi, and has been reported to label capillary 
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endothethial cells in vivo and in vitro (cf Wilkin et aI, 1981). In 
+ 
addition, no FN cells could be identified with either of the morph-
ologies ascribed to capillary endoethelial cells, i.e. small (10 ~m 
perikaryon) cells ~ith flattened velate processes (Wilkin et aI, 1981) 
or more flattened, polygonal cells with short processes (Hansson et aI, 
1980). It appears however that there may be some capillary endothelial 
cells present in these astrocyte cultures as there is low but measur-
able alkaline phosphatase activity in astrocyte cultures (0.18 ± 0.01 
~mol/mg/hr, Murphy unpublished experiments). Alkaline phosphatase is 
believed to be localised to capillary endothelial cells (Kange et aI, 
1978) although there is evidence for its presence in neurons (Sugimura 
and Mizutani, 1979). The activity of the enzyme in rat cerebral micro-
vessels is however markedly higher (7.4 ~mol/mg/hr, Estrada et aI, 
1983) than in astrocyte cultures. GGT as visualised by immuno-
fluorescence is found to be present on all cells in the astrocyte 
cultures and its use as a capillary endothelial cell-specific marker 
in vitro (DeBault and Cancilla, 1980) must be questioned. 
Extensive characterisation of astrocyte-enriched cultures (as 
+ used for larger biochemical experiments) thus showed that GFAP cells 
+ predominate and that the major contaminating cell type(s) are FN 
and probably derived from the meninges. A series of preliminary 
experiments designed to increase the astrocyte content of the 
cult~res were unsuccessful. 
Cytosine arabinoside treatment, as described beXore, destroyed 
all cells present in the cultures. It is possible that replating 
the treated cells as performed by Rougon et al (1983) may be 
crucial for the success of this technique. This would have been 
an unrealistic procedure to add to the method described for producing 
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large numbers of astrocyte cultures. 
+ The use of anti-Thy 1 and complement to destroy Thy 1 cells 
(fibroblasts) in adult astrocyte culutres has been described by 
Lindsay et al (1982) but there are limitations on the use of this 
method to remove Thy 1+ cells in astrocyte cultures derived from 
the neonatal cortex. For example, the levels of Thy 1 in rat 
brain are very low at birth (Schachner and Hammerling, 1974) and 
its exact cellular d1stribution at this stage is unknown. Thus it 
+ + 
is possible that the FN , Thy 1 cells seen in confluent cultures 
of astrocytes may not be those cells which express Thy 1 at birth. 
However, this technique was used "in an attempt to destroy Thy 1+ 
cells in a suspension of cells from the neonatal rat prior to cell 
culture. The procedure followed was apparently too rigorous for 
the cells at this stage, (just after disaggregation of the cortex) , 
as no cells, control or experimental, survived in culture. 
k (). iUv.!r 9- the theoretical and methodological problems involved 
+ in immunocytolysis of Thy 1 cells in neonatal cortex cell suspensions 
and the infeasability of replating large numbers of cultures, the 
+ + possibility of destroying Thy 1 or FN cells in confluent astrocyte 
cultures in situ was examined. It must be noted, however, that some 
+ + 
of the Thy 1 cells at this stage are probably also GFAP , so 
successful treatment with anti-Thy 1 and complement would destroy 
some astrocytes as well as fibroblasts. For the initial study, B1 
and anti-GGT were used as both of these were more available than 
either anti-Thv 1 or anti-FN and both were known to label most cells 
in astrocyte cultures. Thus if the concept of immunocytolysis in 
situ itself was valid, then incubating confluent astrocyte cultures 
with these antisera and complement should produce cell lysis. In 
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fact no cell death was observed in either antibody and complement 
treated cultures. 
+ 
+ This suggested that in order to remove Thy 1 
or FN cells, cultured cells might have to be removed from the 
culture dishes into a suspension, lysed and then replated. This, 
as previously noted, was not practicable for large numbers of 
cultures. 
Astrocyte-enriched cultures prepared by this method therefore 
+ 
contain a population of FN cells, presumably derived from the meninges, 
and t~ese are not readily removed. As these culture were to 
be used as a model for astrocytes in future biochemical studies it 
was important to allow for the contamination with other cell types. 
To this end a simple method for the culture of meningeal cells, the 
most probable contaminants, was developed. The method uses 
meninges removed from brains prior to use in preparing astrocyte 
+ enriched cultures and should represent closely those FN cells 
which are known to contaminate astrocyte cultures. Indeed 
immunodotting experiments show that meningeal cell cultures contain 
substantial amounts of FN (Murphy, unpublished experiments). Further-
more, meningeal cultures may contain cell types which are also 
present in astrocyte cultures but not readily detected by immuno-
cytochemical means. For example, astrocyte enriched cultures are 
commonly regarded as being contaminated with capillary endothelial 
cells as previously djscussed. Immunofluorescence studies however 
did not provide conclusive evidence for the presence of these cells 
in astrocyte cultures. Conversely, the cultures contain alkaline 
phosphatase, an enzyme found predominantly in capillary endothelial 
cells. Meningeal cell cultures would appear to be a useful control 
for this and possibly other contaminating cell types as they too 
contain alkaline phosphatase activity (and thus presumably capillary 
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endothelial cells) and in greater amounts than in astrocyte 
cultures (0.30 ± 0.04 ~mol/mg/hr against 0.18 ± 0.01 ~mol/mg/hr). 
However, it must be noted that the level of alkaline phosphatase 
seen in meningeal cultures is rather less than that seen in 
isolated microvessels (7.4 ~mol/mg/hr, Estrada et ai, 1983) which 
may indicate that capillary endothelial cells do not survive well 
under these culture conditions. 
In summary, a method for the production of astrocyte enriched 
cultures from the neonatal rat cortex has been described and these 
cultures have been well defined with regard to cell type. The method 
produces a culture system highly enriched in astrocytes as 
determined by GFAP immunoreactivity and the level of glutamine 
synthetase activity. The cultures also contain a variable 
+ population of FN cells (estimated at 10 - 15%) which are thought 
to be FN~ Thy 1+ fibroblasts derived from the meninges. In order 
to control for the presence of contaminating cells in cultures 
that were to be used in experiments to determine the action of 
neuroactive agents on astrocytes, a method for meningeal cell 
culture was developed. 
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CHAPTER 4 
+ The effect of changes in extracellular K on 
astrocyte glycogen stores 
In Chapters 2 and 3, bulk separation of astrocytes from the 
adult rat cortex and rat cortical astrocyte cultures were evaluated 
as possible models to be used to examine the effects of putative 
neuron/astrocyte signals (Chapter 1). Due to the methodological 
problems involved in bulk cell separation, astrocytes in primary 
culture were selected. This chapter describes the use of astrocyte 
enriched cultures and cultures of meningeal cells, the cell type(s) 
considered as the most likely contaminant, to examine the effects 
+ 
of changes in [K ]0 on astrocyte glycogen stores. 
Glycogen stores were chosen as a possible indicator of neuron/ 
astrocyte signalling in the mammalian CNS for several reasons. 
First, glycogen in the CNS is localised predominantly in 
astrocytes in both the adult (Sotelo and Palay, 1968; Pheips, 1971; 
Peters et ai, 1976) and in the young or perinatal animal (Bruckner 
and Biesold, 1981). In fact, as stated previously, the possession 
of rich supplies of glycogen is a c~aracteristic feature of 
astrocytes. However, it must be noted that in young rats glycogen 
is also found in the cells of the ch~roid plexus, meninges and 
occasionally in the growing processes ofaxons (Bruckner and Biesold, 
1981). In addition, some neurons in the pons, medulla and spinal 
cord of the rat contain glycogen up to about post-natal day 24 
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(Borke and Nau, 1984). In the adult CNS, glycogen is observed in 
the meninges (Ibrahim, 1975) and in some neuronal processes (Sotelo 
and palay, 1968; KOizumi, 1974) and perikarya (Mossakowski et ai, 
1968; Ibrahim, 1975; Takieuchi, 1975). 
Secondly, although the amount of glycogen stored in the CNS is 
relatively small when compared to the liver, the turnover of 
brain glycogen is higher than that of the liver by several orders of 
magnitude (Ibrahim, 1975) and may ·therefore be important in the 
overall metabolism of the CNS. Alternatively, the high turnover rate 
of CNS glycogen may reflect a higher cell activity, and therefore 
energy demand, in the brain. The enzymes controlling the turnover of 
glycogen in the brain are the same as those in the liver (Fig. 4.1) 
and have been examined previously with respect to their presence, 
activity, localisation and to some extent their regulatory mechanisms 
(see Maker and Lehrer, 1972; Ibrahim, 1975 for reviews; also 
Passoneau and Crites, 1976). 
Thirdly, it has recently been proposed that the glycogen stores 
• 
of glial cells respond to the activity of neurons (Pentreath, 1982) . 
Pentreath and co-workers have examined extensively the inter-
relationships between neurons and glia in invertebrate preparations 
(Pentreath et ai, 1985). Of particular interest have been the 
3 studi~s performed regarding the incorporation of [ H]-2-deoxyglucose 
([3H]-2-DG) into the glycogen stores of the leech (Haemopis 
sanguisuga) abdominal ganglia and the bucca~ ganglia of the snail, 
Planorbis corneus (Kai-Kai and Pentreath, 1981; Pentreath and Kai-Kai, 
1982; Pentreath et ai, 1982). Antidromic stimulation of the nerves 
3 in the ganglia resulted in an increased incorporation of [ H]-2-DG 
into glycogen of glial cells and to a lesser 'extent neurons. 
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Fig. 4.1 
Diagrammatic representation of glycogen 
metabolism in the liver 
a) The synthesis of glycogen is catalysed by glycogen 
synthetase (GS; E.C.2.4.1.11) which transfers the glycosyl 
group of uridine diphospho-glucose (UDP-gl~cose) to the 
end of the glycogen chain. Glucose may also be added to 
the chain through the action of a branching enzyme (Br; 
E.C.2.4.1.18) which incorporates approximately 9% of the 
glycose found in glycogen. Glycogen is degraded by 
glycogen phosphorylase (GP; E.C.2.4.11) . and a debranching 
enzyme (DBr; E.C.2.4.1.25) to yield gl~cose-l-phosphate 
and gl~ose respectively. Both of the principle synthetic 
and degradative enzymes are found in active (a) and 
inactive (b) forms. 
b) The interconversion of the a and b forms of GS and 
GP is controlled by several enzymes whose activities are 
influenced by the levels of the intracellular second 
2+ 
messengers cAMP and Ca • Rising levels of cAMP activates 
protein kinase which evokes a r~uction in glycogen 
synthesis by promoting the conversion of GSa to GSb and 
inhibiting the production of GSa from GSb by phosphatase. 
. 2+ Also, increase in 1ntracellular cAMP or Ca promote the 
conversion of GPb to GPa through activation of GPb kinase 
and inhibition of phosphatase. Thus both the synthetic 
and degradative pathways of glycogen metabolism resulting 
in a net breakdown of glycogen stores. 
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3 3 Similarly, the levels of glycogen formed from [ H]-2-DG ([ H]-2-
deoxyglycogen) extracted from stimulated ganglia were increased 
2 - 3 times over control ganglia (Pentreath and Kai-Kai, 1982). 
The incorporation of [3 H]-2-DG into ganglionic glycogen was also 
+ increased by elevated {K ]0 , as seen by electronmicroscope auto-
radiography and measured by extraction of [3 H]-2-deoxyglycogen. 
3 Notably, the maximal increases in [ H]-2-deoxyglycogen levels 
+ (2.5 - 3 times control) were seen with an increase in [K ]0 of 
around 4 mM (Pentreath and Kai-Kai, 1982) which is considered to 
Occur physiologically as a result of neuronal activity. These 
+ authors suggest that elevated [K ] 0 o..c. f.J (J..!: a neuron/glia signal 
to "provide a significant mechanism for ensuring continual energy 
supplies [for neurons] during and subsequent to intense activity". 
Indeed" a role for astrocytes as a "metabolic link" between blood 
stream and neurons in mammals has already been suggested (Chapter 1, 
see also Gray, 1961; 1964; Kuffler, 1967). Further, Phelps (1971) 
proposed that glucose transported from the blood might be 
stored as glycogen in astrocytes and subsequently released into the 
extracellular space for neuronal use, dependant on neuronal 
requirements, signalled to astrocytes by neurotransmitters. 
Thus glycogen is a) found mainly in astrocytes in the CNS, 
b) rapidly turned over, c) controlled by enzymes which are known 
and relatively well understood, and d) affected by the activity 
of neurons in invertebrate preparations. Changes in astrocyte 
glycogen stores therefore seem to be a suitable response to study 
with respect to possible neuron/astrocyte signalling mechanisms. 
The possible nature of the signal(s) between neurons and 
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astrocytes should now be considered. The signal(s) are presumably 
released from neurons. Tight junctions are not commonly seen between 
neurons and glia (Peters et aI, 1976) so direct transfer seems unlikely. 
Neurons are known to release neurotransmitters which may act on the 
glycogen stores of astrocytes as was suggested by Phelps (1971) and as 
is discussed in Chapter 6. More fundamentally, it is known that neurons 
+ 
release K from their axons and terminals during the course of action 
potential conduction and transmission (Frankenhauser and Hodgkin, 1956). 
. + Indeed it has already been noted that changes 1n [K ]0 can affect 
the glycogen stores of invertebrate glia. Furthermore, one of the 
major facts known about astrocytes in vivo is their responsiveness 
+ e 
to K as reflected in the dependlnce of their membrane potential 
+ 
to [K ] o. 
In the mid 1950s it was reported that there were cells in the spinal 
cord (Coombs et aI, 1955) and cerebral cortex (Phillips, 1956) which had 
large membrane resting potentials and did not show synaptic or action 
potentials when stimulated directly by electrodes, or indirectly by 
nerve volleys. These cells were termed "idle" or "silent" cells. The 
initial supposition that these were glial cells was later proved to be 
correct by various histological studies using intracellular dye 
injection into the "silent" cells after recording (see Orkand, 1978). 
Further studies were then carried out in explant cultures of 
kitten CNS by Hild et al (1938; 1962) and by Kuffler, Nicholls and 
Orkand using the leech CNS and the Necturus (mudpuppy) retina and 
optic nerve (for review see Orkand, 1978). In these systems the 
neuroglial cells were comparatively easy to identify and to record 
from electrophysiologically when compared to astrocytes in situ in 
the mammalian brain. It was seen that glial cells generally have a 
transmembrane potential (Em) of between -70 and -90 mV (inside 
- 87 -
+ 
negative) which is depolarised progressively as the [K ]0 increases. 
Detailed examination of the mud puppy optic nerve showed that the Em 
of the glial cells surrounding the axons of the optic nerve varied 
+ 
with [K ] 0 exactly as predicted by the Nernst equation. This 
indicated that glial cells have a high degree of membrane permeability 
for this ion. Alterations in the concentrations of other ions such as 
+ 2+ + 
Na , Cl and Ca show that the K permeability determines primarily 
this membrane potential (Orkand, 1978). The conclusion for the 
Necturus optic nerve glia has also been shown to be true for 
mammalian astrocytes in vivo, and in primary culture as reviewed by 
Walz and Hertz (1983). 
As previously noted, the ionic fluxes across the neuronal 
+ 
membrane during an action potential result in a loss of K from 
neurons and this release has been implicated as the cause of the 
slow depolarisation of cortical glial cell membranes during increased 
neuronal activity in the cortex (Karamashi and Goldring, 1966). In the 
+ 
cat cortex, K sensitive electrodes have been used to demonstrate the 
. + 
correlation of 1ntercellular K levels with increased neuronal 
activity (Prince et al, 1973). + This K exchange may serve as a 
signalling mechanism at least in the neuron-to-astrocyte direction. 
Thus a series of experiments was designed to examine the eff-ects 
+ 
of [K ]0 on astrocyte glycogen stores with the aim of-determining 
a) whether astrocytes in vitro contain glycogen and b) whether 
+ 
astrocytes respond to changes in [K ]0 using glycogen as an indicator. 
Recent work from our laboratory (Pearce et al, 1985a,b) has 
shown that neonatal rat cortical astrocytes in vitro can 
14 
incorporate [ C]-2-DG into glycogen. However, the use of radio-
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labelled 2-DG incorporation into glycogen as a measure of glycogen 
leads to difficulties of interpretation. This is because the 
increased incorporation of radiolabelled 2-DG into glycogen does 
i 
not dtscriminate between a net increase in glycogen or an increase 
in turnover rate. It is therefore preferable to measure total 
glycogen stores. This can be achieved using the enzymatic breakdown 
of glycogen by amylo- a1,4 a1,6-glucosinase (EC.3.2.1.3) (AG) and 
subsequent measurement of the released glucose by hexokinase and 
glucose-6- phosphate dehydrogenase (Lust and Passoneau, 1975). 
In this chapter it will be shown that:-
i) Glycogen is contained in cultures of astrocytes and 
meningeal cells. 
ii) The glycogen levels of astrocyte cultures are affected by 
increases in + [K ]0 of the order (2.5 mM - 12.5 mM) believed to occur 
in vivo as a result of neuronal activity. 
iii) Meningeal cells in vitro also possess glycogen stores 
+ 
which are affected by increases in [K ]0. However, the time and 
concentration dependlncy'of the effects on meningeal stores differ" 
from that found in astrocyte cultures. 
Methods 
Cetl cultures 
Astrocyte and meningeal cultures were prepared as previously 
described (Chapter 3) and grown on 60 mm diameter piastic dishes. 
The cultures were used at confluence (18 - 22 d.i.v. for astrocytes) 
11 ~ 15 d.i.v. for meningeal cells) with medium changes at 6 d.i.v. 
for astrocyte and meningeal cells, and at 13 d.i.v. for astrocytes only. 
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K exposure 
In order to produce maximal levels of glycogen in these cultures, 
the glucose concentration of the culture medium was increased to 20 mM 
two hours prior to the start of the experiment (Cummins et ai, 1983). 
The culture medium was removed after the 2 hour pre-incubation period 
and the cultures washed with 3 mls of pre-warmed buffer (NaCl, 120 mM; 
NaHC03 , 10 mM; NaH2P04 .2H20, 1 mM; KC1, 2.5 mM; D-glucose, 20 mM; 
MgS04 ·7H20; 1.5 mM; CaC1 2 .2H20, 2.5 mM; HEPES, 20 mM; pH 7.4 with HC1; 
at 37°C); 5 mls of buffer was then added to the washed cultures. In 
° 
experiments where the ~ ]0 was raised, the KCl concentration was 
increased (the NaCl concentration was correspondingly reduced to maintain 
osmolarity) and the cultures washed with buffer containing the 
+ 
appropriate K concentration. The cells were then incubated (35.5 0 C, 
3% co2/air) for 10, 30, 60 or 90 minutes. 
+ Four different [K ]0 were 
used in each experiment, 2.5, 5, 10 and 15 mM. Typically, two 
+ 
cultures were used per concentration of [K ]0' totalling 8 cultures, 
and all cells were incubated for the same time period in anyone 
experiment. At the end of the incubation period, the buffer was 
removed and the cells washed twice with 3 mls of ice cold 0.9% NaCl. 
800 ~l of 0.1 N NaOH was .added to each dish and the cells 
harvested. 
Statistical Analysis 
It was noted that there was marked variability in the glycogen content 
of cell cultures between replicate experiments. In order to reduce 
the effect of this variation, the results were analysed by comparing 
the glycogen contents of experimental cultures to those of control 
+ 
cultures (incubated in 2.SmM[K ]0) from the same experiment. For 
example, the effect of incubating astrocyte cultures with experimental 
+ 
K concentrations for 30 minutes was determined in three experiments 
+ 
with two cultures used per [K ]0 in each experiment. The paired data 
(i.e. experimental and 2.SmM control) from the three experiments were 
then pooled and analysed by matched pair 2 tailed t-test (Snedecor 
and Cochran, 1967). Typically, a significant difference was only 
found when all the values of experimental culture glycogen content 
were less than their corresponding control values. 
Comparisons were also made between the glyocgen contents of cell 
cui tures. at different time points.. As a complete time course was not 
performed in anyone experiment, these data could not be matched and 
analysed as before.. Instead the data. were expressed as percentage 
+ values of their corresponding control value (at 2.SmM [K ]0 and 
analysed using Kruskal-Wallis non-parametric analysis of variance to 
determine whether there were statistically significant changes in 
cell culture glycogen with time. 
The glycogen content of the cultures was determined using a 
method based on Passoneau and Lauderdale (1974), Lust et al (1975) and 
Cummins et al (1983a). 
i) The cell suspension was transferred to 1.5 ml capped, conical 
Eppendorf tubes and the glucose in the suspension was degraded by 
heating at 80°C for 20 minutes (Lust et aI, 1975). 
the 
ii) Aliquots were then taken for determination of protein by 
~~~. 
method of Lowry L(1951), using BSA as a standard (Sigma, fraction V) . 
iii) Material insoluble in O.lN NaOH was removed by centrifugation 
at 12,400 g for 10 minutes (Microfuge 12, Beckman Instruments). 
iv) The supernatant was transferred to 5 ml conical tubes and 
1.6 mls of 95% ethanol was added to the supernatant (final concentration 
approximately 66%) in order to precipitate the glycogen (Bernard, 1857; 
Pfluger, 1904). 
v) The glycogen waspelleted by centrifugation at 3000 r.p.m. 
(1600 g) for 15 minutes in a Coolspin centrifuge (MSE Scientific 
Instruments) . 
vi) After removal of the supernatant the pellet was resuspended 
in 100 ~l of O.lM sodium acetate buffer (pH 4.7) and the glycogen 
reprecipitated and pelleted by the addition of 200 ~l of 95% ethanol 
and centrifugation as in iv). The double precipitation of glycogen 
with ethanol was found to be necessary as glycogen could not be 
detected in aliquots of supernatant taken from step ii) as suggested 
by Cummins et al (1983a). A single precipitation step produced 
variable results in duplicates of control glycogen solutions dissolved 
in O.lN NaOH (data not shown) and so a second precipitation step was 
used to wash out any remaining NaOH. 
vii) The resulting pellet was resuspended in 100 ~l of O.lM sodium 
acetate buffer and degraded to glucose by the addition of 5 ~l 20 mM 
Tris-HCl pH 7.5 + 0.02% BSA (Sigma fraction V) containing 5 ~g of 
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of amylo- a 1,4 - a 1, 6-glucosidase (AG; EC 3.2.1.3; Sigma grade IV from 
A. niger) and subsequent incubation at room temperature for 30 
minutes (Passoneau and Lauderdale, 1974). The addition of 50 ng 
of AG as in the original method (Passoneau and Lauderdale, 1974) did 
not produce any measurable glucose from extracted glycogen standards. 
This may be due to the use of AG from Sigma rather than from 
Boehringer Mannheim GmbH which was used in the original method. 
viii) The glucose thus produced was measured colorimetrically 
using a commercially available test kit (Hexokinase!glucose-6-phosphate 
dehydrogenase method; Boehringer Mannheim GmbH). The sensitivity of 
the assay meant that only one determination per culture was possible. 
ix) Glycogen standards (rabbit liver; Sigma Type Ill, 1 - 10 ~g 
in O.lM sodium acetate buffer pH 4.7, in duplicate) were subjected 
to identical precipitation, enzymatic breakdown and glucose 
measurement procedures as described for glycogen derived from cell 
cultures. A standard curve for glycogen was prepared in each 
experiment. 
x) In some cases, glycogen from cultures was not treated with AG 
in order to estimate the contamination of the purified glycogen with 
glucose, glucose-6-phosphate and other glucose containing compounds 
such as cerebrosides and gangliosides which affect the glucose assay. 
Results 
Glycogen assay 
Fig. 4.2 is a typical standard curve used for the estimation of 
glycogen content in cell cultures. It shows that there is a 
linear relationship between the log of the amount of standard 
glycogen before extraction (1 - 10 ~g) and the log of the change in 
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Fig. 4.2 
A typical standard curve for . 
glycogen estimation 
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absorbance at 340 nM (~) of the glucose assay mixture. The change 
in absorbance is caused by the production of NADPH from the action 
of hexokinase and glucose-6-phosphate dehydrogenase on glucose 
formed from the glycogen standards after extraction and enzymatic 
breakdown. This method permits measurement of amounts of glycogen 
as low as 0.5 ~g per assay but not reproducibly as although the 
standard curve is linear, ~A produced by a particular glycogen 
concentration varies between (but not within) extractions. 
The modified method of glycogen extraction from cell cultures 
used here gives an extract which yields a range for ~A in the glucose 
assay of 0.000 - 0.002 absorbance units (mean 0.001 ± 0.0004, n = 4) 
when pretreatment with AG is omitted. When the cell culture 
extracts were pretreated withAG however the values of ~A were 
between 0.020 - 0.100 for astrocytes and be"tween 0.010 - 0.300 for 
meningeal cells. This indicates that the extract is free of glucose 
and glucose-containing compounds measurable by the glucose assay 
used here. 
Time course of glycogen accumulation in cell cultures 
Fig. 4.3 represents the values for glycogen content in 
+ astrocyte and meningeal cell cultures incubated in 2.5 mM [K ]0 
buffer for varying times (10, 30, 60 and 90 minutes). The results 
show a high degree of variability in the glycogen content of both 
cell types over time. It is evident, however, that there is no 
ongoing net synthesis of glycogen in either astrocyte or meningeal 
(J.f S "'-<.:lw.... I,j \.)'X'...- - w<'4 C""-~J":" &t IJC"",, c\.".u:... . 
cell cultures over 90 minutest It is also noticeable that the 
meningeal cell glycogen content is higher by approximately two 
times, than that in astrocyte cultures under control conditions 
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+ (2.5 mM [K ]0) at all time~points . 
. /
., 
• 
• 
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Fig. 4.3 
Time course of the glycogen content of 
astrocyte-enriched and meningeal cell cultures. 
Astrocyte-enriched (A) and meningeal cell (M) cultures 
were incubated in buffer containing 2.5 mM [K+]o for 
various time intervals and the glycogen content determined 
as in Methods. The results shown are mean values with an 
n of between 6 - 13, where n is the number of individual 
dishes per time point. Bars indicate standard error of 
the mean. 
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+ Effects of changes in [K ]p on astrocyte glycogen stores 
+ Fig. 4.4 shows the effect of increasing [K ]p on astrocyte glycogen stores 
at four time points. 1:he glycogen content of astrocyte cultures was 
statistically significantly less than control values at all time points, 
+ 
except 30 minutes, for 5mM [K Jp. At 10 minutes the reduction was 15%, 
11% at 60 minutes and 10% at 90 minutes. Statistically significant reduction! 
+ in glycogen stores are also seen at 90 minutes for 10mM [K ]p (13%) and 
+ 
at 10 minutes for 15mM [K ]p (30%). A significant increase in glycogen 
content is not seen under any conditions when compared against 2.SmM 
+ [K ]p controls. 
Kruskal-Wallis analysis of variance indicated that there were differences 
between the effects of experimental [Kp] on astrocyte glyocgen content 
with time and indeed a consistent pattern is noticeable in the time 
+ 
course of the effects of all three experimental [K ]p" For all experimental 
[K+]p there is a decrease. in glycogen stores at 10 minutes when compared 
+ to control through this is not statistically significant for 10mM [K ]p. 
This initial decrease .is reversed at 30 minutes for. all experimental 
+ [K ]p to levels not statistically significantly different from control. 
+ Indeed in the case of 15mM [K ]p there is an increase in glycogen levels 
+ over control. By 60 minutes the glyocgen levels at all epxerimental [K JP 
have fallen again to show a decrease when compared to those at 30 minutes. 
+ In the case of 5mM [K ]p the reduction in glycogen at 60 minutes is 
statistically significant when compared to controL. At 90 minutes the 
+ . glycogen content levels off in cultures incubated in 5 and 10mM [K ]p. 
and becomes statistically significantly less than control values with 
+ + 5mM [K ) p and 10mM [K ] p'" The level of glycogen stored in astrocyte 
cultures at 90 minutes becomes progressively less in relation to 
+ 
control levels as the [K )p increases i.e. 10%, 13% and 19% at 
+ 5, 10 and 15mM [K Jp. The changes 
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oil 
in glycogen content of astrocyte cultures over time suggest that 
+ 
after initial responses to increased [K 10 involving both net 
synthesis and net degradation of glycogen, a new level of glycogen 
+ 
content is established which is dependant on [K 1
0
• 
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Fig. 4.4-
The effect of changes in + [K ]0 on 
. 
astrocyte-enriched culture glycogen content 
+ Fig. 4.4 shows the effect of elevated [K ]0 on the 
mean glycogen content of astrocyte cultures e~pressed 
as a percentage of cohtrol, Controls were taken as the 
glycogen content of cultures incubated for the same 
+ time, in the same experiments in 2.5 mM [K ]0. The 
results were obtained from between 2 - 5 experiments 
per time point and an n of between 6 - 11, where n is 
the total number of cultures that were compared against 
+ a mean value of glycogen content at 2.5 mM [K.]o 
derived from 2 cultures per experiment. Bars indicate 
the standard error of the mean values; for graphical 
presentation one direction is usually shown. 
* Indicates a significant difference from control of 
p<0.05 or less (matched pair, two-tailed t-test) . 
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+ Effects of changes in [K ]0 on meningeal cell glycogen 
+ Fig. 4.5 shows the effect of increasing [K ]0 on the glycogen 
stores of meningeal cell cultures at four time points. Only two 
statistically significant changes in meningeal glycogen content are 
+ + 
seen, at 10 minutes with 10mM [K ]0 and 60 minutes with 15mM [K ]0' 
showing decreasesof. 32% and 17% respectively. No statistically 
significant increases are seen.in meningeal glycogen over controls 
+ 
when exposed to increased [K ]0. However, analysis of variance 
indicated that there were differences between the effects of experimental 
+ [K ]0 on meningeal cell glycogen content with time. As in the case 
+ 
with the effect of [K ]0 on astrocyte glycogen stores, there is a 
consistent pattern evident in the time course of the effects of all 
+ 
three experimental [K ]0 but this pattern is different from th~~ 
described for astrocytes. There is an increase in levels of glycogen 
as compared to control values between 10 and. 30 minutes for all 
+ ,.. 
experimental [K ]0 in menigeal cell cultures as there is in astrocyte 
cultures. This relative increase is also seen to diminish subsequently 
to levels below control values, in one case a statistically significant 
+ decrease (60 minutes at 15mM [K ]0) as is seen in astrocytes but a 
similar levelling off or further decrease which is observed at 90 
minutes in astrocyte cultures is not apparent. Instead there is a 
second increase in glycogen stores to above that of control. The 
+ time course of the effects of increased [K ]0 on meningeal cell glycogen 
taken as a whole suggests that whilst both net synthesis and net 
+ degradation of glycogen occur in response to increased [K ]0' the 
responses are a) highly variable, and b) only statistically significant 
+ 
at higher levels of [K ]0 (10 and 15mM) than those seen to reduce 
+ 
consistently the glycogen content of astrocyte cultures (5mM [K )0). 
103 
Fig. 4.5 
+ The effect of changes in [K la on meningeal 
cell culture glycogen content 
+ This figure shows the effect of increasing [K 10 
on the mean glycogen content of meningeal cultures 
expressed as a percentage of the glycogen content in 
cultures incubated for the same time, in the same 
+ 
experiment in 2.5 mM [K 10 as control. The results 
were obtained from 3 experiments per time point and 
an n of between 5 and 7 where n is the total number 
of individual cultures that were compared against a 
+ mean value of glycogen content at 2.5 mM [K 10 
derived from 2 cultures per experiment. Standard 
errors of the means varied between 5, - 18% and are 
not shown for reasons of clarity. 
* Indicates a signficant difference from control 
of p<0.05 or less (matched pair, two-tailed, t-test). 
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Discussion 
The major findings of this study are:-
i) Both astrocyte and meningeal cells in culture metabolise glycogen. 
ii) There is no net synthesis or degradation of glycogen stores in 
astrocyte or meningeal cell cultures over the incubation period used. 
+ 
iii) Changes in [K lo affect the glycogen stores of astrocytes and 
meningeal cells but the two cell types differ in their responses 
+ 
to [K 1 o. 
iv) These cultures have thus been shown to contain viable cells 
which respond to changes in their environment and as such constitute 
a good model to examine the effects of putative neuron/astrocyte 
signals controlling glycogen stores in astrocytes. 
+ Prior to discussion of the [K lo evoked responses observed here 
and of whether or not the responses might form the basis of a neuron/ 
astrocyte signalling mechanism, it is important to know the normal 
+ 
levels of [K lo in the CNS at rest and during neuronal activation. 
Experiments with ion selective electrodes estimate the resting 
[K+l o in the mammalian cortex at between 2.8 mM and 3.4 mM (Walz 
+ 
and Hertz, 1983 review), so a value of 2.5 mM [K lo in the experimental 
buffer might be used to estimate control levels of glycogen in cell 
+ cultures. Sensory stimulation produces increases in [K lo in the 
region of 0~1 - 1 mM in the mammalian CNS (Kelly and van Essen, 1974; 
Somjen, 1979) and direct stimulation of the cat cortex does not 
+ 
increase [K lo beyond 12 ~M (Grossman et al, 1969; Prince et al, 1973). 
Only during the abnormal conditions of seizures, spreading depression 
+" 
and hypoxia do [K lo levels rise above 10 - 12 mM; 13 mM in seizures 
and between 30 mM and 100 ~~ in spreading depression and hypoxia 
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+ (lvalz and Hertz, 1983). The use of 10 mM and 15 mM [K loin 
experiments designed to examine a proposed neuron/astrocyte signalling 
+ 
mechanism through K release from neurons undergoing the normal 
depolarisations involved in action potential conduction and transmission, 
+ may therefore seem irrelevant. However, the increases in [K lo 
measured in in vivo experiments generally employ "ion selective" 
+ electrodes which respond to a range of compounds other than K (Wuttke 
and Schlue, 1982). Furthermore,. an electrode creates a dead space 
around the tip which may reduce the estimated size of a transient 
+ 
increase in [K lo due to the resulfant delay in measuring an ion 
which is both actively and passively removed from the extracellular 
space both by neurons and astrocytes (Walz and Hertz, 1983). The 
+ 
possibility that [K lo may routinely reach 15 mM locally cannot be 
+ entirely exclude~ although experiments which estimate [K lo by measuring 
+ glial depolarisation and assuming that this is a perfect K electrode 
system agree that direct stimulation never raises [K+l
o 
beyond 12 mM 
(Kelly and van Essen, 1974). 
+ Previous studies on the effect of K on cerebral glycogen stores 
have generally been confined to experiments using relatively high 
+ 
[K lo (in the region of 25 - 50 mM) and cortical slices, or pathological 
conditions such as ischaemia and seizures, and are therefore of limited 
value when considering physiologically relevant neuron/astrocyte 
signals. + However, these studies suggest that increased levels of [K lo 
may favour a net reduction in glycogen stores. 
For example, Quach et al (1978), who examined the effect of 
+ 
elevated [K lo on glycogen stores in mouse cortical slices, showed an 
87% reduction in glycogen synthesised from radiolabelled glucose. 
+ 
However, the stimulus was 50 mM [K lo which might have elicited the 
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release of a wide range of neurotraZLitters and these may have effects 
on glycogen stores (Chapter 6). Magistretti et al (1983) also showed 
+ 
that increases in [K 10 could evoke the breakdown of radiolabelled 
glycogen (30%), in this case using rat astrocytes in primary culture, 
+ but only examined the effect of 50 mM [K 1
0
• 
Therefore, there are few published data concerning the effects 
+ 
of changes in [K 10 on astrocyte glycogen stores. Furthermore, only 
the work of Pentreath and co-workers (see Introduction) has examined 
+ 
the effects of increased [K 10 on glial glycogen stores with respect 
to the concept of neuron/glia signalling. This is also true when 
other aspects of glial metabolism are considered. It is well known 
+ 
that high levels of [K 10 have profound effects on glial cell 
metabolism e.g. a reduction in ATP levels and an activation of 
+ + 
Na /K ATPase (see review by Hertz and Schousboe, 1975). In 
particular it has often been shown that K+ stimulates oxygen uptake 
in bulk prepared glia (Haljamae and Hertz, 1971) and in cultured 
astrocytes (Hertz et al, 1973). However, these experiments again use 
+ 
particularly high levels of [K 10 , in the region of 50 mM, and there 
+ 
are few data on the effects of changes in [K 10 more commonly found in 
the mammalian CNS. For example, Orkand et al (1981) have shown that 
+ 
changes in [K 10 in the range 3 - 9 mM produce an increase in the 
+ 
oxidation of NADH to NAD , and an increased uptake and incorporation 
of radiolabelled glucose into organic and amino acids in the 
denervated Necturus optic nerve. In addition, Cummins et al (1975) 
+ 
observed that an increase in [K 10 from 7 mM to 12 mM caused an 
increase in [3Hl-2-DG uptake and a i decrease in methionine uptake 
into primary cultures of rat astrocytes. 
When the data presented here are considered, it is seen that the 
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glycogen content of astrocyte cultures prepared as previously 
described (Chapter 3 and Methods) is lower than had previously been 
reported for rat astrocytes in vitro. Cummins et al (1983a) 
measured the glycogen content of neonatal rat primary cultures of 
astr9cytes, together with the activities of GS and GP, subsequent 
to treating the cultures with glucose. Glycogen content was 
measured essentially-as described here, i.e. by enzymatic breakdown 
to glucose which was measured by the hexokinase/glucose-6-phosphate 
dehydrogenase method. However, Cummins et al (1983a) measured 
_glycogen in unextracted aliquots of cell suspension which was not 
possible here (see Methods). The reason for this difference is unclear. 
It may reflect the more frequent medium changes used by Cummins et al 
(1983a, every two days) or a greater number of cells in their 
cultures. Alternatively, it may be due to an increased meningeal 
cell contamination in their cultures, suggested by the fact that their 
cultures reach confluence more quickly (12 - 14 d.i.v.). The 
glycogen content of adult mammalian brain is approximately 30% of that 
perinatally (Kohle and Vanucci, 1977). This developmental loss in 
glycogen stores may be maintained in vitro in that older cultures such 
as those used here (18 22 d.i.v.), show a relative reduction in 
glycogen levels compared to younger cultures. However, it was 
possible to measure glycogen in the astrocyte cultures used here by 
concentrating it using ethanol precipitation. 
Another pOint which is very clear from the results of early 
experiments measuring glycogen content of cell cultures is that 
meningeal cells contain almost twice as much glycogen per mg protein 
+ 
as astrocytes. Taking the value of 15% FN cell contamination of 
astrocyte cultures (Chapter 3) to represent 15% meningeal cells, 
then, simplistically, it might be estimated that about 30% of the 
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glycogen in astrocyte cultures is found in meningeal cells. Bearing 
this point in mind it is seen that neither astrocytes nor meningeal 
cells show a net synthesis or degradation of glycogen stores 
over the experimental period (10 - 90 minutes). Indeed this 
provided a base line for further experiments on the glycogen content 
of astrocytes (Chapter 6). However, when the effects of increasing 
+ 
[K ]0 on cell culture glycogen stores are determined it is clear 
that in this respect astrocytes and meningeal cells respond quite 
differently. This is exemplified by the fact that the statistically 
significant differences from control in the glycogen content of the 
. + two types of cell culture when exposed to lncreased [K ]0 show no 
overlap. Thus the only statistically significant differences from 
control values for the glycogen content of meningeal cells are 
+ 
caused by [K ] 0 of 10 mM (10 minutes) and 15 mM (60 minutes). At 
these points, astrocyte glycogen levels are not sigdficantly different 
~ 
from control. These comparisons suggest that meningeal cell glycogen 
is not the only, or even principal, store of glycogen in astrocyte 
cultures. However, the possible contribution of meningeal cell 
~lycogen to the total pool of glycogen in astrocyte enriched cultures 
cannot as yet be discounted. For example, if meningeal cells do 
contribute around 30% of the glycogen in the astrocyte culture glycogen 
pool then one might suggest that the non-statistically significant 
reduction in glycogen levels of astrocyte cultures at 10 minutes with 
+ 
10_mM [K ]0 (13%) results from a 32% drop in meningeal cell glycogen. 
. + 
In spite of this, it is clear that [K ]0 evoked changes in meningeal 
cell glycogen do not account for those i~ astrocyte cultures. Moreover 
it is quite probable that meningeal cell glycogen, as a relatively 
K unresponsive and variable pool (Fig. 4.4, Chapter 3), serves 
not only to contribute to the variability seen in astrocyte enriched 
culture stores of glycogen but also to dilute the observed effects of 
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+ 
[K 10 on astrocyte stores. Unfortunately, as nothing is known about 
the glycogen stores of meningeal cells present in astrocyte cultures, 
it is impossible to correct for this eventuality. This will be 
discussed again later (Chapter 6) where it is suggested that meningeal 
cell glycogen contributes little to the total glycogen pool in 
astrocyte cultures as evidenced by the differential effects of adrenergic 
agonists on the glycogen stores of both types of cell culture. 
Whilst the responses of the glycogen stores of astrocytes and 
+ meningeal cell cultures to increases in [K 10 are statistically 
+ significant at different incubation times and [K 1
0
, there are 
similarities in the time course of these responses. In astrocyte 
cultures, and to a more varied degree in meningeal cell cultures, the 
+ first response to increased [K 10 measured (at 10 minutes) is a 
reduction in glycogen stores compared to control. Thus 5 mM and 15 mM 
I [K+Jn evoke statistically significant decreases in astrocyte cultures as 
+ 
does 10 mM [K 10 in meningeal cell cultures. After this initial 
reduction, there is a period of resynthesis of glycogen between 10 _ 
30 minutes. This may restore levels of glycogen to control levels 
or above at 30 minutes prior to a subsequent relative loss of 
glycogen seen at 60 minutes in both cell cultures. In the case of 
astrocyte glycogen stores a new base line of glycogen content, below 
control, may now be established e.g. with 5 and 10 ~~ [K+l
o
' or the 
glycogen content may continue to fall in relation to control 
+ 
(15 mM [K 1 0 ), In contrast meningeal cell glycogen stores undergo 
a second phase of net glycogen synthesis compared to control, such 
that at 90 minutes all experimental cultures contain more glycogen 
on average than control cultures. It must be stressed again that 
+ 
the [K 10 evoked changes in meningeal cell culture glycogen content 
are rarely statistically significant but the contrast to the responses 
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+ 
of astrocyte cultures to increased [K 10 at this time is marked. 
It is notable that the most consistent (with time) reductions 
in astrocyte glycogen content occur as a result of relatively 
+ 
small changes in [K 10 (2.5 - 5 mM) which are of the order known 
to occur in vivo as a consequence of neuronal activity. In contrast 
meningeal cell glycogen stores only respond to larger increases in 
+ . [K ]0 (2.5 - 10 and 15 mM). It is also notable that the time course 
+ 
of the effects of increased [K ]0 on astrocyte glycogen content 
suggests.that after a period during which processes of both net 
synthesis and degradation occur, a new level of glycogen content is 
established below that of control. Furthermore, the level to which 
the glycogen content of astrocyte cultures falls in:·relation to control 
values at 90 minutes becomes greater at higher [K+]o (10%, 13% and 
+ 19% reductions at 5, 10 and 15 mM [K ]0 respectively). 
The observation that + increases in [K ]0 produce 
a lower level of glycogen content in astrocyte cultures is consistent 
with the model of Phelps (1971) who suggested that the amount of 
glycogen stored in astrocytes is dependant on the activity (and thus 
energy requirements) of neurons. The model proposed by Pentreath 
3 (1982h from work using [ H]-2-DG incorporation into the glycogen 
stores of invertebrate glia,also suggests that glial glycogen may be 
affected by the activity of neurons. However, in this case, under 
+ 
conditions where glucose supply is optimal, K released from active 
neurons is proposed to stimulate the synthesis of glycogen in glial 
cells as a reserve energy store for neurons. Indeed, in the liver, 
+ glycogen synthesis is favoured by high levels of K (cf. Pentreath and 
Kai-Kai, 1982). . +j ~oreover, lncreases in [K 0 (to 5 and 15 mM but not 
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+ 
to 10 mM [K lo) are seen to stimulate the incorporation over one 
hour of [14Cl-2_DG into the glycogen stores (37% and 44% respectively) 
of similarly prepared astrocyte cultures to those used here (Pearce 
et al, unpublished observations). Before considering the implications 
of this apparent contradiction, certain points need to be made about 
the use of radiolabelled 2-DG. 
Originally developed by Sokoloff et al (1977) for the estimation 
and mapping of energy utilisation in the CNS, 2-DG is taken up and 
phosphorylated by hexokinase in an identical manner to glucose, 
forming 2-deoxyglucose-6-phosphate (2-DG-6-P) (Sols and Crane, 1954). 
2-DG-6-P is not a substrate for glucose-6-phosphate dehydrogenase 
and therefore cannot undergo glycolysis or be metabolised by the 
pentose phosphate shunt (Pentreath et al, 1982). However, it is 
metabolised by glucose-6-phosphatase in the brain (Karnosvsky et al, 
1980), an enzyme present in astrocyte cultures (1.23 ± 0.04 umol G-6-
P/mg protein/hour n=3, Grimble unpublished observations). A130, as 
3 
previously noted [ Hl-2-DG can be incorporated into glycogen where it 
is assumed to be trapped (Pentreath et al, 1982). Some of the 
2-DG-6-p is probably reconverted to 2-DG which may help to explain 
why only 2 - 10% of added 2-DG is incorporated when glycogen has a 
high rate of turnover in the brain (Ibrahim, 1975) and in primary 
culture (Cummins et al 1983a). The statement that "2-DG is trapped 
in glycogen" means that there are only four enzymes of glycogen 
metabolism which can have an influence on its presence in glycogen. 
These are UDP-glucose pyrophosphorylase, phosphoglucomutase, 
glycogen synthetase and the branching enzyme, i.e. the enzymes 
involved in synthesis. 
The time course results for the effects of both 5 mM and 15 mM 
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+ [K 10 on astrocyte glycogen stores show a marked net resynthesis 
of glycogen between 10 and 30 minutes which could produce an increase 
in the incorporation of [14Cl-2-DG into glycogen. Notably, the time 
+ 
course for the effects of 10 mM [K 10 on astrocyte glycogen shows a 
less marked period of resynthesis between 10 and 30 minutes which may 
14 
account for the lack of increased [ Cl-2-DG incorporation into 
glycogen seen with this concentration. 14 Thus the [ Cl-2-DG results 
of Pearce et al are in agreement with the measurements of total 
glycogen presented here and suggest that part of the response to 
+ 
increased [K 10 is an increased synthesis of glycogen. This 
agreement depends on 2-DG being trapped in glycogen as asserted by 
Pentreath (1982). If 2-DG were not trapped in glycogen, but was 
removed by glycogen phosphorylase and/or the debranching enzyme in 
14 
the same way as glucose, then the [ Cl-2-DG incorporation data should 
mirror values for total glycogen stores. 
The trapping of 2-DG in glycogen is equivocal as freeze-blowing 
techniques (Veech and Hawkins, 1974) show ~hat over 60% of [3Hl-2-DG 
incorporated into glycogen in adult rat brain is released during 
decapitation and dissection followed by freezing in liquid N2 (Nelson 
et ai, 1984). Although it is known that there is a rapid activation 
of GPa Post-mortem (Ibrahim, 1975), the exact mechanisms involved in 
the post-marten release of 2-DG from pre-labelled glycogen in whole 
brain are not known" and may not be active in the astrocyte cultures 
used here~ Indeed it would be difficult to reconcile the results 
shown here if [14Cl-2_DG were not trapped in the glycogen stores of-
astrocyte cultures under the experimental conditions previously 
described. 
Prior to further discussion of the data presented here, the non-
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physiological aspects of the study of glycogen metabolism in the 
cell cultures used should be noted. 
Firstly, the exposure of astrocytes to prolonged increases in 
+ [K 10 is unlikely to occur in vivo although it will depend on the 
substained activity of the neurons and the proximity of the 
+ 
astrocytes to the neurons. K is actively and passively removed 
from the extracellular space by uptake primarily into glia (Walz 
+ . 
and Hertz, 1983) as a mechanism of [K ]0 homeostat1s. Therefore 
greater emphasis might be placed on the initial glycogenolytic 
+. . 
effects caused by [K ]0 1n the astrocyte cultures. 
+ Secondly, passive uptake of K by spatial buffering does not 
occur in primary cultures due to the uniform exposure of the cell to 
+ 
K (Walz and Hertz, 1983). Bulk prepared adult astrocytes respond 
+ + 
to increases in [K ]0 by an increase in the active uptake of K via 
+ + 
the Na /K ATPase system (Franck et al, 1983). If this stimulation 
of an active uptake process is also present in the primary astrocyte 
cultures used in the present study then it might be argued that the 
initial period of glycogenolysis seen in astrocyte cultures is the 
result of the mobilisation of glycogen to provide energy for this 
uptake. As glucose is freely available in the experimental buffer 
used for these studies this is considered unlikely. 
Finally, the astrocyte and meningeal cell cultures used here 
+ have been grown in a medium containing approximately 5 mM K for 
2 - 3 weeks as this is not optimal for neuronal survival (Chapter 3) . 
The data previously discussed for the glycogen content in astrocyte 
+ 
and meningeal cell cultures under all conditions of [K 10 might 
+ 
therefore be interpreted differently, using 5 mM [K ] 0 as a control 
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value for estimation of glycogen content. As the astrocyte 
+ + membrane is selectively permeable to K it will act as a K 
+ electrode and show a relative hyperpolarisation when the [K ) 0 
is changed from 5 mM in culture medium to 2.5 mM under experimental 
conditions. Hyperpolarisation of glial membranes also occurs after 
the termination of direct cortical stimulation (Grossman and Rosman, 
1971; Ransom and Goldring, 1973a). 
If the results are expressed as % values for glycogen content 
+ 
of cultures exposed to 5 mM [K )0 as control, then a decrease in 
+ 
[K )0 to 2.5 mM results in statistically significant increases in 
glycogen stores in astrocytes at 10, 60 and 90 minutes (15%, 11%, 
10% respectively). The increases in stores of glycogen do not 
appear to involve an increase in glycogen synthesis as the 
incorporation of [14C]_2_DG over 60 minutes is less in 2.5 mM [K+]o 
+ 
than in 5 mM [K )0 as previously noted. However, the apparent 
increase in astrocyte glycogen stores could be accounted for by a 
decrease in GPa activity in cells exposed to 2.5 ~~ [K+) 0 compared 
+' to GPa activity in those cells exposed to 5 mM [K ]0. To explain 
, 14 
the higher incorporation of [ C]-2-DG into astrocyte glycogen 
+ + 
stores at 5 mM [K ]0 compared to that at 2.5 mM [K ]0 after 60 
minutes when the net glycogen content is greater in cultures exposed 
+ 
to 2.5 mM [K ] 0' a higher activity of both GSa and GPa must occur 
+ 
in 5 mM [K Lo treated cells i.e. a greater turnover rate. Such a 
mechanism whereby a hyperpolarisation of glial membranes promotes 
glycogen synthesis by reduced GPa activity (an "off" signal from 
neurons to astrocytes) is 'not mutually exclusive with an alternative 
interpretation of the present results that a depolarisation caused 
+ 
by rising [K )0 (an "on" signal from neurons) evokes glycogenolysis. 
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+ The intracellular mechanisms through which [K 10 might affect 
glycogen metabolism in cell cultures are unclear. Ververken et al 
(1982) noted that the activation of GPa observed in mouse cortical 
+ 
slices caused by incubation with 25 mM [K 10 was not accompanied 
+ by any rise of cAMP level. The degree of K stimulated activation 
2+ 
of GPa was reduced by the addition of the Ca chelating agent 
EGTA and also LaC1 3 , to the experimental buffer. This suggests 
that the stimulation of GPa activity caused by 25 mM + [K 10 is 
mediated by a cAMP independant, Ca 2+ dependant process .. Quach et 
+ 
al (1978) suggest that 50 mM [K 10 may also elicit glycogenolysis 
e-
of glycogen pre-labelled with [3Hl-~lucose in a cAMP independtnt 
+ manner. In addition, although not examining the effects of [K 1
0
, 
Passoneau and Crites (1976), in experiments to determine the 
mechanisms of regulation of glycogen metabolism in C6 cells, 
suggest that the control of glycogen metabolism by glucose is 
~ 
cAMP independlnt. These results suggest that there may be a level 
of control of glycogen metabolism in the CNS, particularly 
glycogenolysis, which is not linked directly to cAMP. No 
information is available concerning the mechanism(s) by which 
+ 
increases in [K 10 might evoke the increases in glycogen synthesis 
reported here. 
+ Therefore, the exact mechanism(s) by which increases in [K 10 
may affect the glycogen metabolism of astrocytes ~s unclear. 
Indeed, the direction of the effect, i.e. an increase or decrease 
in glycogen_stores, depends to some extent on what is regarded as a 
+ 
control level of [K 10 , However, it is evident that alterations in 
+ + [K 10 over the accepted physiological range (2.5 mM - 5 mM [K 10) 
influence the net glycogen stores found in astrocyte cultures. 
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Two models have previously been proposed (Phelps, 1971; Pentreath, 
1982) which suggest that neurons control the metabolism of glyco~en 
in astrocytes in order to ensure a continued supply of energy for 
neuronal activity. The results shown here provide additional 
evidence for this idea. In addition, a role for meningeal cells is 
proposed. In vivo meningeal cells, and other cells of the CNS 
vascular system, are interposed between blood and astrocytes. 
Isolated rat brain microvessels take up glucose through a 
facilitated transport mechanism (Djuricic, 1983) and meningeal 
cells synthesise glycogen in vivo (Ibrahim, 1975) and in vitro 
(this chapter). Statistically significant net reductions in 
meningeal glycogen stores are seen to be caused by increases in 
+ [K lo (10 and 15 mM) although these increases are greater than those 
which first produce effects on astrocyte glycogen stores (from 
2.5 to 5 mM). This may indicate that the glycogen reserves are 
+ 
utilised only when [K lo reach pathological levels (see Introduction) 
and may constitute an emergency reserve of energy for neurons. 
+ However, little is known of the [K lo to which meningeal cells are 
normally exposed. 
The inherent assumption of the models previously discussed is 
that there is a transfer of glucos~ or other metabolic substrates 
from astrocytes to neurons which is c~ntrolled by neurons. In this 
+ chapter, the role of one putat~ve signal has been investigated [K lo' 
Before considering this postulated transfer more fully (Chapter 7), 
the role of other possible signals between neurons and astrocytes, 
namely neurotransmitters, wl.tl be examined (Chapters 5 and 6) . 
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Summary 
1) Astrocytes and meningeal cells in primary cultures contain 
glycogen which they metabolise as shown by measurements of glycogen 
stores. 
2) Both astrocyte and meningeal cell cultures respond to changes 
+ 
in [K 10 by alterations in glycogen metabolism. 
+ 3) The responses to [K,lo by astrocyte and meningeal cell 
cultures are different. Astrocytes in culture respond to smaller 
changes in [K+l o than do meningeal cell cultures. 
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CHAPTER 5 
Neurotransmitter receptors on astrocytes 
Introduction 
It has been shown that rat cortical astrocytes in vitro 
+ 
respond to variations in [K ]0 with changes in their metabolism 
of glycogen. In addition, it has been suggested that changes in 
+ [K ]0 might represent one means by which neuronal activity could 
'.,.... '·w be signalled to astrocytes in vivo, the result of which might be 
to increase supplies of metabolic substrates for neurons. Further, 
it has been suggested that neurotransmitters released from neurons 
might also serve as signals from neurons to astrocytes. This 
latter suggestion implies that astrocytes possess receptors for 
neurotransmitters on their membranes. To seek evidence for such 
a suggestion, this chapter describes experiments designed to 
examine the binding of three radiolabelled neurotransmitter receptor 
." ligands to membranes prepared from astrocyte-enriched and meningeal 
cell cultures of newborn rat cortex. The three transmitter receptor 
ligands are [3 H]_ dihydroalprenolol ([3 H]_ DHA; 8-adrenergic 
3 . 
receptor antagonist), [ H)-serotonin (serotinergic receptor 
agonist) and [3 H]_ quinuclidinyl benzilate ([3 H]_ QNB; muscarinic 
cnolinergic_receptor antagonist). Receptors for the first two have 
been implicated in the mediation of neurotransmitter-induced 
glycogenolysis in a variety of systems {Chapter 6r 
stimulation of the muscarinic cholinergic receptor has not been 
reported to have effects on glycogen stores in the brain. 
Reports of neurotransmitter receptors on astrocytes whether in 
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Table. 5.1. 
A survey of the receptors for neurotransmitters 
which have bee!n reported to be present on astrocytes. 
- 121 -
'_ 
"""""''-
Table 5.1 Astrocyte neurotransmitter receptors 
Receptor 
B-adrenergic 
a -adrenergic 
Serotonin 
Dopamine 
Histamine 
(HI and H2) 
Adenosine 
(AI and A2) 
Muscarinic 
chol inerg ic 
- Benzodia zepines 
System 
Chick & Rodent 
pr imary cuI ture 
Rodent explant culture 
C6 glioma 
Human astrocytoma 
Rodent primary culture 
Rodent explant culture 
C6 glioma 
Rodent primary culture 
Bulk separation of 
horse striatum 
C6 glioma 
Bulk separation of 
rat CNS, bovine candate, 
horse striatum 
Rodent primary culture 
Rodent primary culture 
Rodent explant culture 
Human astrocytoma 
Rodent primary culture 
Chick primary cutlure 
Human astrocytoma 
Chick primary culture 
Human astrocytoma 
C6 glioma 
Rodent primary culture 
Rodent primary culture 
Bulk separation of 
bovine cortex and 
caudate 
Peptides Rodent primary culture 
Chick primary culture 
(VIP, MSH, SP, Hu~~n astrocytoma 
SOM, glucagon, 
ACTH, parathyrin, 
clacltonll1, 
morphine, 
enkepha 11n) 
Prostaglandins C6 glioma 
Rodent primary culture 
Amino-"clds Roc! .. nt prllTlo!lry culturo 
(Glutamate, 
aspartate, GAnA) 
Technique 
Electrophysiology 
Ligand Binding 
cAMP assay 
Autoradiography 
Taurine release 
Electrophysiology 
Autoradiography 
Ligand Binding 
cAMP assay 
Inositol phspholipid 
metabolism 
Ligand binding 
cAMP assay 
Ca2+ influx 
Inositol phospholipid 
metabolism 
cAMP assay 
cAMP assay 
Electrophysiology 
Autoradiography 
Ligand binding 
cAMP assay 
Ligand binding 
Electrophysiology 
cAMP assay 
Inositol phospholipid 
metabolism 
Ligand binding 
cAMP assay 
[14C) -2-DG 
incorporation 
cAMP assay 
ElectrophYBio)o~y 
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primary culture, bulk separated adult glia or transformed cell 
line~ are numerous (Tqble 5.1). Some evidence has come from 
radiolabelled ligand binding studies, for example the binding of 
[3HJ _ diazepam to bulk separated astrocytes from the bovine 
cortex (Henn and Henke, 1978). However, the bulk of the evidence 
is derived by inference from studies which examined the effects 
of transmitter agonists on astrocyte cyclic nucleotide levels 
often, particularly in early work, using C6 glioma (see Van Calker 
and Hamprecht, 1980, for review, also Table 5.1). 
Since the review of Van Calker and Hamprecht (1980) the use 
of better defined astrocyte culture preparations and techniques of 
immunofluorescence, autoradiography and electrophysiology have 
provided additional evidence for some, but not all, neurotransmitter 
receptors on astrocytes. The most convincing demonstration of this 
comes from "the work of McCarthy and co-workers (Harden and MCCarthy, 
1982; McCarthy, 1983; Trimmer et aI, 1984) who have shown by 
combined autoradiography and immunofluorescence that approximately 
85% of astrocytes in vitro prepared from neonatal rat cortex 
possess S-adrenergic receptors. Moreover, by using highly 
purified astrocyte cultures (>97%) they have shown that this 
receptor is of the Sl subtype. Additional-evidence for the presence 
of S-receptors on astrocytes comes from the autoradiographic and 
electrophysiological studies of Hosli et al (1982a; 1982b) using 
explant culutres of the foetal and neonatal rat brain ste"tn, 
cerebellum and spinal cord. In the same system these authors have 
also shown the presence of a 1 and a 2 adrenoreceptors on astrocytes, 
again by autoradiography and electrophysiology, in partial agreement 
with the electrophysiological studies of Hirata et al (1982) who 
did not differentiate between the two a-receptor subtypes. 
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Interestingly, stimulation of a a,n,d S . .,-r.eceptors produces 
different effects on the membrane potential of astrocytes in vitro. 
a- receptors seem to mediate the noradrenaline evoked depolarisation 
of astrocyte membranes (Hosli et aI, 1982b; Hirata et aI, 1982) 
whereas isoproterenol stimulation of 8- receptors produces a 
hyperpolarisation (Hosli et aI, 1982b). Further experiments by 
Hosli et al (1984a; 1984b), again using explant culture and auto-
radiography and electrophysiology, suggest that both histamine 
receptors, (H 1 and H2 ) are present on astrocytes and that 
activation of the two receptor subtypes produces different effects 
on the astrocyte cell membrane, analogous to the case for 
adrenergic receptors. Thus, stimulation of H1 receptors produces 
a depolarisation, and of H2 receptors, a hyperpolarisation. Notably 
in rat cerebral cortex slices H1 and a 1 receptors are believed to 
be linked to inositol phospholipid metabolism (Brown et aI, 1984; 
Schoepp et aI, '1984) whilst H2 and B receptors are thought to have 
effects on the adenylate cyclase system (cf. Brown et aI, 1984) . 
Electrophysiology has also been used to show that some amino 
acid neurotransmitters, notably glutamate and aspartate, depolarise 
rat cortical astrocytes in primary culture and that this effect may 
be m~diated by kainate preferring receptors (Kettenman et aI, 1984; 
Bowman and Kimelberg, 1984). However, the evidence is, as yet, 
+ equivocal as these 'experiment were performed in the presence of Na 
which might have resulted in changes in membrane potential as a' 
+ 
result of the Na -dependant glutamate transport systems. Also the _ 
authors of these two papers (Kettenman et ai, 1984; Bowman and 
Kimelberg, 1984) disagree over the efficacy of GABA to depolarise 
astrocytes. It is notable that there is no evidence from cyclic 
nucleotide studies or receptor binding studies that amino-acid 
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neurotransmitter receptors occur on astrocytes. In particular, 
3 3 Ossola et al (1980) reported that neither [ H]-GABA nor [ H]-
muscimol bound to membranes prepared from primary cultures of 
rat astrocytes. 
Highly purified astrocyte cultures (>95%) have been used by 
Rougon et al (1983) and Evans et al (1984) to demonstrate that a 
number of peptide hormones and prostaglandin El (PGE
1
) stimulate 
adenylate cyclase activity e.g. vasoactive intestinal peptide 
(VIP), melanocyte stimulating hormone (MSH) and adrenocorticotropin 
(ACTH). Other peptides augment the stimulatory effect of nora-
drenaline on astrocyte cAMP content, e.g. substance P (SP), VIP and 
somatostatin (SOM) (Rougon et aI, (1983) although Evans etal (1984) 
stated that somatos~atin inhibited an isoproterenol induced cM4P 
increase. In addition morphine and met-enkephalin were shown to 
antagonise the noradrenaline evoked increase in astrocyte cAMP 
content (Rougon et aI, (1983). 
iJ Evidence for the presence of receptors on astrocytes 
published after Van Calker and Hamprecht (1980) and other than 
that reviewed above, has been derived from glioma cell lines, bulk 
separated cells or primary cultures of neonatal chick or rodent 
brain. These cultures have often been characterised by one or two 
astrocyte specific immunocytochemical techniques and mi-ght therefore 
contain other cell types. Alternatively, the cultures may have 
been rigorously characterised and found in fact to contain other 
cell types (Hansson et aI, 1984). However such cultures, and also--
bovine or equine bulk prepared astrocytes, have been used and 
suggest that a variety of neurotransmitters stimulate the 
production of cyclic nucleotides in astrocytes (Table 5.1 e.g. 
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dopamine, Hansson et aI, 1984). Also such cultures have been used 
to show the binding of various radio1abelled transmitter ligands 
to astrocytes although notably not to membranes prepared from rat 
cortical astrocytes (Table 5.1 e.g. [3H]-serotonin, Tardy et aI, 
1982) . 
It is important to note that the contamination of primary 
"astrocyte" cultures has produced. misleading data concerning 
neurotransmitter ligand binding. For example, Ebersolt et al 
(1981b) suggested that mouse cortical astrocytes in primary 
culture possess both a 1 and a 2 adrenergic receptors whereas Trimmer 
et al (1984) have shown that the a 2 receptors found in rat cortical 
primary astrocyte culture are localised to contaminating meningeal 
cells. It is also known that the adenylate cyclase activity in 
meningeal cells in vitro is stimulated by B-adrenergic, purinergic 
and dopaminergic agonists and also by PGE
1 
(Ebersolt et aI, 1981b; 
Evans et ai, 1984). Evans et al (1984) also suggested that, as is 
the case in astrocytes, a-adrenergic receptor agonists could reduce 
a B-receptor mediated agonist evoked rise in meningeal cell cAMP 
content. In addition~ endothelial cells prepared from bovine 
cerebral microvessels have muscarinic cholinergic binding sites as 
detected_by [3 H]_QNB binding (Estrada et aI, 1983). Therefore, when 
considering_the presence of neurotransmitter receptors on astrocytes 
-7--
in primary cultures of less than l~O% purity, one must also consider 
the possibility of, for example, radiolabelled ligands binding to 
contaminating cells which are probably derived from the meninges. 
This is also true for any agonist evoked intracellular effects. 
This chapter will show for the first time that membranes 
prepared from neonatal rat cortical astrocytes in vitro express 
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3 3 3 binding sites for [ H]-DHA, [ H)-serotonin and [H]-QNB. In 
addition membranes from meningeal cells in culture possess binding 
sites for [3 H]_DHA and [3 H]_ serotonin (but not for [3 H)_QNB) with 
similar apparent affinity (Kd values) but lower receptor densities 
(Bmax) than in astrocyte membranes. 
Methods 
Cell culture and membrane preparation 
Astrocyte-enriched cultures from the neonatal rat cortex were 
grown to confluence (19-22 d. i. v.) in 60 mm diameter dishes as 
described in Chapter 4. Meningeal cells were cultivated as 
before except tl1a·t for the binding experiments with 
[3 H]-DHA and f 3H]-serotonin, the meninges from eight newborn rats 
were disrupted and plated onto 6 x 250 ml tissue culture. flasks 
(Falcon). The meningeal cell cultures grown in flasks were used 
at confluence (14 d.i.v.). 
Astrocyte and meningeal cell cultures were washed twice with 
3 ml of ice-cold PBS per dish or 10 mls of ice-cold PBS per flask 
and then harvested into ice-cold distilled water. The cells were 
further disrupted by sonication (Soniprep, MSE Scientific 
Instruments, amplitude setting 14 for 10 secs.) and allowed to 
stand on ice for 30 minutes to lyse any vesicles formed and to 
wash out any endogenous ligand. A Cf'u.Je.., pe.u.e.""~"}('-~ prepared for 
all binding studies by centrifugation at 50,000 g for 30 minutes 
(Sorvall RC-5B ultracentrifuge, Du Pont Instruments) the pellets 
being resuspended in assay buffer and aliquots taken for protein 
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determination (Lowry et ai, 1951), using BSA as a standard. 
[3 H]-DHA binding assay 
3 
The binding of [ H]-DHA was determined as in By~und et al 
(1978). 100 ~g protein aliquots of membrane were incubated with 
a range (0.02-1nM final concentration) oL [3 H]_DHA concentrations 
(Amersham International; specific activity 71 Ci/mmol) in 50 mM 
Tris-HCl pH 8.0 assay buffer, total volume 1 ml, for 30 minutes at 
25°C. The samples were then rapidly filtered uneer vacuum on 
Whatman GFfC glass fibre filter discs followed by 2 x 4 ml aliquots 
of ice-cold assay buffer. Filters were then placed in scintillation 
vials and dried overnight before the addition of 8 mls of 
scintillation flUid (Scintran Cocktail T, BDH) and determination of 
the bound radioactivity in a Beckman scintillation counter (LS 7500, 
Beckman Instruments) at a counting efficiency of approximately 55%. 
3 Specific binding was determined as the difference in [-oH] -DHA 
bound to the filters in the presence or absence of 1 ~M i-isoproterenol 
(Sigma) as a specific displacer. All determinations were made in 
duplicate or triplicate. Specific binding constituted 26 - 69% of 
the total binding, mean 50%. 
[3 H]-serotonin binding assay 
[3 H]-serotonin binding was performed as in Uzbekov et al (1979). 
100 ~g protein aliquots of cell membranes were incubated with a 
range (1 - 100 nM) of [3 H]-serotonin concentrations (Amersham 
International; creatine sulphate salt, specific activity 12.3 Cif 
mmol) in 50 mM Tris HCl pH 8.5 assay buffer, total volume 2 mls 
containing 2 ~M pargyline hydrochloride (Sigma), for 10 minutes at 
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37°C. The assay was terminated by rapid filtering of the membranes 
over Whatman GF/B filters, followed by 4 x 5 ml washes of ice-cold 
50 mM Tris-HCl pH 8.5. The non-specific binding was defined as 
the binding of [3HJ-serotonin in the presence of 20 ~M non-
radiolabelled serotonin. Specific binding constituted 36 - 70% of 
the total binding, mean 49%. The radioactivity bound to the filters 
was determined as for [3HJ - DHA binding, the counting efficiency was 
approximately 63%. 
[3HJ-QNB binding assay 
The method of Gross et al (1981) was used to determine 
[3HJ - QNB binding to 100 ~g protein aliquots of cell membranes. p 
The membranes from astrocyte and meningeal cultures were incubated 
with a range (0.025 - 5 nM)[3HJ-QNB (i-isomer, Amersham International, 
specific activity 40.4 Ci/mmol) for one hour at 25°C in 1 ml 50 mM 
+ + 
Na /K phosphate buffer (pH 7.4) in the presence or absence of 125 nM 
atropine sulphate to determine non-specific binding. The samples 
were then filtered over Whatman GF/B filter discs followed by 3 x 5 ml 
washes of ice-cold assay buffer. The radioactivity remaining on the. 
filters was counted as before, with an efficiency of approximately 
49%. Specific binding constituted 15 - 60% of total binding, 
mean 38%. 
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Results 
i) S -adrenergic receptors 
It is clear from Fig. 5.1 and 5.2 that astrocyte-enriched and 
meningeal cell cultures possess binding sites for [3 HJ -DHA, a S-
adrenergic receptor ligand. Whilst the ~sults for [3HJ-DHA binding 
to meningeal cell membranes are<-.from.a preliminary experiment, both 
astrocyte and meningeal cell binding sites are seen to possess 
similar affinities for this ligand (Kd = 88 pM and 56 pM respectively) . 
However, the receptor density (Bmax) for meningeal cell membranes 
(39fmol/mg protein) is less than that for astrocyte membranes 
(51 fmol/mg protein) as determined by Scatchard analysis (Figs 5.1b 
and 5.2b) . 3 The Hill plot of the results for.the binding of [ HJ-
DHA to astrocyte membranes (5.1 c) reveals a slope of less than one 
(0.72) which suggests that there are multiple binding sites for this 
ligand on membranes prepared from astrocyte enriched cultures. The 
lack of data for [3 HJ - DHA binding to meningeal cell membranes 
obtained from an experiment designed only to demonstrate the presence 
or absence of [3 HJ - DHA binding sites on meningeal cell membranes, 
restricts its interpretation. However, the Hill plot of this data 
(Fig. 5.2c) has a slope of close to unity (0.99) which suggests 
that in contrast to membranes from astrocyte enriched cultures, there 
3 
is only a single class of [ H]-DHA binding site present on meningeal 
cell membranes. 
ii) Serotonin receptors 
[3HJ-serotonin binds to both astrocyte and meningeal cell 
membranes with a similar affinity (Kd = 70 and 76 nM respectively) 
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Fig. 5.1 
[3 H]-DHA binding to astrocyte 
culture membranes 
Four binding experiments were conducted as 
described in Methods using [3 H1 - DHA at 2-4 concentrations 
in duplicate or triplicate in each experiment. The pooled 
tro~ & (l.¥~u;",tl.Jo.~S 
dataLare expressed as a saturation curve (A), a Scatchard 
plot (B; r=O_74, n=12, p<O_Ol) and as a Hill plot (c; 
slope=O. 72) . 
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. -~.'h_ 
[3 H1 - DHA binding to meningeal cell 
culture membranes 
Meningeal cell membranes were incubated with 5 
concentrations of ligand in duplicate, in one experiment. 
The results are expressed as a saturation curve (A), a 
Scatchard plot (B; r=O.83, n=5) and a Hill plot (c; 
slope=O.99) . 
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Fig. 5.3 
[3HJ-serotonin binding to astrocyte 
culture membranes 
This figure shows the pooled results of 4 experiments 
3 
to determine the binding of [ HJ-serotonin to astrocyte 
membranes using 2-4 concentrations of the ligand in duplicate 
or triplicate in each experiment. The results are expressed 
as a saturation curve (A), a Scatchard plot (B; r=O.82, n=14, 
p=<O.OOl) and a Hill plot (C; slope=O.98) 
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Fig. 5.4 
[3Hl-serotonin binding to meningeal 
culture membranes 
Meningeal cel~ culture membranes were incubated 
with a range of [3Hl-serotonin concentration as described 
in Methods. The figure shows data derived from one 
experiment performed in duplicate expressed as a 
saturation curve (A) and a Scatchard plot (B; 4=0.94', 
n=4, p<O.Ol). 
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Fig. 5.5 
r3HJ-QNB binding to astrocyte 
culture membranes 
r
3
HJ-QNB binding to astrocyte membranes was 
performed as in Methods. The figure represents data 
pooled from 4 separate experiments each using 2-4 
concentrations of ligand in duplicate or triplicate. 
The results are expressed as saturation curve (A), 
a Scatchard plot (B; r=O.86, n=13, p<O.Ol) and a Hill 
plot (C; slope=1.2). 
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Table 5.2 
Ligand 
[3 HJ -DRA 
[3HJ-serotonin 
[3 HJ -QNB 
Legend 
. ... 
Summary of radiol~g!and binding results 
v 
Astrocytes Meningeal 
Kd Bmax Kd 
(nM) (pmol/mg (nM) 
protein) 
0.088 0.051 0.058 
--
70.0 4.4 76.0 
0.079 0.044 
-
Cells 
Bmax 
(pmol/mg 
protein) 
0.039 
1.5 
-
.. The kinetic parameters shown here were determined by Sctatchard 
(...-
analysis of data presented elsewhere. - = no specific binding of 
this ligand 
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but with markedly lower receptor density on meningeal cells 
(Bmax = 1.5 pmol/mg protein compared to 4.4 pmol/mg protein as 
derived from Scatchard analysis (Figs S.3b and S.4b) . 3 [ HJ-
serotonin binds to a single population of binding site on 
astrocytes as indic~ted by the Hill analysis of this data 
(Fig. S.3c) revealing a slope close to unity (0.98). 
iii) Muscarinic receptors 
3 
When [ HJ-QNB binding to cell culture membranes is considered (Fig. 
5.5) it is evident that in this case only astrocytes possess binding 
sites for this muscarinic cholinergic ligand. No specific binding of 
[3HJ-QNB to meningeal cell membranes was seen over the range 1.3 _ 
327 pM [3HJ-QNB in two separate experiments. Hill analysis of the 
data (Fig. S.Sc) suggests that [3HJ-QNB binds to a single site 
on astrocyte membranes as the slope (1.2) is not markedly different 
from one. 3 The affinity of this site for [ HJ-QNB is Kd=79 pM and 
receptor density (Bmax) = 44 fmol/mg protein. 
The results of the experiments described here are summarised in 
Table 5.2. 
Discussion 
The principal aim of this series of studies was to determine whether 
rat cortical astrocytes in primary culture possess binding sites for 
neurotransmitters. The results presented here show that membranes pre-
pared from cortical astrocytes possess binding sites for three neuro-
transmitter ligands; [3 HJ - DHA , [3HJ-serotonin and [3Hl-QNB. This 
suggests the presence of B-adrenergic, serotfnergic and muscarinic 
cholinergic receptors on the'se cells. In addition, membranes prepared 
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from meningeal cells 
ligands, [3 HJ - DHA and 
in vitro express binding sites for two of these 
3 (MJ.. Off N (i .M.c-te; tJ- (4(J 15 ~ e.oJc.ulo.J-~J. 
[ HJ-serotonini Thus experiments to determine the 
functional role of these receptors in astrocyte enriched cultures, 
which are know to contain meningeal cells (Chapter 3) must also consider 
possible actions of neurotransmitter agonists on meningeal cells. 
The binding of [3 HJ - DHA to membranes prepared from neonatal mouse 
cortical cultures has been described by Ebersolt et al (1981b) and to 
intact chick astrocytes in vitro by Maderspach and Fajszi (1983). 
However, to the author's knowledge, the data presented here constitute 
the first report of the binding of this ligand to rat cortical 
astrocyte cultures. 
There is some variation in the previously reported Kd values for 
[3HJ - DHA binding to astrocytes. Ebersolt et al (1981b) state that 
[3 HJ - DHA binds to mouse astrocyte membranes at a single site with a Kd 
of 500 pM and Bmax of 145 fmol/mg protein. In chick astrocyte cultures 
the binding of [3 HJ - DHA is also to a single site but with an affinity 
6 
of 44 pM and Bmax of 3.3 fmol/10 cells (approximately 33 fmol/mg 
protein; Maderspach and Fajszi, 1983). The value for Kd presented 
here (88 pM) is thus within the range of those previously reported for 
[3HJ - DHA binding to astrocytes. It is also very similar to those 
reported for the binding of [125IJ-Pindolol derivatives (S-adrenergic 
antagonists) to rat cortical astrocytes in vitro i.e. 4.4 - 52 pM 
(Harden and McCarthy, 1982; McCarthy, 1983; Trimmer et aI, 1984) and 
to C6 glioma, i.e. 5.6 - 150 pM (Schmitt and Pochet, 1977; Barovsky 
and Brooker, 1980; Shitara et ai, 1984). 
However, not all of the r3HJ-DHA binding to "astrocyte" 
membranes can be attributed to astrocytes alone as preliminary data 
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, 3 
suggests that [ H]-DHA also binds to meningeal cell membranes. 
In this respect it is notable that a Hill analysis of the [3 H]_ 
DHA binding to astrocyte membranes suggests that there are more 
than one class of [3H]-DHA binding sites present on these 
membranes, with differing affinities for the ligand. When it is 
considered that Trimmer et al (1984) showed that astrocytes in 
vitro express only the Sl-adrenergic receptor subtype (the 8 2-
receptor subtype being expressed by meningeal cells) and that 
[3 H] -DHA has di.fferent affinities for the two B-receptor subtypes 
3 (U'Prichard et aI, 1980), i.t is probable that some of the [ H] -DHA 
binding to "astrocyte" membranes is to 82-receptios on meningeal 
cell membranes. I Membranes prepared from both astrocyte-enriched 
and meningeal cell cultures also possess binding sites for (3H]_ 
serotonin. In the case of astrocyte membranes, the binding is 
to a single site (Kd = 70nM) as shown by Hill analysis 
- ttt4--
Previous evidence for the binding of [3 H]-serotonin to 
astrocytes or meningeal cells in vitro is very limited. Indeed 
for meningeal cells there is none. Hertz et al (1979) showed 
that [3 H]-serotonin binds to intact mouse primary astrocyte 
cultures, although saturation binding kinetics were not determined. 
3 In the report of Hertz et al (1979) both 11 nM and 33 nM [ H]-
serotonin were seen to bind to the astrocytes with a value for 
specific binding of 50 fmol/mg protein. From this evidence the 
authors suggest that the Kd value for the [3 H]-serotonin binding 
site'was probably below 11 nM~ A later study by Tardy et al (1982) 
also examined the binding of [3H]-serotonin to mouse astrocyte 
cultures and derived a value for the affinity of the binding site 
of Kd = 15 nM and receptor density Bmax = 180 fmol/mg protein. A 
similar value of affinity (10 nM) for [3 H]-serotonin binding to 
astrocytes has been given by Fillion et al (1983) who examined the 
binding of this ligand to astrocytes bulk prepared from the 
horse striatum. 
3 Binding of the muscarinic cholinergic receptor ligand [ H]-
QNB to membranes prepared from astrocytes , in 
culture indicate that there is a single class of binding site for 
3 [ H]-QNB on astrocytes with an affinity of 79 pM and Bmax of 44 fmol/ 
mg protein. Again, this is the first report of such a binding site 
to membranes prepared from rat cortical astrocytes in primary culture 
and other evidence for the expression of such a site on astrocytes 
is very limited. Repke and Maderspach (1982) show that [3Hl-QNB 
binds to intact astrocyte cultures prepared from chick hemispheres 
(i.e. an intact cell preparation) with a Kd of 94 pM and Bmax of 
76 fmol/mg protein. 3 , [ H]-QNB also b~nds to 1321Nl 
astrocytoma cell membranes with a Kd in this case of 6.3 pM (Evans 
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et al~ 1984). The kinetic parameters given here (Table 5.2) are 
thus within the range of previously published results. 
3 In contrast, there is no specific binding of [ HJ-QNB to 
meningeal cell membranes. However, Estrada et al (19~3) and 
Grammas et al (1983) have reported that [3HJ-QNB binds to 
endothelial cells from bovine cerebral cortex and to microvessels 
from the rat cerebral cortex respectively. It is possible that 
the lack of [3Hl-QNB binding to meningeal cell membranes may reflect 
a paucity of endothelial cells in meningeal cell_cultures, as 
previously discussed (Chapter 3) . 
Whilst the binding of these three neurotransmitter ligands 
to astrocytes in vitro has not been extensively studied prior to 
this report, their existence had been inferred (but not proved) 
by studies of the effects of neurotransmitter agonists on cyclic 
nucleotide levels (see Introduction). In fact the stimulation of 
cyclic nucleotide second messengers by transmitter agonists 
constitutes the major source of evidence that neurotransmitter 
binding sites on astrocytes represent functional receptors. By 
far the most studied receptor from this respect has been the S-
adrenergic receptor. It is now well accepted that S-adrenergic 
receptor agonists stimulate cAMP production in a variety of 
astrocyte systems (see Introduction). Indeed isoproterenol (a S-
receptor agonist) stimulates the production of cAMP (70 fold) in 
similarly prepared astrocytes to those used in this study (Murphy et al -
submitted for publication). This latter observation suggests that the 
S-adrenergic binding site found on astrocyte membranes may be a 
functional receptor although, as meningeal cells also respond (11 fold) 
to isoproterenol by cAMP production (Murphy et al - submitted), 
- 146 -
an additional stimulation of these cells in astrocyte cultures 
cannot be excluded. 
The case for the [3Hl-serotonin and [3Hl-QNB binding sites 
found on astrocyte membranes constituting receptors linked to 
an intracellular second messenger system modulating a physiological 
response, is not as well established. Both primary cultures of 
mouse cortical astrocytes (7-14 d.i.v.) and astrocytes separated 
from the horse striatum, have been reported to show increases in 
the level of cAMP after stimulation by serotonin (Fillion et aI, 
1980; 1983). However, it is notable that the action of serotonin 
on cAMP content of astrocytes is equivocal. Ebersolt et al (1981c) 
showed no stimulation of adenylate cyclase activity by serotonin 
in older mouse cortical cultures (18 - 20 d.i.v.). Also, 
Bottenstein and de Vellis (1978) reported that serotonin affected the 
cAMP levels of C6 glioma cells only at high levels (300 ~~) and that 
the effect observed was a decrease in cAMP. More recently Sugino 
et al (1984) have shown that serotonin causes an increase in the 
intracellular ca
2
+ concentration in a subclone of C6 gliomoa cells. 
Furthermore, in this laboratory it has been shown that serotonin 
elicits an increase in inositol phospholipid turnover in primary 
cultures of rat cortical astrocytes (Pearce et aI, 1985c). It 
appears therefore that the [3Hl-serotonin binding site on astrocyte 
membranes reported in this chapter may be linked to a second 
messenger system which might effect physiological responses in 
astrocytes (Chapter 6) . 
As was the case for serotinergic sites on astrocytes, 
stimulation of the muscarinic cholinergic receptor on these cells 
has been reported to affect the activity of adenylate cyclase 
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although in this case, the effects are inhibitory. Thus activation 
of the muscarinic cholinergic receptor on C6 cells by agonists such 
as carbachol reduces the basal level of cAMP and also cGMP 
(Bottenstein and de Vellis, 1978). It has also been reported that 
carbachol reduces the noradrenaline or isoproterenol-evoked rise in 
2+ 
cAMP in glioma cell lines by a Ca dependSnt process (Gross and 
Clark, 1977; Bottenstein and de Vellis, 1978; Evans et ai, 1984). In 
1321N1 astrocytoma cells, carbachol is thoughrto reduce cAMP levels 
~ activation of phosphodiesterase(s) (cf Evans et ai, 1984). Recent 
work in our laboratory has shown that carbachol also reduces the 
isoproterenol evoked CAMP production in astrocyte primary cultures 
(Murphy et al - submitted) in this case directly via an inhibitor of 
adenylate cyclase. Furthermore, it has also been shown in our 
2+ laboratory that carbachol causes a Ca dependant, atropine sensitive 
increase in the accumulation of [3 H] inositol phosphates in astrocyte 
cultures pre-labelled with [3 H] myo-inositol (Pearce et ai, 1985c). 
These data indicate that astrocytes possess both M1 and M2 muscarinic 
receptor subtypes which are linked to either inositol phospholipid 
metabolism or adenylate cyclase respectively (Evans et ai, 1984). In 
contrast, as predicted by the lack of 13H]-QNB binding to meningeal 
cell membranes, carbachol has only a slight stimula~ory effect on 
inositol phospholipid metabolism in meningeal cells (Pearce et ai, 
1985c) and does not reverse isoproterenol-stimulated CAMP levels 
(Murphy et al - submitted). 
Work performed in our own and other laboratories, therefore 
suggests that the binding sites shown to be present on astrocytes 
in vitro (this chapter) may be linked to second messenger 
systems. However, the possible intracellular effects of activation 
of these receptors subsequent to second messenger production are in 
the main unknown. Most of the known effects of receptor activation 
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I 
, 
have been reviewed by Van Calker and Hamprecht (1980). Briefly, 
in C6 glioma cells, S-adrenergic stimulation increases the activity 
of lactate dehydrogenase, ornithine decarboxylase, CNPase and GPDH 
and an increase in carbonic anhydrase activity in astrocyte primary 
cultures. The significance of these Changes is, as yet, unknown. 
S-adrenergic agonists also induce "morphological differentiation" of 
astrocytes in vitro, i.e. the cells change from a flattened poly-
.' gonal shape to a bipolar or astrocyte-like morphology with extensive 
processes. Of particular interest have been the reports that some 
neurotransmitter~or their agonists can stimulate glycogenolysis in 
astrocytes (see Chapter 6). The glycogen stores of astrocytes have 
al~eady been suggested to constitute a pool of metabolic 
intermediates which can be used by neurons. Moreover, the 
metabolism of astrocyte glycogen can be influenced by neuronal 
activity (Chapters 1 and 4). The next chapter will therefore 
examine the intracellular consequence of astrocyte neurotransmitter 
receptor activation reflected by changes in the metabolism of the 
glycogen stores of astrocyte and meningeal cell cultures. 
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CHAPTER 6 
The effects of neurotransmitter agonists and 
antagonists on astrocyte glycogen stores 
Introduction 
In Chapter 1 the concept of neuron/glia signalling was 
introduced. It was shown in Chapter 4 that astrocytes in primary 
culture ,do respond to one such~utative s~gnal i.e. a change in 
+ 
[K J o ' by alterations in glycogen metabolism. Astrocyte glycogen 
stores have been suggested to constitute an important reser~e pool 
of metabolic intermediates for neurons, indeed,in the CNS,glycogen 
is localised predominantly to astrocytes (see Chapters 1 and 4). It 
was also suggested that astrocytes might respond to other signals 
released from neurons such as neurotransmitters, by alterations in 
glycogen metabolism. Chapter 5 showed that astrocyte cultures possess 
binding sites for at least three neurotransmitters, noradrenaline 
(S-adrenergic), acetycholine (muscarinic) and serotonin. However, as 
previously stated, the presence of receptors for neurotransmitters on 
cell membranes implies nothing about what, if any, intracellular 
consequences might occur after the receptors are activated. ' This 
chapter will examine the effects of activation of these particular 
receptors on the glycogen metabolism of neonatal rat cortical 
astrocytes in primary culture. 
Previous studies, albeit few, have suggested that the glycogen 
stores of astrocytes in vitro can be influenced by neurotransmitters. 
The most studied transmitter in this respect is noradrenaline and 
there are a few reports of serotonin, but not of acetylcholine effects 
on astrocyte glycogen stores. For example, stimulation of adrenergic 
receptors has been shown to evoke glycogenolysis in C6 cells (Opler 
and Makman, 1972; Browning et aI, 1974; Passoneau and Crites, 1976). 
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In addition, noradrenaline, as well as histamine, serotonin and 
3 
adenosine, stimulate the hydrolysis of [ Hl-glycogen newly formed 
3 
from [ H)-glucose in rat hemisphere primary cultures (Magistretti 
et aI, 1983). 
Frequently, the control of astrocyte glycogen metabolism by 
neurotransmitters is considered to be via a cAMP dependant mechanism. 
For example, noradrenaline and isoproterenol are known to increase 
cAMP in astrocytes via 8-adrenergic receptors (see Van Calker and-
Hamprecht", 1980). Passoneau and Crites (1976) observed that the 
noradrenaline evoked increase in cAMP accumulation in C6 cells was 
mirrored by an increase in GPa activity, a reduction in'GSa activity 
and a consequent reduction in total glycogen content. Also Cummins 
et al (1983b) showed that the noradrenaline evoked glycogenolysis in 
(Herpes virus transformed-) astrocyte cultures was blocked by the 
adrenergic receptor antagonist propranolol. Furthermore, the 8-
receptor agonist isoproterenol causes glycogenolysis in these cells 
whilst the a-adrenergic receptor agonist phenylephrine was ineffective. 
However, a direct link between cAMP and glycogenolYSis in astrocytes 
has not been shown. Moreover, transmitter control of astrocyte 
glycogen is not always regarded as being cAMP dependant. Magistretti 
et al (1983) proposed that histamine evoked glycogenolysis in rat 
astrocyte cultures through a cAMP independant manner. In addition 
cAMP is not thought to be involved in the control of glycogen 
metabolism in C6 cells by glucose (Passoneau and Crites, 1976) or in 
+ 
the K evoked glycogenolysis seen in mouse cortical slices (Ververken 
et aI, 1982) 
Notably in the liver it has recently become clear that 
adrenergic control of glycogen stores involves non-c~MP linked, 
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a-receptor mediated effects as well as cAMP linked, S-receptor 
effects (Williamson et aI, 1981). Indeed in some species such as 
the rat, non-cAMP linked, a-adrenergic receptor control of hepatic 
glycogen metabolism prGdominates over B-adrenergic control (Kunos, 
1984). Moreover, when considering the neurotransmi~ter control of 
the glycogen stores of astrocytes in vitro it is important to note 
that Kunos (1984) suggests that an incr~ased contribution of S-
adrenergic receptor mediated_Fontrol of glycogenolysis over a-adrenergic 
receptor control may result from a lack of cellular 
differentiation. This is of particular interest as the majority of 
studies regarding neurotransmitter control of astrocyte, glycogen stores 
have used C6 cells or virus-transformed astrocytes which might be 
regarded as relatively undifferentiated or dedifferentiated cells. 
Therefore,while increases in intracellular levels of cAMP have 
been reported to stimulate glycogenolysis in astrocytes, there is no 
direct evidence to support the idea that neurotransmitters influence 
astrocyte glycogen metabolism through such a mechanism. 
The experiments described in this chapter were designed to 
answer three basic questions. 
a) Does activation of any of the three neurotransmitter receptors 
known to be present on the membranes of rat cortical astrocytes in 
vitro (Chapter 5) alter the metabolism of glycogen? 
b) Are any effects on astrocyte glycogen stores specific to a 
particular receptor or do they represent a general consequence of 
receptor activation? 
c) Is the noradrenergic control of glycogen metabolism in 
astrocytes in vitro mediated by a- or S-adrenergic receptors? 
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As astrocyte-enriched cultures are known to be contaminated 
with cells presumably derived from the meninges (Chapter 3), and it 
is known that meningeal cells in vitro contain glycogen (Chapter 4) 
and express neurotransmitter receptors (Chapter 5), the Rffects of 
transmitter receptor activation on the glycogen stores of meningeal 
cells were also examine~ 
This chapter will show that:-
~" ... ~~ 
a)L9lycogenolysis in astrocyte cultures is not a general 
consequence of receptc..>r activation but is confined to two of the 
three receptor types examined, i.e. adrenergic and serot~nergic 
but not muscarinic cholinergic. 
b) In the case of the noradrenergic control of astrocyte 
glycogen stores, the action of noradrenaline cannot be sufficiently 
explained by mediation through either CL or 8-receptors alone but it 
is clear that 8-receptor stimulation is not the predominant route of 
noreadrenaline evoked glycogenolysis. 
In addition: 
a) Meningeal cells in vitro respond to noradrenaline by a 
reduction in glycogen stores but in this case both CL and 8 -adrenergic 
agonists are capable of eliciting glycogenolysis. 
b) Cells in astrocyte-enriched and meningeal cultures may 
release a monoamine transmitter (possibly serotonin in astrocyte 
cultures) which exerts an endogenous control of glycogen stores. 
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Methods 
For these experiments, confluent astrocyte-enriched and meningeal 
cell cultures were prepared in 60 mm diameter dishes (Falcon) as des-
cribed in Chapter 3. The cell cultures were pre-incubated for 2 hours 
in medium supplemented with 20 mM glucose to maximise glycogen content 
as described in Chapter 4. However, in the case of reserpine treatment 
of clIltures, the cells were incubated overnight (16 - 17 hours) with 
10 ~ reserpine in buffer containing 20 mM glucose (see Chapter 4) and 
were not pre-incubated in glucose~supplemented medium • 
After pre-incubation with glucose-supplemented medium or 10 ~M 
reserpine in buffer, the cultures were washed with 3 mls of buffer 
and incubated (37 0 in 35.5% CO2/air) for one hour in 5 mls of fresh 
buffer containing a variety of pharmacological agents. Where the 
effects of monoamine neurotransmitters, their aqonists or antagonists 
were being examined, pargyline hydrochloride (100·~M), tropolone 
(100 ~) and ascorbic acid (1 mM) were added to both the wash and 
experimental buffer to inhibit the breakdown of amines by monoamine 
oxidase, catechol-o-methyl transferase and oxidation respectively. 
In all experiments control cultures were incubated in buffer alone 
± metabolic inhibitors as .:tppropriate. Where the effect of an ant-
agonist on the agonist-evoked change in glycogen level of the cell 
cultures was being examined, the effects of the agonist and anta-
gonist alone were also tested during the same experiment. Thus all 
statistical comparisons reported here were performed using a matched 
pair, two-tailed t-test as in Chapter 4 (Snedecor and Cochran, 1967). 
All chemicals were obtained from the Sigma Chemical Company 
except phentolamine (CrBA Geigy), prazosin (Pfizer Ltd) and forskolin 
(Hoechst) . 
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Results 
The effects of neurotransmitter agonists on the glycogen 
content of cell cultures 
Fig. 6.1 shows the effects of neurotransmitter agonists on the 
J glycogen-content of astrocyte-enriched and meningeal cell cultures. 
Only noradrenaline (50 ~M) is seen to evoke a statistically signficant 
change in the glycogen content of astrocyte cultures when compared 
to control (a 33% decrease), whereas serotonin and carbachol are 
without effect. Noradrenaline also causes a statistically significant 
net glycogenolysis (20%) in meningeal cell cultures although the 
effect is less than that in astrocyte cultures. The muscarinic 
cholinergic agonist carbachol evokes apparent small decreases in astrocyte 
glycogen stores at each of four different concentrations, 500 ~M 
(16%),5 ~M (6%), 1 ~M (9%) and 0.5 ~M (18%) but none of these are 
statistically significant when compared to controls run in parallel. 
Similarly, 50 ~M carbachol causes an apparent but not statistically 
significant change in meningeal cell glycogen (a 4% increase). The 
apparent increase in astrocyte glycogen content seen after incubation with 
50 ~M serotonin is not statistically Significant when compared 
to control. 
When astrocyte and meningeal cell cultures are exposed to 
specific adrenergic receptor sub type agonists (Fig. 6.2a) it is 
evident that neither the glycogenolYSis evoked by 50 ~M isoproterenol 
(S-receptor agonist, 5%) nor by 50 ~M phenylephrine (a-receptor 
. 
agonist, 13%) in astrocyte cultures are statistically significantly 
less than control values. However, if meningeal cell cultures are 
exposed to 50 ~M isoproterenol there is a statistically significant 
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Fig. 6.1 
Effects of neurotransmitter agonists on 
cell culture glycogen content I 
Astrocyte-enriched and meningeal cell cultures 
were incubated in buffer containing 50 ~M 
noradrenaline (NA), 50 ~M serotonin (5-HT) or 500~ 
carbachol (CAR) and the glycogen content determined 
as in Methods. n is not less that 4 for all 
determination~where n represents the number of 
treated cultures. The data were obtained from ~~~ 
. experiments .r~(\)l.o,)". 
* represent a value statistically significantly 
different from control (p<0.05 or less) 
Error bars indicate the standard error of the 
mean 
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Fig 6.2a 
Effects of neurotransmitter agonists on 
cell culture glycogen content 11 
Astrocyte-enriched and meningeal cell cultures were 
incubated in buffer containing 50 ~ noradrenaline (NA) , 
50 ~M isoproterenol (ISO), 50 ~M Phenylephrine (PHE) , 
1 mM dibutyryl cAMP (DB) or 20 ~M forskolin (FOR) and 
glycogen content determined as in Methods. n is not 
less than 11 for all determinations, the data being 
derived from .I'\,.e,.. "u. .... ~~,. of experiments .rt..OlUA. 
* represents a value statistically significantly 
different from control (p<0.05 or less) 
Error bars indicate the standard error of the mean 
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Fig. 6.2b 
Effect of noradrenaline in the pres ence or 
absence of forskolin on astrocyte glycogen content 
Astrocyte-enriched . 
. cultures were 
incubated in 50 ~M noradrenaline (NA), 50 ~ nora-
drenaline and 20 ~ forskolin (FOR), and 20 ~ forskolin 
alone. Glycogen content was measured as described in 
Methods. n for this series of experiments is 10 in each 
case, the data being derived from 5 experiments. 
* represents a value statistically significantly 
different from control (p<0.05 or less) 
Error bars indicate the standard error of the mean 
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decrease (33%) in glycogen content. There is also a decrease (40%) 
in glycogen stored in meningeal cell cultures after incubation with 
50 ~M phenylephrine. 
Compounds which raise the level of intracellular cAMP without 
interaction with transmitter receptors cause marked reductions in the 
glycogen content of astrocyte and meningeal cell cultures (Fig 6.2a). 
lmM dibutyryl cAMP (dEcAMP) causes a 38% loss of astrocyte glycogen 
and 20 ~M forskolin evokes a 37% decrease. The effect of forskolin 
is even greater on the glycogen stores of ucningeal cells. (52%). 
Also when 20 ~ forskolin is added to astrocyte cultures in 
combination with 50 ~ noradrenaline (Fig 6.2b) the resulting glycogen 
breakdown (57% of control) is not significantly greater than that seen 
in the presence of 20 ~ forskolin alone in this series of experiments 
(63% of cont~ol). This may indicate that forskolin and noradrenaline 
do not evoke glycogenolysis by completely independent means or, 
alternatively, that the breakdown evoked by 20 ~ forskolin 
represents maximal glycogenolysis. 
The effects of receptor antagonists on adrenergic agonist-
evoked changes in the glycogen content of cell cultures 
Fig. 6.3. shows the results of experiments where the a and 
S-adrenergic receptor antagonists phentolamine and propranolol were 
used in attempts to block the noradrenaline evoked glycogenolysis 
seen in astrocyte and meningeal cell cultures. In astrocytes, 200 ~~ 
propranolol did not reverse the effect of noradrenaline on glycogen stores 
but it is clear that propranolol itself causes a breakdown of glycogen. 
Phentolamine (200 W'I) also produces a statistically significant reduction 
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Fig 6.3 
Effects of a- and 8-adrenoreceptor antagonists 
on noradrenaline evoked glycogenolysis 
in cell cultures 
Astrocyte-enriched and meningeal cell cultures were 
incubated with 50 ~ noradrenaline (NA) and/or 200 ~M 
propranolol or 200 ~M phentolamine and the glycogen 
content determined as in Methods. Antagonists were 
added 1-2 minutes before the addition of noradrenaline. 
n is not less than 6 in each case, the data being 
derived from l-I..ct. ""lA"",!3~" 01 experiments . .1"0&':>"-. 
* represents a value statistically significantly 
different from control (p<0.05 or less) 
Error bars indicate the standard error of the mean 
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in astrocyte glycogen content (20%) and it does not reverse the 
effect of noradrenaline. The glycogenolytic effect of propranolol 
is also seen in meningeal cell cultures where it is more marked 
(44% loss of glycogen) . 
When a-receptor antagonists selective for a (prazosin, 1 ~~) 
1 
and a 2 (yohimbine, 1 ~M) receptor subtypes are used in combination 
with phenylephrine (Fig 6.4) it is noticeable that neither of these 
reverses the slight reduction seen in astrocyte glycogen stores after 
incubation with phenylephrine alone (13%). However, phenylephrine 
and yohimbine together evoke a 27% decrease in astrocyte glycogen 
which is statistically significantly less than controls. This effect 
is not reversed by 1 ~M prazosin. Prazosin at this concentration 
also does not reverse the effect of 50 ~M phenylephrine on meningeal 
cell glycogen (Fig 6.4), although the combination produces a net 
reduction in glycogen content (23%), close to that loss caused by 
prazosin alone (20%). 
The effects of reserpine on the glycogen content of cell cultures 
Fig. 6.5 shows that when astrocyte-enriched cultures are 
incubated overnight in buffer and reserpine (10 ~) there is a marked 
statistically significant increase (55%) in glycogen stores over 
control cultures incubated in buffer alone. However, when meningeal 
cell cultures are similarly treated there is a statistically significant 
re~uction (19%) in glycogen content. 
When astrocyte cultures pre-treated with reserpine are incubated 
with noradrenaline there is a slight, non-statistically significant 
increase in the action of noradrenaline on glycogen stores (a 14% 
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Fig. 6.4 
Effects of al- and a2-adrenoreceptor anatagonists 
on phenylephrine evoked glycogenolysis in 
cell cultures 
Cell cultures were incubated with 50 ~M phenylephrine 
(PHE) and/or 1 ~M prazosin (PRAZ) or 1 ~ yohimbine (YO) 
and glycogen content determined as in Methods. Antagonists 
were added 1-2 minutes before the addition of phenylephrine. 
n is not less than 6 in each determination, the data 
being derived from YI."e, "U""'~Q.I" o~. experiments .r~OIo,')A. 
* represents a value statistically significantly 
different from control (p<0.05 or less) 
Error bars indicate the standard error of the mean 
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Fig. 6.5 
Effects of reserpine on the glycogen 
content of cell cultures 
Cell cultures were incubated with 10 ~M reserpine 
(RES) overnight as described in Methods and the glycogen 
content determined with or without further exposure to 
50 ~ noradrenaline (NA) or 50 ~ serotonin (5-HT). 
n is not less than 6 in each case, the data being 
derived from "L..e.... "u. ..... !,tr of experiments. SL..o&.)"'. 
* represents a value statistically significantly 
different from control (p<0.05 or less) 
Error bars indicate the standard error of the mean 
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reduction to a 23% reduction). Moreover, the effect of serotonin 
on the glycogen stores of non-reserpine treated astrocyte cultures 
(a 14% increase) is reversed by reserpine pre-treatment to produce 
a 28% decrease in glycogen which is a statistically significant. 
Discussion 
The effects of neurotransmitter agonists on the glycogen 
content of cell cultures 
It has previously been suggested that neurons may signal to 
astrocytes via their release of neurotransmitters. This may result 
in the modification of the glycogen metabolism of astrocytes thus 
maintaining a supply of metabolic i~termediates for neuronal use. 
The main aim of the current study was to establish whether stimulation 
of three neurotransmitter receptor sites, 8-adrenergic, serotinergic 
and muscarinic cholinergic, found on the membranes of astrocytes in 
vitro could result in a change in the metabolism of astrocyte glycogen 
stores. The results presented in this section suggest that stimulation 
of the serotinergic and muscarinic cholinergic receptors is without 
effect on the net glycogen content of astrocyte cultures. Only nor-
adrenaline is seen to evoke a statistically significant change in 
astrocyte glycogen stores (a reduction of 33%). Clearly, the smaller 
efiect of noradrenaline on meningeal cell glycogen content (a 20% 
~r 
reduction) is not sufficient to accountlthe change in astrocyte cultures. 
The work of Magistretti et al (1983) has also demonstrated that 
noradrenaline can evoke glycogenolysis in astrocyte cultures. 
However, it is n~taole that the effect of noradrenaline observed by 
3 . this group (a 60% hydrolysis of [ Hl-glycogen) 1S greater than that 
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seen here. Moreover, this report also shows that serotonin elicits 
[3Hl-glycogen hydrolysis (37%) in astrocyte cultures. This is not 
in agreement with the results presented here as it has been shown 
that serotonin has no statistically significant effect on astrocyte 
glycogen stores. These discrepancies may be explained in part by 
the differences between the two methods used to estimate the effects 
of serotonin on astrocyte glycogen. Magistretti et al (1983) 
3 
measured the ability of serotonin to Hydrolyse [ Hl-glycoaen newly 
3 
synthesised by astrocyte cultures from [Hl-glucose. In order for 
the values of [3Hl-glycogen hydrolysis to represent total glycogen 
breakdown (i.e. the difference in glycogen content of treated and non-
treated cells), [3Hl-glucose residues and non-labelled glucose residues 
in [3Hl-9lycose must be equally available for release by GPa. Glycogen is 
formed by the addition of the glycosyl group of UDP-glucose to the 
terminal glucose of an amylose chain (Chapter 4), so [3Hl-glycogen will 
be formed by the addition of [3Hl-glucose (and non-labelled glucose) to 
a pre-existing chain of unkno;vn length. Subsequent hydrolysis of [3 H1 _ 
glycogen may therefore overestimate the total amount of glycogenolysis. 
Indeed, if there is a large amount of non-labelled glycogen in relation 
3 
to [ Hl-glycogen,then the glycogenolysis evoked by, for example, 
serotonin, whilst eliciting marked hydrolysis of [3Hl-glycogen, may 
not be greater than experimental variation when the resultant changes 
in glycogen content are determined. 
Irrespective of these methodological consideration, it is clear 
that noradrenaline evokes glycogenolysis in astrocyte cultures. 
Another aim of the current study was to clarify which adrenergic 
receptor mediates the effects of noradrenaline on astrocyte glycogen 
stores. As stated in the Introduction, previously published data had 
suggested that adrenergic control of glycogenolysis in astrocytes 
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might be mediated by f-receptor, cAMP-linked effects, analogous to 
the early hypothesis of adrenergic control of hepatic glycogenolysis. 
Therefore, it might be expected that the noradrenaline evoked net 
glycogenolysis observed in the astrocyte cultures used here occurs 
via a cAMP dependent mechanism. Indeed, dBcAMP and also forskolin, 
(which directly sti"""mulates adenylate cyclase (Seamon et aI, 1981) do 
produce glycogenolysis in astrocyte c~ltures (38% and.37% respectively). 
Whilst forskolin also stimulates glycogenolysis in meningeal cellsJ. 
(52%) it is not sufficient to account for the decrease seen in astrocyte 
cultures (assuming approximately-30% contamination of the total 
glycogen pool with meningeal cell glycogen). However, whilst increases 
in intracellular cAMP levels can evoke glycogenolysis in astrocyte 
cultures it does not necessarily follow that noradrenaline, although 
known to increase cAMP levels in astrocytes (Chapter 5), elicits 
glycogenolysis through this mechanism. Notably, the stimulation of 
astrocyte S -receptors by isoproterenol is also known to increase 
cAMP in astrocytes (Chapter 5) but it does not produce statistically 
significant net glycogenolysis (5%) in astrocyte cultures. This is 
particularly interesting for several reasons:-
i) As there is a marked, statistically significant loss of 
glycogen in meningeal cell cultures after incubation with isoproterenol 
(33%) it is unlikely that contaminating meningeal cells contribute 
significantly to the glycogen pool in astrocyte enriched cultures as 
previously suggested (Chapter 4) . 
ii) Increases in intracellular cAMP evoked by transmitter receptor 
activation do not lead automatically to a net breakdown of astrocyte glycogen. 
iii) As isoproterenol (50 ~) stimulates the incorporation of 
14 
[ C]-2-DG into the glycogen stores of astrocyte cultures (60%; 
Pearce et al, 1985a), S -receptor activation must therefore also 
stimulate glycogenolysis, resulting in no net change in glycogen 
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content, i.e. an increase in turnover rate. 
iv) The net glycogen breakdown caused by noradrenaline may 
not therefore be mediated solely by S-receptors but may involve 
a-receptors,as is the case in the rat liver where a
1
- receptor control 
-of glycogenolysis predominates (Williamson et ai, 1981; Kunos, 1984). 
However, it is evident that phenylephrine, an a-adrenergic 
agonist, whilst eliciting a greater reduction in astrocyte glycogen 
stores (13%) than isoproterenol, does not statistically significantly 
alter the level of astrocyte glycogen. In contrast, phenylephrine 
is particularly effective in reducing the level of glycogen in 
meningeal cell cultures (40%). 
These results suggest that, while increased intracellular levels 
of cAMP can elicit glycogenolysis in astrocyte cultures; this may not 
be the sole mechanism by which noradrenaline reduces astrocyte 
glycogen stores. Noradrenaline may evoke glycogenolysis in astrocyte 
cultures via an action on both a- and S-receptors, unlike the case in 
meningeal cell cultures where activation of either receptor results 
in glycogenolysis. In order to examine further the question of 
whether a- or S-receptors are involved in the action of noradrenaline 
on astrocyte glycogen stores, selective adrenergic receptor antagonists 
were used. 
Effects of adrenergic antagonists on agonist-evoked 
glycogenolysis in cell cultures 
In view of the inability of a S-receptor agonist (isoproterenol) 
to elicit net glycogenolysis in astrocytes, the observation that 
propranolol (a S-receptor antagonist) was ineffective in reversing 
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, 
noradrenaline-evoked glycogenolysis in these cells was not un-
expected. More surprisingly perhaps, propranolol does not alter 
the noradrenaline-evoked loss of glycogen in meningeal cell 
cultures which are known to respond to isoproterenol by a net 
glycogen breakdown. However, propranolol ,·in the absence of 
transmitter agonists also causes glycogenolysis in both cell 
cultures (26% and 44% respectively) . This effect may mask any 
reversal <;>f the action of noradrenaline on both cell cultures. 
The mechanism by which propranolol reduces glycogen stores is unclear 
but it is known that it has a va.riety of effects other than blockade 
of S-adrenergic receptors. These include blockade of serotonin 
receptor~: (Middlemiss, 1984), an increased production of phosphatidic 
acid (a proposedca 2+ ionophore) ·in rat brain microsome preparations 
2+ (Pappu and Hauser, 1983) and an inhibition of ATP evoked Ca uptake 
into rabbit skeletal muscle (Herbette et al, 1983). Therefore, the 
eJfects of propranolol on glycogenolysis may be non-specific and 
involve the intracellular distribution of ca2+. The importance of 
2+ 
Ca with respect to glycogen metabolism will be discussed later. 
Phentolamine (an a -receptor antagonist) also has ~ffects on 
the glycogen stores of astrocytes when added in the absence of 
adrenergic agonists (a 20% reduction) but does not reverse the 
effect of noradrenaline. As was the case for propranolol, the 
exact cause of the phentolamine effect is not clear. Thus, 
phentolamine was of little use as an a-adrenergic antagonist in this 
case so in order to examine the effects of a-adrenergic stimulation 
on the glycogen stores of cell cultures, more specific a-adrenergic 
antagonists were used. 
The results from experiments using the a
1
-receptor antagonist 
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prazosin and the a 2-receptor antagonist yohimbine are difficult 
to interpret. Clearly the small effect of phenylephrine on astrocyte 
glycogen stores is not reversed by prazosin, suggesting that 
phenylephrine does not act via an al-receptor. This is in contrast 
- to the effect of prazosin on phenylephrine-e'voked glycogenolysis 
in meningeal cell cultures where the level of glycogen in the presence 
" 
of both agonist and antagonist (L7%) is very close to that in the 
presence of antagonist,oalone (80% of control). Surprisingly, the 
effect of phenylephrine and yohimbine (an a 2-receptor antagonist) 
together on astrocyte glycogen stores, i~greater than that of 
phenylephrine alone (73% and 87% of control respectively). Further-
more, the combination of phenylephrine and yohimbine produces a 
statistically significant reduction in astrocyte glycogen content. 
This may suggest that the stimulation of a'2-receptors by phenylephrine 
may inhibit ai-mediated, phenylephrine-stimulated glycogenolysis. 
However, prazosin does not reverse the effect of phenylephrine and 
yohimbine, a result which contradicts this suggestion. 
Phenylephrine is known to potentiate the forskolin evoked stim-
. 
ulation of cAMP accumulation in rat astrocyte cultures via S-receptors (Wu 
and de Vellis, 1983). It has also been shown to reduce the rises in 
cAMP evoked by forskolin and S-receptor agonists in astrocyte cultures 
via a-receptors (Wu and de Vellis, 1983; Evans et aI, 1984). It 
might be suggested that phenylephrine evokes glycogenolysis 
through stimulation of cAMP (via S-receptors) which is promoted 
by the inhibition of the antagonistic effects of a
2
-receptors by 
yohimbine. However, presumed increas:/in cAMP associated with 
S-receptor stimulation (by isoproterenol) do not stimulate 
glycogenolysis. 
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Clearly the action of phenylephrine is complex, and while 
it is known that u -receptor agonists can inhibit the B--adrenergic 
agonist evoked rises in cAMP in astrocytes (Evans et al, 198~, 
nothing is known of the possible interactions of u 1- and u2
-
receptor mediated intracellular responses. 
The intracellular effects of u 1-receptors in a variety of 
systems are usually taken to be mediated by stimulation of inositol 
2+ phospholipid metabolism and effects on intracellular Ca 
distribution (Exton, 1981). Indeed, noradrenaline evokes increases 
in inositol phospholipid turnover in astrocytes via an u 1-receptor 
(Pearce et ai, 1985c). In contrast u 2-receptor effects are commonly 
associated with an inhibi.tion of adenylate cyclase (cf. Evans et ai, 
2+ 1984a. Notably, an interplay between Ca and cAMP has been reported for a 
variety of systems (see Rapp and Berridge, 1976). Moreover, complex 
2+ interactions between Ca levels and adenylate cyclase have been 
reported in astrocyte cultures (Brostrom et ai, 1976; Ebersolt et ai, 
1981c; Latzkovits et ai, 1982). Therefore, it is possible that the 
u 2-receptor affects u 1-receptor mediated responses via complex inter-
actions at the level of ca 2+ and adenylate cyclase second messenger systems. 
Further discussions of such interactions between transmitter 
receptors and between second messenger systems are beyond the scope of 
this thesis. However, it is apparent that the effect of noradrenaline 
on astrocyte glycogen stores may not be mediated solely by 8-
receptors but may involve complex, obligatory interactions between 
all three adrenergic receptor sybtypes examined, u 1-, u 2
- and 8-
receptors. In contrast, the action of noradrenaline on meningeal cell 
glycogen content may be mediated by u1-receptors (blocked by prazosin) 
or 8-receptors. 
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The intracellular mechanism(s) by which noradrenaline affects 
glycogen metabolism in astrocytes subsequent to second messenger 
production is also not clear. In the liver, adrenergic control of 
glycogen metabolism is mediated predominantly via a
1
-receptors and 
2+ 
affects on intracellular Ca levels possibly through increases in 
the turnover of inositol phospholipids (see Introduction, also Hems 
and Whitton, 1980; Burgess et al, 1984). 2+ Ca is thought to activate 
phosphorylase b kinase and thus convert GPb to GPa and 90 evoke 
glycogenolysis (Williamson et al, 1981). In cardiac muscle, nora-
2+ drenaline causes glycogenolysis by activation of both cAMP and Ca 
second messengers which act at different parts of the enzyme cascade 
then links receptor activation to glycogen breakdown (Rasmussen 
1970). Indeed in the liver, cAMP and Ca 2+-linked glycogenolytic 
hormones may act on separate, but overlapping parts of the enzyme 
cascade (Kunos, 1984). 
It has been shown that stimulation of the astrocyte cutlures 
with selective adrenergic agonists (phenylephrine and isoproterenol) 
does not evoke net glycogenolysis. This may suggest that noradrenaline 
acts on astrocyte glycogen stores by an obligatory action on both 
2+ 
cAMP and Ca • However, as presumed increases in astrocyte cAMP levels 
not associated with neurotransmitter activation, for example that 
caused by forskolin, can evoke glycogen breakdown, clearly there must 
be other control mechanisms involved in receptor activation which 
influence glycogen metabolism. These may include antagonistic effects 
of receptors such as that suggested to exist betweena
2
- and a
1
-
receptors. Furthermore, as the effects of forskolin and noradrenaline 
are not additive, there may be a common limiting mechanism of the 
control of glycogen stores. It is noticeable that the glycogen 
stores of astrocyte cultures are never reduced to less than 
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55 - 60% of control (see also Chapter 4) which suggests that there 
is in fact such a mechanism. 
The exact intracellular mechanism(s) by which noradrenaline 
evokes glycogenolysis in astrocytes is therefore not evident. 
However, the main aim of this current study was not to determine 
such mechanisms but to examine the net effects of neurotransmitter 
agonists on the glycogen content of astrocytes. As a result of 
this study it is suggested'that (a) carbachol and serotonin do not 
stimulate net glycogen breakdo.wn in astrocytes and (b) the adrenergic 
control of astrocyte glycogen stores involves both B-adrenergic, cAMP-
dependant effects and a-adrenergic, cAMP independant effects and may 
2+ involve changes in the intracellular distribution of Ca , as is 
believed to be the case in the liver. 
The effects of reserpine on the glycogen stores of cell cultures 
The anomalous effects of propranolol on the glycogen content of 
astrocytes have been suggested to be explained by non-specific actions 
on intracellular ca2 + distribution, implicated in the 
control of glycogen metabolism in the liver. However, it might also 
be suggested that noradrenaline is present in the experimental buffer 
and that propranolol and/or phentolamine act by disturbing the 
endogenous control of glycogen metabolism, although the possible 
mechanisms for such effects are far from obvious. There are two 
possible sources of noradrenaline in the experimental buffer. Firstly, 
noradrenaline may be derived from the serum present in the culture 
medium. This seems unlikely as the cell cultures are washed prior to 
experimental incubations. Furthermore, astrocytes in vitro possess 
uptake mechanisms for noradrenaline (Kimelberg and Pelton, 1983) and 
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are capable of metabolising noradrenaline by catechol-o-methyl 
transferase and both monoamine oxidase A and B (Pelton et ai, 1981; 
Hansson and Sellstrom, 1983; Schoepp and Azzaro, 1983). 
The only other possible source of noradrenaline in the cell cultures 
is from the cells themselves. To examine this hypothesis, the action 
of reserpine on the glycogen content of astrocytes and meningeal cell 
cultures was determined. 
Reserpine is known to cause a decrease in amine levels 
in the brain (e.g. Glowinski et ai, 1966) by an inhibition of their 
uptake into neuronal storage vesicles (Shimizu and Ishii, 1964), result-
ing in subsequent enzymatic breakdown. The reserpine-induced reduction 
in monoamine neurotransmitter levels is thought to be the reason for 
the reserpine evoked accumulation of glycogen in the eNS (e.g. Mrsulja 
and Rosic, 1974) which is observed primarily in astrocytes'(Shimizu 
and Ishii, 1964; Phelps, 1972). 
When astrocytes in vitro are treated with reserpine (10 ~) it 
is seen that they contai.n subsequently more glycogen (55%) than control 
astrocyte cultures. The increase in astrocyte glycogen levels caused 
by reserpine provides evidence that the level of glycogen in astrocyte 
cultures is controlled by at least one endogenous monoamine neuro-
transmitter which may act to promote net glycogenolysis. In contrast, 
reserpine treatment of meningeal cell cultures results in a 
statistically significant decrease in glycogen content (19%). This 
suggests that the glycogen metabolism of meningeal cells in vitro may 
also be controlled by an endogenous monoamine neurotransmitter but in 
this case the endogenous control promotes net glycogen synthesis. 
However, it must be noted that the mechanism of action of reserpine on 
astrocytes is unknown. Reserpine is generally considered to act by 
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~ 
inhibiting the stor;age of monoamines in neuronal vesicles by a long-
~ 
. .' 2+ 2+ 
lasting action on veslcular Ca /Mg. ATPase (Sourkes, 1972). Such 
vesicles have not been reported to occur in cultured astrocytes. 
, 
Moreover, it has not been shown that astrocytes in vitro contain or 
synthesise neuroactive amines although dopamine S-hydroxylase, an 
enzyme which is involved in noradrenaline synthesis has been detected in 
astrocyte cultures.by immunobinding (Murphy, unpublished observations). 
In addition, it has not been shown that reserpine reduces the level of 
neuroactive amines in astrocyte or meningeal cell cultures. Some further 
evidence for the endogenous control of astrocyte glycogen stores is 
provided by the action of noradrenaline on astrocyte glycogen after 
pre-treatment with reserpine. 
Data from both control and peripheral systems suggest 
that changes in the affin'ity and/or density of adrenergic 
receptors are related to alterations in the availabiltiy of nora-
drenaline to interact with these receptors (Williams and Lefkowitz, 
1978; Bylund, 1979). Indeed reserpine is reported to increase the 
number of a 1- and S1-receptors in the brain (U'Pr~chard and Snyder, 
1978) and to cause the appearance of a 2-receptors in rat salivary 
glands (Bylund and Martinez, 1980). The observed increases in 
receptor density are matched by an increase in the potency of 
adrenergic agonists to stimulate second messengers e.g. in the brain 
reserpine treatment increases the stimulation of adenylate cyclase by 
noradrenaline and isoproterenol (Dismukes and Dalay, 1974). 
Therefore, it might be expected that if noradrenaline is released 
by cells in astrocyte cultures, then a postulated reduction in nora-
drenaline levels caused by reserpine might increase the subsequent 
noradrenaline-stimulated reduction in glycogen stores. In fact this 
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is shown to be the case, (Fig. 6.5) but the augmentation of the 
effect of noradrenaline is only slight (8%). This might suggest 
that noradrenaline is not'the endogenous amine controlling the 
level of glycogen in astrocyteJin vitro but might equally suggest 
that the concentration of noradrenaline used (50 ~M) is maximal 
for stimulation of glycogenolysis irrespective of reserpine pre-
treatment. 
Two other neuroactive amines have been suggested to affect 
(reduce) the glycogen content of rodene astrocytes in vitro, namely 
histamine and serotonin (Magistretti et al, 1983). Under 
the experimental conditions used in the current study, serotonin does 
not reduce the glycogen content of astrocyte cultures. However, 
when serotonin is added to astrocyte cultures pre-treated with 
reserpine, there is a statistically significant loss of glycogen 
(27%) compared to control. As the corresponding effect on meningeal 
cells has not been determined, it must be noted that it is not clear 
which cell type in astrocyte cultures responds to serotonin. This 
result suggests that cells in astrocyte cultures (not necessarily 
ast.t:"oc'{tes) release serotonin which in turn regulates the level of 
glycogen content. Furthermore, as serotonin does not cause net 
glycogenolysis in astrocyte cultures without pre-treatment with 
reserpine, the amount of serotonin released may be maximal for 
glycogenolysis. 
The mode of action of serotonin is even less clear than that of 
noradrenaline. As stated in Chapter 5, a stimulation of cAMP by 
serotonin in astrocytes has not been established. However, the 
responses of astrocyte cultures to serotonin with respect to cAMP 
accumulation may be affected by the presence of endogenously 
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released serotonin. Fillion et al (1981) have shown that prior exposure 
of astrocyte isolated from the horse striatum to serotonin reduces the 
subsequent stimulation of cAMP by this compound. Recent work by 
Sugino et al (1984) has shown that serotonin increases the level of 
intracellular Ca 2+ in C6 glioma. 2+ This may indicate a role for Ca 
in serotonin-evoked glycogenolysis in-astrocytes. 
In conclusion, the main aim of this study was to determine the 
effects of stimulation of three neurotransmitter receptors known to 
be present in astrocyte cultures on glycogen metabolism. 
A secondary aim was to determine the receptor type which mediates 
the noradrenergic control of glyc~gen breakdown in astrocytes. It 
has been shown that the control of glycogen metabolism in both 
astrocyte-enriched and meningeal cell cultures is complex. The results 
from experiments examining the effects of reserpine on the glycogen 
content of cell cultures provided evidence for the release of one or 
more monoamine neurotnansmitter from both types of culture. Thus any 
considerations of the mechanisms controlling glycogen metabolism in 
cell cultures are complicated by several unknown factors. For 
example, nothing is known of the possible effects of neurotransmitter 
agonists on the release of endogenous neuroactive amines. These 
considerations aside, it is apparent that the control of astrocyte 
culture glycogen content by noradrenaline is unlikely to be mediated 
by 8-receptor, cAMP-dependant effects alone as had previously been 
suggested or assumed (e.g. Opler and Makman, 1972). In addition, 
a-receptor, cAMP-independant effects are also indicated to play an 
obligatory role in such control, possibly through actions on the 
. 1 2+ . f 1nterna Ca concentrat1on 0 astrocytes. 
Irrespective of the exact mechanisms, it is clear that neuro-
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transmitters such as noradrenaline and serotonin can influence the 
metabolism of glycogen in astrocyte cultures. This is consistent 
with the suggestion that neurc·transmitters may act as signals 
from neurons and modify astrocyte glycogen metabolism. 
It has been proposed that metabolic intermediates derivecLfrom 
glycogenolysis may be utilised by neurons (Chapters 1 and 4). In 
the final chapter, the evidence for such a transfer from experiments 
performed in our laboratory and otb?~s is discussed, together with 
the future di~ections of research indicated by the results in this 
and preceeding chapters. 
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Summary 
1. The effects of various neurotransmitter agonists have been 
studied on the glycogen stores of astrocyte-enriched and meningeal 
cell cultures. Only noradrenaline evokes a statistically significant 
change (a 33% reduction) in the glycogen content of non-reserpine 
treated astrocytes. 
2. Noradrenaline but not carbachol, stimulates glycogenolysis in 
meningeal cell cultures (20%). 
3. Isoproterenol does not stimulate net glycogenolysis in astrocyte 
cultures (a 5% reduction) whereas it markedly reduces the glycogen 
content of meningeal cells (33%). 
4. Phenylephrine alone does not statistically significantly reduce 
the glycogen stores of astrocytes (13%) but the addition of yohimbine 
and phenylephrine evokes a statistically significant reduction (27%) 
which is not blocked by prazosin. 
5. Phenylephrine stimulates net glycogenolysis in meningeal cells 
(40%) which is substantially reversed by prazosin. 
6. Reserpine treatment of astrocyte cultures causes marked 
changes in the glycogen content (a 55% increase) and in the effect 
of serotonin (a 28% loss in glycogen stores). 
7. Reserpine treatment of meningeal cell cultures causes a 
reduction in glycogen content (19%). 
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CHAPTER 7 
General conclusions and future directions 
The overall aim of this thesis has been to examine the 
concept that neurons may signal to astrocytes using a variety of 
means. The work ?escribed in the preceeding chapters was performed 
in order to fulfil a series of aims. First, a model system for 
astrocytes had to be established-in_order to examine the effects 
of putative signals on astrocyte biochemistry. Chapter 2 
described attempts to separate astrocytesfrom the adult rat 
cortex/which resulted in "astrocyte" fractions unsuitable for 
further work of the type described here. Primary cultures of' 
astrocytes from the neonatal rat cortex were therefore used as 
an alternative model for astrocytes in vivo and were extensively 
characterised with respect to cell types present (Chapter 3) .• 
Secondly, a possible measure of the responsiveness of astrocytes 
to proposed neuron/astrocyte signals wo., chosen. Changes in the 
glycogen stores of astrocytes were taken as such an indicator. This 
was principally due to the known localisation of CNS glycogen to 
astrocytes in vivo and the suggested role of glycogen, at least 
in invertebrate glia, as a store of metabolic intermediates for 
neurons (Pentreath, 1982), 
Thirdly, the nature of suggested signal(s) which may be used by 
neurons to influence the behaviour of astrocytes was considered. 
Previous work had shown that astrocytes respond to changes in [K+]o' 
e.g. by changes in membrane potential, but moreover, this putative 
signal had been suggested to influence the metabolism of glycogen in 
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invertebrate glia (Pentreath, 1982). Thus the effects of changes 
+ 
in [K 10 on the glycogen stores of astrocytes were examined (Chapter 4). 
+ It was seen that increases in the [K 10 over the physiological range 
+ (2.5 - 5 mM [K 10 ) evoked reductions in the level of glycogen stores of 
+ 
astrocytes. This suggested that changes in [K 10 may represent a 
signal from neurons to astrocytes, conErolling glycogen stores. 
Glycogen in meningeal cells, used as a control for contaminating cells 
. + in astrocyte cultures, was also reduced by increases ~n [K 10 but only 
at higher concentrations (10 - 15 mM -[K+1 0) • 
Neurotransmitters were also considered as possible neuron/ 
astrocyte signals. Indeed, binding sites for three neurotransmitter 
ligands (S-adrenergic, serot~nergic and muscarinic cholinergic) 
I 
were found on membranes prepared from astrocyte cultures (Chapter 5). 
However, S-adrenergic and serotfnergic binding sites were also found 
on membranes prepared from meningeal cells. 
It is evident from experiments described in Chapter 6 that 
activation of some of the receptors found on membranes prepared from 
astrocyte and meningeal cell cultures results in complex effects on 
• 
the glycogen stores of both cell cultures. Adrenergic effects on 
astrocyte glycogen turnover may involve both a- and S-receptors, 
both on glycogen synthesis and degradation. The exact mechanism 
through which noradrenaline causes a net loss of glycogen in 
astrocyte cultures is unclear. Serotonin also reduces the level of 
glycogen in astrocyte cultures but only after reserpine treatment. 
Indeed, reserpine treatment itself causes increases in the level of 
glycogen in astrocyte cultures. These results suggest that cells in 
astrocyte cultures may release monoamine neurotransmitters, possibly 
serotonin. 
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The control of glycogen stores in meningeal cell cultures by 
neurotransmitter agonists is also complex but these cells do not 
contribute large amounts of glycogen to the pool found in astrocyte 
cultures. However, as shown by the reduction of meningeal 
cell culture glycogen content caused by reserpine, these cells may 
also release monoamine neurotransmitters. 
The results presented in this thesis indicate areas of future 
research regarding neuron/astrocyte signalling, not only concerned 
directly with the responsiveness of astrocytes to neuronal signals 
with respect to glycogen metabolism but also concerned with broader 
aspects of neuron/astrocyte interaction. There are many areas of 
interest regarding the effects of putative signals on astrocyte 
glycogen stores, some of which are noted here. 
The model proposed by Pentreath (1982) suggested that the 
glycogen stores of glial cells could be utilised by neurons as a 
reserve store of metabolic intermediates when glucose was not 
available or was insufficient to maintain neuronal activity. In the 
experiments described in Chapters 4 and 6, the glucose concentration 
of the buffer (20 mM) is favourable for net glycogen synthesis in 
astrocyte primary cultures (Cummins et al, 1983a). In this respect 
it is notable that in no case in either Chapter 4 or 6 did the 
stimulus used to evoke glycogenolysis decrease the mean astrocyte 
glycogen content below 55 - 60% of control. Therefore, it might 
be proposed that the net loss of astrocyte glycogen elicited by such 
+ 
putative neuron/astrocyte signals,such as an increase in [K Jo,would be 
more marked under conditions of reduced external glucose concentration. 
Similarly, the ability of neurotransmitters to reduce astrocyte 
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glycogen may also be increased by altering the buffer in this way. 
+ Moreover, as it is known that [K 10 is increased in vivo during 
periods of increased neuronal activity, activity which presumably 
results in the release of neurotransmitters, the effects of neuro-
transmitter agonists on the glycogen metabolism of astrocytes may 
also be more marked and more closely represent the case in vivo, 
+ 
under conditions of increased [K 10 • Similarly, it is k~own that 
2+ during periods of neuronal activity, the external Ca concentration 
falls, particularly in the region of the synapse (see Latzkovits et 
al, 1982). This reduction may in itself represent a signal from-
neurons to astrocytes and be manifest in alterations of astrocyte 
glycogen metabolism. Furthermore, the combination of various 
putative signals such as changes in [K+l
o
' neurotransmitters and 
ib h . . 1 2+ . 1 poss' le c anges 1n externa Ca concentrat10n, may resu t in 
different effects on astrocyte glycogen metabolism than the 
individual signals alone. In addition, the responses of astrocytes 
to putative neuronal signals may also vary with the astrocyte type and 
location in the brain. In order to examine these suggestions, 
astrocyte cultures from areas of the CNS other than the cerebral 
cortex might be used in experiments analogous to those performed here 
e.g. cerebellum, spinal cord or corpus callosum, where fibrous 
astrocytes predominate (Peters et ai, 1976). 
Whilst the experiments already described, and those proposed 
here for future work, are concerned with possible signalling 
mechanisms from neurons to astrocytes, they do not examine the 
effects on astrocyte biochemistry of signals derived directly from 
neurons. The use of neuron and astrocyte co-cultures and/or of 
neuronal culture conditioned medium, may therefore be useful in 
further exploration of the possibility of neuron/astrocyte signalling. 
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Such experiments might be designed to answer a variety of questions 
e.g. a) is the glycogen content of astrocyte cultures altered by 
exposure to neurons or neuron conditioned medium! b) does the ability 
of neurons to influence astrocyte glycogen stores change during 
neuronal development! c) do neurons from different parts of the eNS 
have different effects on astrocyte glycogen stores; d) are any 
possible effects of neurons on astrocyte glycogen levels altered by 
stimulation of the neurons with, for example, neurotransmitter agonists? 
These considerations could overlap to some extent with proposed 
experiments to-examine the effects of possible neuronal signals on 
different astrocyte sub-types and/or astrocytes derived from 
different areas of the brain. 
The results presented in this thesis might therefore form the 
basis of extensive further research with respect to the concept of 
neuron/astrocyte signalling, using changes in astrocyte glycogen stores 
as an indicator of astrocyte responsiveness to neuronal signals. 
In addition to these relatively specific suggestions, more broad 
areas of research are also suggested by the results reported here. 
It is evident that the predominant response of astrocyte 
glycogen to a variety of possible signals is a net reduction in stores. 
The breakdown of glycogen will initially yield glucose-I-phosphate 
(through the activity of GPa) and glucose (through the activity of the 
debranching enzyme). The fate of these products subsequent to their 
+ release from glycogen after stimulation by increase in [K 10 or, for 
example, noradrenaline, is totally unknown. However, previous studies 
have suggested that astrocytesmay release a variety of metabolic inter-
mediates for neuronal use. Both Phelps (1972) and Pentreath (1982) suggested 
that metabolic substrates may be transferred to neurons from astrocytes 
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as a source of energy for neuronal activit~although no evidence was 
provided concerning what may be released. However, Selak et al 
(1984) have recently shown that primary astrocyte cultures release 
pyruvate into the culture medtum. Moreover, these authors state 
that pyruvate is the major trophic factor in astrocyte conditioned 
medium which promoted the survival of CNS neurons in vitro. An 
-
alternative view of the possible transfer of metabolic- intermediates 
from astrocytes to neurons is given by Shank and Campbell (1984a; b) 
who suggest that the neurotransmitter pools of glutamate and 
aspartate in some neurons are replenished by the transfer of a-
ketoglutarate and/or malate derived from astrocytes. 
Thus a transfer of metabolic intermediates from astrocytes to 
neurons has been proposed to fulfil a variety of functions/although 
these are by no means mutually exclusive. However, there is very 
little published data to support the release of metabolic inter-
mediates from astrocytes and none considering the stimulation or 
inhibition of this release by putative neuron/astrocyte signals. A 
major direction of research which is indicated from the work shown in 
this thesis is therefore to determine whether astrocytes release 
metabolic intermediates such as glucose or a-keotoglutarate which 
might be used by neurons. Furthermore, the effects of putative 
signals from neurons to astrocytes on this release could also be 
determined. 
Current work in our laboratory has shown that astrocytes do 
indeed release metabolic intermediates, in particular pyruvate, 
a-keotoglutarate and lactate but not malate (Morrow, unpublished 
observations). The effects of increased [K+]o and neurotransmitter 
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agonists e.g. noradrenaline on the release of these intermediates 
are now being determined and may clarify the role of the released 
intermediates. For example, the release of lactate by astrocyte 
cultures may reflect only a predominance of anaerobic glycolysis 
in these cells, as a result of-culture conditions, and might not be 
expected to show a stimulation-evoked release. 
The results shown in Chapter 6 provide evidence that cells in 
astrocyte cultures may release compounds other than metabolic inter-
mediates, i.e. neuroactive monoamines, in particular serotonin. This 
suggestion may also represent a basis for extensive further research. 
In particular, as the evidence for the release of serotonin from 
ast~ocyte cultures is purely circumstantial( based on the increased 
effect of serotonin on the glycogen stores of astrocyte cultures) it 
must be established that monoamine transmitters are 
released from these cultures. Furthermore, it must be determined 
from which cells in astrocyte cultures such monoamines are 
re.leased. It is notable that the effects of reserpine on meningeal'cell 
culture glycogen content (a reduction) suggested that these cells 
may also release neuroactive amines. Moreover, if astrocytes do 
release monoamine neurotransmitters, it is conceivable that they may 
release other neuroactive compounds. It is also possible that .the 
release of neuroactive compounds from astrocytes may be influenced 
by neuronal signals which mayor may not affect astrocyte glycogen 
metabolism. For example, carbachol has no effect on astrocyte 
glycogen stores but markedly stimulates the turnover of inositol 
phospholipids in astrocyte cultures (Pearce et al, 1985c) which in 
turn may result in increases in the production of arachidonic acid, 
a precursor of prostaglandins (see Berridge, 1984). In this respect 
it has recently been shown in our laboratory that astrocyte cultures 
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.. 
synthesise and release prostacyclin, thromboxane and PGE
2 
(Murphy 
et al, unpublished observations). Thus1although changes in 
glycogen turnover are useful and indeed rare indicators of 
astrocyte responsiveness to neuronal signals, they may not 
represent the only feature of neuron/astrocyte interaction. 
There is a clear need to examine other aspects of astrocyte bio-
chemistry and the possib~e affects on these of signals from 
neurons. For example, the synthesis of glutamine in astrocyte 
cultures (which removes toxic ammonia) is not influenced QY the 
extracellular concentration of ammonia (Yu et al, 1984) but may 
instead be controlled by signals from active neurons, which may 
also be producing increased levels of ammonia. 
While this thesis has been concerned primarily with the concept 
of neuron to astrocyte signalling, the possibility that astrocytes 
may release neuroactive compounds, such as monoamine neurotransmitters, 
suggests that the reverse may also occur, i.e. that astrocytes 
signal to neurons. Whether this is indeed the case has yet to be 
determined. Indeed the possible functions of any signals that 
might be released from astrocytes are unknown. The neuronotrophic 
role of factors released from astrocytes is currently the subject of 
extensive research in other laboratories (cf. Rudge et al, 1985). 
Notably, serotonin, which may be released from astrocytes, has been 
proposed to have many trophic functions in the eNS such as the 
control of neuronal differentiation (see Lauder, 1983). The 
interactions between neurons and astrocytes may therefore not be a 
undirectional control of astrocyte biochemistry by neurons,but be 
a complex, and dynamic, two-way process. 
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